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Abstract 
This thesis uses transgenic approaches to alter expression of candidate mechanosensors 
in physiological and pathological conditions to determine their contribution to the 
sensations of touch and pain. 
Transient receptor potential (TRP) ion channels have highly conserved roles in sensory 
function and a great deal of evidence implicates them in the process of 
mechanotransduction. Their propensity to form heteromeric complexes as well as the 
functional redundancy they exhibit makes them difficult to study. We used animals with 
global deletion of multiple canonical TRP (TRPC) channels to minimise the effects of 
these features and found that TRPC1, TRPC3, TRPC5 and TRPC6 have a modality 
specific and combinatorial role in innocuous mechanosensation. 
Next, we looked at the role of TRPC channels and TRPA1 and TRPV1 in mechanical 
hypersensitivity in the monosodium-iodoacetate (MIA) model of Osteoarthritis (OA). 
The results show TRPC3, TRPC6 and TRPV1 do not contribute to mechanical 
hypersensitivity in OA. However, TRPA1 appears to be necessary for the full 
manifestation of OA induced mechanical hypersensitivity.  
We also investigated the role of Annexin A6 in mechanosensation and OA. The Annexin 
A6 protein binds to NMB-1, a blocker of mechanically activated currents. We found that 
it negatively regulates mechanosensation and that by overexpressing the protein using a 
gene therapy approach we are able to partially attenuate mechanical hypersensitivity in 
the MIA model of OA. 
Finally, we investigated the role of ASIC4 in pain and mechanosensation through 
generation and behavioural characterisation of a global knockout mouse. The function of 
ASIC4 is largely unknown but in vitro it regulates expression and function of other ASIC 
subunits, some of which have roles in noxious and mechanosensory processes. We found 
a role for ASIC4 in formalin induced pain and in visceral inflammation which is the first 
report of a somatosensory function for this poorly understood protein. 
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1 Introduction 
1.1 Introduction to Neurobiology  
The nervous system can be divided into its central and peripheral components. The central 
nervous system consists of the brain and spinal cord while the peripheral nervous system 
encompasses all neurons outside of this which include both sensory and motor 
components. The motor component consists of efferent neurons which can be classified 
as somatic (involved in voluntary functions) or autonomic (involved in automatic 
functions); the latter can then be subdivided into sympathetic and parasympathetic 
nervous systems which are responsible for ‘fight or flight’ functioning and maintenance 
of normal ‘at rest’ functions, respectively. The sensory component of the peripheral 
nervous system (PNS) consists of afferent neurons which convey information to the CNS. 
 
Figure 1.1 Nociceptors are a subtype of primary afferent neuron, all of which have their 
cell bodies in dorsal and trigeminal root ganglia. They express transduction channels at 
their peripheral terminals which confer sensitivity to thermal, chemical and mechanical 
stimuli. Voltage gated sodium channels and potassium channels are involved in 
propagation of the action potential to the dorsal horn of the spinal cord and voltage gated 
calcium channel allow release of neurotransmitter across the synapse. (Adapted from 
Raouf et al. (2010)).  
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The primary afferent neurons of the PNS all have their cell bodies in dorsal or trigeminal 
root ganglia; they are pseudo-unipolar neurons which project from these cell bodies to 
the periphery and to the dorsal horn of the spinal cord (Figure 1.1). These neurons have 
been classified according to a number of different features including conduction velocity, 
myelination state, diameter and presence or absence of specific molecular markers.  So 
called Aβ fibres have a large diameter and are thickly myelinated hence their rapid 
conduction velocity of around 10-30m/s. Aδ fibres are lightly myelinated while C fibres 
have no myelination and have a much smaller diameter leading to conduction velocities 
of 1.2-10m/s and <1.5m/s, respectively.  
The Aδ and C fibres described are considered ‘nociceptors’ which are defined by the 
International Association for the Study of Pain (IASP) as “a central or peripheral neuron 
of the somatosensory nervous system that is capable of encoding noxious stimuli”. Their 
differences in conduction velocity therefore give rise to separate nociceptive responses 
involving a ‘first pain’ (mediated by Aδ fibres) and a ‘second’, slower pain (mediated by 
the slower conducting C fibres). These subpopulations of sensory neurons respond to 
combinations of thermal, mechanical and chemical stimuli though their sensitivity 
profiles can be altered in pathological pain states. Aβ fibres, however, fall under the 
functional category of ‘non-nociceptors’ which are largely responsible for conveying 
light touch information. This category also includes Aα fibres which are involved in 
conveying proprioceptive information and can be extended to some Aδ and C fibres 
which respond to low threshold mechanical inputs.  
These subsets of sensory neurons also have defining patterns of projection to the spinal 
cord and terminals in the skin and muscle. While C fibres terminate largely in lamina I 
and II of the spinal cord, Aδ fibres mostly terminate in inner lamina II and in lamina III 
and Aβ fibres in deeper laminae III-V (though there is a degree of overlap)(Lallemend 
and Ernfors, 2012). Nociceptive neurons largely exhibit free endings in the periphery 
whereas non nociceptive neurons are more commonly associated with various 
mechanosensory end organs. 
As well as being distinguished by the qualities described above, primary afferent neurons 
can be classified by the molecular markers they express. Large diameter fibres which 
convey proprioceptive information are sensitive to neurotrophin-3 as they express the 
TrkC receptor. Fibres which convey low threshold mechanical inputs express TrkB and 
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Ret, sometimes with TrkC, so are sensitive to BDNF and GDNF. C fibres, on the other 
hand, can be subdivided into peptidergic and non peptidergic groups; peptidergic C fibres 
express the TrkA receptor and respond to nerve growth factor (NGF), while non-
peptidergic nociceptors bind isolectin B4 (IB4) and, during development, lose sensitivity 
to NGF and instead begin to express the Ret receptor.  
More recently, single cell RNA sequencing technology has provided a detailed molecular 
profile of sensory neurons leading to differentiation of eleven functionally distinct 
subtypes (Usoskin et al., 2015). This includes four main families of neurons (1) those 
expressing neurofilament (NF), traditionally associated with myelinated neurons (2) a 
class of peptidergic (PEP) neurons expressing Substance P, TrkA and calcitonin gene 
related peptide (CGRP), (3) non peptidergic (NP) and (4) unmyelinated neurons defined 
by the presence of tyrosine hydroxylase (TH) which express high levels of Piezo2 (Figure 
1.2). As well as correlating transcript expression with known functions, the markers of 
these cell subtypes allow prediction of roles in other sensory functions. This work builds 
on the existing knowledge of molecular expression patterns and cell size as markers of 
cell subtypes and highlights functionally relevant gene expression patterns providing a 
fundamental foundation for an increased understanding of the contribution of different 
neuronal populations to touch, pain and itch sensation. It is important to note that this 
classification was performed in tissue taken from naïve animals and therefore the 
transcriptional profile of these neuronal subsets may be altered in pathological conditions. 
In order to convey sensory information from the periphery, these neurons express 
channels which selectively transduce sensory stimuli (Figure 1.1). These include TRP 
channels, acid sensing ion channels (ASICs), ATP receptors and G protein coupled 
receptors (GPCRs) among others and can be activated by thermal, chemical or mechanical 
stimuli. Once the primary afferent neuron has been depolarised, voltage gated sodium 
channels are involved in transmission of the action potential along the length of the fibre 
(Figure 1.1). Nav1.1-1.3 and Nav1.6-1.9 are expressed in the nervous system. Voltage 
gated calcium channels are also involved and play a crucial role in the release of 
neurotransmitter vesicles across the synaptic cleft. The roles played by these channels are 
vital for normal functioning and alterations in channel function can hugely influence 
sensitivity to sensory inputs.  
 21 
 
 
Figure 1.2 Single cell RNA sequencing has identified eleven distinct subtypes of sensory 
neurons. Gene products on top are suggested markers for identification of subtypes (red, 
new markers; black, selected previously used markers). Gene products at bottom are 
examples of a distribution of gene products commonly studied in the field. Proposed 
relation of sensory subtypes to modality-specific functions or previous functional 
classification is indicated below brackets. Myel., myelinated; Unmyel., unmyelinated 
(Adapted from Usoskin et al. (2015)). 
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1.2 Mechanosensation 
Mechanosensation, the sensitivity to a mechanical stimulus, is a sensory modality which 
is vital for normal functioning. It is a feature which is highly conserved across species 
from basic organisms exhibiting sensitivity to osmotic pressure and more complex 
species requiring cutaneous sensitivity to touch and noxious mechanical stimuli for 
normal life. The importance of mechanosensitivity in humans is vast, ranging from the 
ability to manipulate objects, requiring sensitivity to tactile input, to avoiding aversive or 
noxious stimuli. Moreover, dysfunction of the mechanisms involved in 
mechanosensitivity can lead to touch hypersensitivity which is seen in many instances of 
inflammatory and neuropathic, chronic pain conditions. 
1.2.1 Primary afferent neurons and mechanosensory end organs 
Primary afferent neurons are involved in conveying information regarding mechanical 
stimuli which are transduced by mechanosensory end organs at their peripheral terminals. 
Different classes of end organs are innervated by different combinations of primary 
afferent neuron and work to encode specific qualities of mechanosensory input.  
Mechanosensory end organs involved in cutaneous touch are all involved in detection of 
different qualities of a mechanical stimulus. Meissner’s corpuscles, found in the glabrous 
skin, are responsive to the deformation and motion of skin and are innervated by rapidly 
adapting type I (RAII) Aβ low threshold mechanoreceptors (LTMRs). Pacinian 
corpuscles, located deeper in the dermis, are innervated by RA type II (RAII) Aβ LTMRs 
and are sensitive to vibrations. Slowly adapting type I (SAI) Aβ LTMRs are involved in 
detection of indentation depth via Merkel endings in glabrous skin. These endings consist 
of groups of cells which are all linked to the same Aβ fibre and are specialised for their 
function through their high spatial resolution. Importantly it has recently been shown that 
Merkel cells themselves, and not just the fibres which innervate them, are sites of 
mechanotransduction (Poole et al., 2014). Skin stretch is perceived via the activity of 
slowly adapting type II (SAII) Aβ LTMRs which associate with Ruffini endings. Free 
nerve endings in the epidermis from Aδ and C fibres are responsible for the detection of 
noxious  stimuli however the molecularly distinct C-LTMRs (Li et al., 2011)are also 
implicated in the sensation of pleasant touch, showing intense firing in response to brush 
strokes at a velocity considered to be pleasant (Loken et al., 2009) as well as noxious 
mechanosensation and mechanical hyperalgesia (Seal et al., 2009). 
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Figure 1.3 Mechanosensory end organs are differentially innervated and respond to 
distinct components of mechanical stimuli (Taken from Abraira and Ginty (2013)). 
 
These end organs are largely associated with mechanosensitivity in glabrous skin. The 
hair follicles found in hairy skin form a separate, complex class of mechanosensory end 
organ. Li et al. (2011) performed a comprehensive investigation into the peripheral and 
central LTMRs innervating the hairy skin of mice.  The most abundant hair type (~76% 
trunk hairs) found in mice are the fine Zigzag hairs while the shorter Auchene hairs make 
up ~23% of the hairs on the trunk. Guard hairs are the least abundant and longest hair 
type, making up a mere ~1% of the hairs on the trunk.  
C-LTMRs and Aδ-LTMRs associate with Zigzag and Auchene hairs, often forming 
interdigitated (or interlocking) innervation patterns in a single hair follicle. Aβ-LTMRs 
are separated into SAI Aβ LTMRs, which innervate Merkel cells which are in turn linked 
to Guard hairs and RAI Aβ LTMRs which associate with Guard and Auchene hairs 
(Figure 1.3). This complex pattern of sensory innervation of hair follicles led Li et al. 
(2011) to suggest that each of the three hair types are distinct mechanosensory end organs 
which form peripheral LTMR units consisting of a central Guard hair surrounded by ~20 
Auchene hairs and ~80 zigzag hairs. This, they argue, means individual qualities of a 
mechanical stimulus involve different combinations of hair follicles which in turn will 
lead to unique combinations of activity in LTMRs. This is furthered by their finding that 
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columns of LTMR terminals occur in the dorsal horn and that these columns are linked 
to innervation of the same or adjacent LTMR units in the periphery (Figure 1.4). This 
complex and integrated suggestion for the expression patterns of LTMRs provides a 
detailed insight into the complexities surrounding cutaneous mechanosensory 
innervation. 
 
 
Figure 1.4 LTMRs are arranged in unique combinations around each of the three types of 
hair follicles. Peripheral LTMR units project to the dorsal horn where they form columns. 
Each column is made up of projections from the same or adjacent peripheral LTMR units 
(Taken from Li et al. (2011)).  
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1.2.2 The electrophysiological properties of mechanosensitive fibres 
Mechanosensory neurons exhibit characteristic electrophysiological properties. The first 
whole cell patch clamp recordings of rat DRG neurons in culture showed inward cationic 
currents in response to mechanical stimuli (McCarter et al., 1999). It was subsequently 
determined, through the use of mechano-clamp electrophysiology, that these 
mechanically induced currents could be classified into three groups, rapidly adapting 
(RA), intermediately adapting (IA) and slowly adapting (SA), which could be detected in 
the soma and neurites of sensory neurons in vitro (Drew et al., 2002, Hu and Lewin, 2006) 
(Figure 1.5) and whose defining decay kinetics are distinct. RA decline in <20ms whereas 
SA currents are sustained for around 100ms. 
Fibres responding to low threshold stimuli exhibit rapidly adapting currents while slowly 
and intermediately adapting currents, as well as some rapidly adapting currents, are 
associated with neurons expressing nociceptive markers (Drew et al., 2004). Indeed, 
NMB-1, a blocker of SA and IA currents selectively inhibits behavioural responses to 
high threshold, noxious, mechanical stimuli (Drew et al., 2007). 
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Figure 1.5 Electrophysiological properties of mechanosensory fibres. Slowly and 
intermediately adapting currents are associated with fibres which have a high threshold 
and respond to noxious mechanical inputs. Responses to light touch are more commonly 
associated with rapidly adapting currents, though there is some overlap in these current 
response profiles (Modified from Wood and Eijkelkamp (2012)).  
 27 
 
1.2.3 Potential mechanisms of mechanotransduction 
There is much debate surrounding the mechanisms by which mechanotransduction 
channels may be activated. Direct activation may occur whereby ion channels respond to 
distortion of, or changes in tension of, the membrane. Alternatively, the activation may 
be mediated by tethering molecules linking accessory proteins to the membrane or may 
involve an indirect mechanism involving second messenger pathways (Figure 1.6). 
There is much support for a direct gating mechanism in bacterial mechanosensitive 
channels, MscL and MscS (Kung, 2005) and the stretch activated channel (SAC) in 
Xenopus oocytes which has a response latency of <5ms (Hamill and McBride, 1992). 
Indeed, for a channel to be directly gated by mechanical stimuli the latency from 
stimulation to activation would be short. For example, it has been shown that currents 
induced in cultured sensory neurons are activated 0.4-0.8ms after application of a 
mechanical stimulus (Hu and Lewin, 2006). This latency is likely insufficient for a second 
messenger mediated response and thus supports the idea of a directly activated channel. 
In the hair cells of the inner ear, it is widely supported that mechanotransduction is 
mediated by a tethering mechanism. Although it has been shown that tip links are 
necessary for mechanotransduction (Assad et al., 1991) it is unclear if they are attached 
to the channel and mediate opening in this way or if displacement or motion of the 
surrounding membrane is involved (Kung, 2005). NMB-1, a blocker of SA and IA 
currents, is able to reduce the uptake of FM1-43 dye into the hair cells of the cochlear. 
Since this dye is known to be taken up through mechanosensitive channels, it is argued 
that the mechanisms involved in cutaneous and hair cell mechanosensation have common 
features (Drew et al., 2007). As such, the potential for a tethering mechanism in cutaneous 
touch has also been investigated and it was found that treatment of cultured sensory 
neurons with proteases that ablate an extracellular protein tether led to abolition of RA 
mechanosensory currents (Hu et al., 2010). 
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Figure 1.6 Potential mechanisms of mechanotransduction include direct activation of the 
channel by deformation of the cell membrane, second messenger pathways, interaction 
of the channel with a tethering protein (Modified from Eijkelkamp et al. (2013b)).  
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1.2.4 Mechanotransduction in the inner ear 
Hair cells in the Organ of corti are responsible for mechanotransduction that allows the 
detection of sound (Figure 1.7). They are present on the basilar membrane with one row 
of inner hair cells and three rows of outer hair cells arranged in a gradient whereby 
responses to high frequency stimuli occur at the basal end of the basilar membrane and 
to low frequency stimuli at the apical end. Oscillations in air pressure created at the 
tympanic membrane are converted to oscillations in fluid pressure in the cochlea that 
cause vibration of the basilar membrane. The outer hair cells are connected to the tectorial 
membrane which remains static when the basilar membrane vibrates. The resulting 
shearing movement deflects hair cell bundles on the inner hair cells as they are not 
connected to the tectorial membrane. Each hair cell projects a bundle of stereocilia which 
are arranged in rows of increasing height with the tallest row being made up of 
kinocilium. These stereocilia contain tip links which connect ion channels and which are 
displaced, upon movement of the bundle, towards the tallest stereocilia in the bundle. The 
tension put on the proteinaceous tip links causes ion channels to open and the auditory 
input is transduced into an electrical impulse that can be propagated along the auditory 
nerve.  
Hair cells are also a key component of the vestibular system which is made up of three 
semi-circular canals and two otolith organs which, along with the cochlea, make up the 
inner ear. Hair cell mechanotransduction in the vestibular system is similar to that in the 
auditory system whereby deflection of projecting stereociliary bundles by fluid 
movement leads to opening of mechanosensitive ion channels.  
Although the process of inner ear mechanotransduction is fairly well understood (Phillips 
et al., 2008, Schwander et al., 2010), the identity of the channel responsible has remained 
a mystery. However it is considered that, once elucidated, a mechanotransduction channel 
in the cochlea may also be involved in cutaneous mechanotransduction. 
 30 
 
 
Figure 1.7 The outer, middle and inner ear make up the auditory sense organ. The cochlea 
is located in the inner ear. The Organ of corti contains the basilar membrane which is 
caused to vibrate by fluid pressure oscillations leading to displacement of stereociliary 
bundle located on the hair cells. (Adapted from Schwander et al. (2010)). 
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1.2.5 Mechanotransduction candidates 
The search for mechanotransduction channels has led to the emergence of a number of 
favourable candidate groups.  
The family of Piezo proteins 1 and 2, previously known as Fam38a and Fam38b, are 
critical in mechanotransduction. Mechanically activated currents in a mouse 
neuroblastoma cell line were found to be dependent on Piezo1 expression; the protein 
was also able to confer mechanical sensitivity to a number of other cells lines (Coste et 
al., 2010). Similarly, expression of Piezo2 in cultured cells robustly induced a 
mechanically activated RA current (Figure 1.8) while knockdown of Piezo2 in cultured 
DRG neurons reduced these kinetically distinct currents (Coste et al., 2010). Piezo2 has 
been shown to contribute to the pore of mechanically sensitive channels (Coste, 2012). 
Piezo2 is expressed in sensory neurons and is the major transducer of touch stimuli. 
Knockdown of Piezo2 results in increased threshold to touch stimuli and reduces 
allodynia induced by cAMP and in neuropathic pain conditions (Eijkelkamp et al., 
2013a). In addition to expression in sensory neurons, Piezo2 is expressed in Merkel cells. 
Use of an inducible Cre recombinase driven by the Advillin promoter deleted Piezo2 from 
both of these cell types and caused a dramatic reduction of behavioural responses to a 
variety of innocuous mechanical stimuli (Ranade et al., 2014). Interestingly, knocking out 
Piezo2 from Merkel cells alone produced only a mild light touch impairment though 
cultured Merkel cells lost their mechanosensitivity (Maksimovic et al., 2014, Woo et al., 
2014). Piezo2 deletion from sensory neurons caused a significant reduction in the 
proportion of cells expressing RA currents and an increase in mechanically insensitive 
Aβ fibres (Ranade et al., 2014). Conditional Piezo2 knockout mice also showed a loss of 
velocity sensitivity in the RA fibres which innervate hair suggesting Piezo2 mediates 
mechanosensitivity in hairy as well as glabrous skin. 
Identification of Piezo2 has produced remarkable progress in the understanding of 
mechanotransduction. However, there are likely to be other proteins involved in 
responses to mechanical stimuli; for example the threshold for Piezo2 activation can be 
modulated by other proteins (Poole et al., 2014) while mechanisms responsible for 
production of the SA mechanically activated current are incompletely understood. 
Candidate proteins for mechanotransduction complexes have included the TRP family of 
ion channels as well as ASICs, both of which are involved in mechanosensory processing 
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in other systems, such as cardiovascular and renal mechanosensation, and have 
mechanosensory roles in other species. 
 
 
 
Figure 1.8 Example traces of mechanically activated, RA currents produced by Piezo2 
when transfected into Neuro2A and HEK293T cells (Modified from Coste et al. (2010)). 
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1.3 Pain and nociception 
The International Association for the Study of Pain defines pain as ‘an unpleasant sensory 
and emotional experience associated with actual or potential tissue damage, or described 
in terms of such damage’. Pain is a complex phenomenon which is usually the result of 
tissue damage caused by a noxious stimulus and as such has a protective function as well 
as being important for allowing healing of damaged tissue. Nociception is defined as ‘the 
neural process of encoding noxious stimuli’ and while it leads to activation of neurons, it 
does not necessarily result in pain sensation.  
Noxious stimuli can be mechanical, thermal or chemical, and they activate nociceptors, a 
type of sensory afferent neuron whose cell bodies lie in the dorsal and trigeminal root 
ganglia. As discussed in section 1.1, the two main categories of nociceptor are commonly 
known as Aδ and C fibres which are thinly myelinated and unmyelinated, respectively. 
As a result of their myelination state and their larger diameter, Aδ fibres have a greater 
conduction velocity than C fibres and are responsible for the so-called first pain, a 
pinprick sensation which precedes the burning sensation, and the ‘second pain’ mediated 
by small-diameter unmyelinated C fibres.   
Although pain usually arises from a peripheral stimulus it can occur without noxious input 
or outlast the initial insult, becoming chronic at which point it has no physiological or 
protective function. Indeed, human microneurography studies have demonstrated that the 
relationship between noxious stimulation and pain perception is not linear and that in 
pathological conditions this relationship can be altered (Torebjork et al., 1984, Torebjork 
et al., 1992). A large-scale survey estimated that approximately 19 % of people in Europe 
suffer from chronic pain (Breivik et al., 2006) making it a huge clinical problem; the 
comorbidities associated with chronic pain are numerous and debilitating, including 
depression, anxiety and insomnia. Chronic pain is a problem in a huge number of 
prevalent conditions including arthritis, fibromyalgia, irritable bowel syndrome, diabetic 
or herpetic neuropathy and cancer or chemotherapeutic drug induced pain. The processes 
responsible for pain in these inflammatory and neuropathic conditions have been shown 
to be mechanistically different (for example (Abrahamsen et al., 2008, Minett et al., 
2014b, Lolignier et al., 2015a)) while the mechanisms for some are incompletely 
understood. Moreover the mechanisms underlying the transition from acute to chronic 
pain are poorly understood and reasons why persistent acute pain does not always become 
chronic is also unclear (Reichling and Levine, 2009). 
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Current analgesic therapies include opioids and nonsteroidal anti-inflammatory drugs 
(NSAIDs) which are often successful as acute pain therapies. However, a number of 
issues are associated with these drug classes. For example, the NNT (number needed to 
treat) values assigned to analgesics identify the number of people who need to take a drug 
for one person to achieve 50% pain relief; for morphine this value is three (McQuay et 
al., 1999) indicating the limited efficacy of one of the most commonly used analgesics. 
In addition, long term analgesic use in chronic pain conditions is frequently associated 
with undesirable side effects. Long term treatment with NSAIDs are associated with 
adverse gastrointestinal (Wolfe et al., 1999), cardiovascular and renal (Bleumink et al., 
2003) issues while use of opioids can induce side effects including nausea, pruritus and 
opioid induced hyperalgesia as well as causing tolerance and dependence (Moore and 
McQuay, 2005) while overdosing can cause respiratory depression and ultimately death 
meaning that they are not favourable for long term use. The use of selective serotonin and 
noradrenaline reuptake inhibitor and tricyclic antidepressant drugs have also proved 
clinically useful, though they too produce undesirable side effects. 
The search for new, improved analgesics has not been without success. The development 
of the anticonvulsant drug, gabapentin was a huge development in the treatment of 
neuropathic pain; it is believed to act through binding of α2-δ subunits of voltage gated 
calcium channels (Field et al., 2006). Monoclonal antibodies designed as analgesics show 
improved target specificity, for example binding to NGF (Lane et al., 2010). However 
many other blockers of key pain mediators are less effective than preclinical studies 
predicted indicating other mechanisms are likely to contribute to the analgesia produced 
by knockout studies. A recent development which may go some way to explaining this 
discrepancy is the finding that loss of function of VGSC, Nav1.7 produces a concurrent 
upregulation of the endogenous opioid precursor, preproenkephalin (Minett et al., In 
Press). Loss of function mutations in Nav1.7 produce robust pain insensitivity in humans 
and mice (discussed further in section 1.6) but pharmacological blockers of Nav1.7 are 
surprisingly ineffective analgesics, for example Protoxin II which alters action potential 
firing without having any analgesic effect on acute nociception (Schmalhofer et al., 2008). 
Minett et al. (In Press) suggest that in addition to its role in electrical signalling, Nav1.7 
may have other functions and as such, the fact that total loss of function of Nav1.7 in mice 
leads to an increase in endogenous opioid signalling is something pharmacological 
inhibitors are unable to recapitulate. Newly developed analgesics demonstrate the benefit 
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of identifying novel analgesic targets to act where existing therapeutics have shown 
limited success. Similarly, the development of new, more effective analgesics clearly 
requires a more complete understanding of the mechanisms underlying pain and 
nociception in order to prove effective in the clinic. 
  
 36 
 
1.3.1 Inflammatory and neuropathic pain 
In states of chronic inflammatory and neuropathic pain, sensitivity to sensory inputs is 
altered as a result of peripheral and central sensitisation. This manifests as enhanced 
sensitivity to noxious stimuli (hyperalgesia), pain that occurs in response to a normally 
non noxious stimulus (allodynia) and in the case of neuropathic insults, spontaneous pain 
(Figure 1.9) (Sandkuhler, 2009). 
 
 
Figure 1.9 In pathological pain states, there is a shift in pain thresholds. Hyperalgesia is 
increased pain sensitivity which can occur from a decrease in threshold or increased 
response to a suprathreshold stimulus. Allodynia is pain which occurs in response to a 
non-noxious stimulus normally by a stimulus which is incapable of activating nociceptors 
(Modified from Sandkuhler (2009)). 
Inflammation induces thermal and mechanical hyperalgesia that can occur at the site of 
inflammation (primary hyperalgesia) or at distal sites (secondary hyperalgesia). 
Characteristic features of neuropathic pain include tactile allodynia, spontaneous pain, 
sensations such as pins and needles, deficits in proprioceptive feedback as well as 
numbness all at sites innervated by the injured or dysfunctional nerve. Animal models 
aim to recapitulate these symptoms. Rodent models of inflammation include 
subcutaneous injection of Freund’s Adjuvant and carrageenan which produce thermal and 
mechanical hyperalgesia while neuropathic pain is commonly modelled in rodents 
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through surgical lesions (Figure 1.10), or using chemically induced disease models. For 
example, the chemotherapeutic agent oxaliplatin causes neurotoxicity leading to 
mechanical and cold allodynia, while streptozocin is used to induce diabetic neuropathy. 
These rodent models have provided indispensable insight into the differential 
mechanisms underlying different types of neuropathic and inflammatory pain, some of 
which are examined below. 
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Figure 1.10 Surgical models of neuropathic pain. 1. SNL; spinal nerve ligation; tight 
ligation of L5 and L5 spinal nerves.  2. PSNL; partial sciatic nerve ligation; tight ligation 
of one third – one half of the sciatic nerve. 3. SNT; sciatic nerve transection; complete 
transection of sciatic nerve. 4. CCI; chronic constriction injury; 3-4 loose ligatures 
around sciatic nerve. 5. SNI; spared nerve injury; tibial and common peroneal branches 
of the sciatic nerve are ligated and transected distal to its trifurcation. (Adapted from 
Sexton et al. (2014)). 
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Inflammation is associated with pain, redness, heat and swelling. These symptoms are the 
result of tissue damage which causes accumulation of pro-inflammatory mediators and 
endogenous factors which are released by neurons and surrounding non neuronal cells 
into the affected area. Pro inflammatory mediators include peptides such as substance P, 
neurotransmitters, eicosanoids, cytokines and neurotrophins and form what is known as 
an ‘inflammatory soup’. These pro-algesic agents mediate their effects through direct 
binding to cell surface receptors or through activation of second messenger cascades 
leading to an alteration in the sensitivity profile of cells in the affected area (Figure 1.11). 
For example, the neurotrophin NGF binds the TrkA receptor activating signalling 
pathways which induce modifications of proteins at the peripheral terminals of 
nociceptors causing them to become sensitised, for example through phosphorylation of 
TRPV1 (Chuang et al., 2001). NGF can also be retrogradely transported to the cell soma 
where it causes upregulation of transcription of pro-nociceptive factors, such as TRPV1 
and substance P. NGF also activates non neuronal cells such as mast cells which release 
further pro-inflammatory cytokines such as prostaglandins, bradykinin, ATP and 5-HT 
which adds to the inflammatory milieu and potentiates the inflammatory response. The 
analgesic action of non-steroidal anti-inflammatory drugs (NSAIDs) is achieved by 
inhibiting cyclooxygenase enzymes (COX-1 and COX2) to prevent synthesis of 
prostaglandins though a ceiling effect is often problematic as many other pro-algesic 
agents remain.  
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Figure 1.11 Pro-inflammatory mediators are released in the periphery by neuronal and 
non-neuronal cells following tissue damage. These pro-algesic agents act on cell surface 
receptors and lead to neuronal sensitisation (Taken from Basbaum et al. (2009). 
 
 
In neuropathic pain conditions, damage to peripheral neurons leads to a loss of trophic 
support to the damaged neuron, which is unable to transport neurotrophins to the cell 
soma where they would normally have neuroprotective functions. Impaired neuronal 
trafficking can also lead to accumulation of ion channels in the damaged neuron that may 
cause ectopic firing activity. Degeneration of damaged neurons leads to release of 
compounds such as neurotrophins, neurotransmitters and inflammatory mediators into the 
surrounding area which sensitises intact neurons (Li et al., 2000). Altered gene expression 
is also found in both neuronal and non-neuronal cells in the peripheral and central nervous 
systems. Indeed, sensitisation of peripheral neurons can occur through changes in both 
transduction and transmission processes. For example, upregulation of expression of 
transduction channels such as TRP channels and ASICs are observed, while Piezo2, a 
primary mechanotransduction channel is sensitised in a model of neuropathic pain 
(Eijkelkamp et al., 2013a). Similarly, voltage gated ion channels which contribute to 
action potential transmission show changes in expression levels as well as aberrant firing 
activity (Figure 1.6).  
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Under these pathological conditions, the response profile of peripheral neurons changes. 
Small diameter, unmyelinated C fibres become sensitised and some subsets of these 
neurons which are normally sensitive to just thermal stimuli can become polymodal. 
Microneurographic recordings in humans have demonstrated the role for a subset of C 
fibres, known as mechanically insensitive afferents (MIAs), in the maintenance of chronic 
pain (Orstavik et al., 2003, Orstavik et al., 2006). These MIAs have been shown to 
develop mechanical sensitivity in conditions such as erythromelalgia and diabetic 
neuropathy and therefore contribute to altered sensitivity in chronic pain conditions. 
Furthermore, a population of C-LTMRs (which appear to be implicated in normal noxious 
mechanical responses too) have been found to be responsible for the maintenance of 
mechanical hypersensitivity in inflammatory and neuropathic pain states (Seal et al., 
2009). 
Although many of the molecular and downstream intracellular mechanisms underlying 
peripheral sensitisation in mechanical hyperalgesia and mechanical allodynia are thought 
to share some features, distinct differences have also been observed (Lolignier et al., 
2015b). For example, cAMP is implicated in nerve injury induced mechanical allodynia 
and inflammatory hyperalgesia. Similarly, PKC activity is implicated in peripheral 
sensitisation in both inflammatory and neuropathic pain, as well as the additional ‘primed 
state’ where nociceptors exhibit normal, basal nociceptive thresholds but show increased 
sensitivity to agents such as inflammatory mediators (Aley et al., 2000, Parada et al., 
2003). However, PKA, which is produced downstream of cAMP does not appear to be 
necessary for the development of allodynia although evidence suggests it contributes to 
mechanical hyperalgesia (Hucho and Levine, 2007).  
Central sensitisation is typically characterised by increased responses to suprathreshold 
stimuli in both areas of tissue damage and surrounding areas, increased spontaneous 
activity and reduced thresholds for activation of dorsal horn neurons of the spinal cord 
and expansion of receptive fields (Latremoliere and Woolf, 2009). This contributes to 
hypersensitivity in a number of ways through mechanisms involving neuronal 
sensitisation and neuronal disinhibition as well as changes mediated by non-neuronal 
cells. The barrage of peripheral neuron input into the spinal cord which occurs after injury 
is considered to be a trigger for further central changes which potentiate hypersensitivity 
(Han et al., 2000). The increase in neuronal activity leads to an increase in 
neurotransmitter release at the central terminals of primary afferents. Under normal 
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conditions, depolarisation of second order neurons in the spinal cord occurs through 
activation of postsynaptic glutamate receptors such as the AMPA receptor. However, in 
the presence of increased neurotransmitter, sufficient levels of depolarisation can be 
reached to activate the NMDA receptor which is normally blocked by the presence of an 
Mg2+ ion. NMDA receptor activity leads to potentiation of the activity in second order 
neurons when depolarised by subsequent afferent input as well as through increased 
intracellular Ca2+ levels which activate a number of signalling cascades further 
potentiating activity of spinal projection neurons. Altered activity and signalling in 
inhibitory interneurons in the spinal cord can also contribute to the maintenance of 
persistent pain. For example, activity of TRPV1 in a set of GABAergic interneurons can 
cause long term depression (LTD) of these interneurons which leads to central 
sensitisation through disinhibition of ascending spinothalamic tract projections (Kim et 
al., 2012b). This ultimately leads to neuropathic pain induced mechanical allodynia which 
is independent of peripherally expressed TRPV1 function. A loss of GABAergic 
transmission has also been reported after nerve injury (Moore et al., 2002). Facilitation 
of GABAA activity in spinal cord interneurons can attenuate inflammatory and 
neuropathic hypersensitivity (Knabl et al., 2008) while prostaglandins have been shown 
to reduce the inhibitory activity of glycinergic interneurons, the net effect of which is 
disinhibition of spinal projection neurons (Ahmadi et al., 2002, Harvey et al., 2004).  
As well as changes in neuronal properties, other non-neuronal cells contribute to 
peripheral and central sensitisation. For example, microglia in the CNS proliferate after 
nerve damage and surround the central terminals of damaged primary afferent neurons 
and display changes in surface receptor expression and expression of inflammatory 
mediators. Indeed, activation of microglial ATP receptors has been shown to be critical 
for the development and maintenance of neuropathic pain. Activation of the microglial 
ATP receptor, P2X4 leads to release of factors such as BDNF which contribute to a 
depolarising shift such that the activity of GABAergic neurons produces depolarising, 
rather than hyperpolarising responses in second order neurons (Tsuda et al., 2003, Coull 
et al., 2005, Trang et al., 2009, Beggs et al., 2012). Altogether, these mechanisms 
potentiate the activity of ascending signalling pathways and contribute to the maintenance 
of persistent pain. 
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1.3.2 Central pain pathways 
Peripheral afferent neurons terminate in the dorsal horn of the spinal cord where they 
synapse onto second order spinal neurons. Peripheral nociceptive neurons primarily 
project to the superficial laminae (I and II) of the dorsal horn (Todd et al., 2002) though 
the terminals of muscle and visceral afferents show more sparse terminations through 
superficial and deeper laminae (Sugiura et al., 1989) while deep dorsal horn neurons 
mainly receive input from non-nociceptive afferents. Spinal neurons include nociceptive 
specific neurons which are activated by noxious stimulus intensities and wide dynamic 
range (WDR) neurons which respond to both noxious and non-noxious inputs. These 
spinal neurons form ascending pathways such as the spinothalamic tract which project to 
brainstem nuclei, thalamocortical structures and onto to the cortex where pain perceptions 
are integrated (Figure 1.12). Projection neurons play a critical role in pathological pain 
states. For example, a subset of neurons which project from lamina I and express the NK1 
receptor, which binds substance P, develop in early postnatal stages (Man et al., 2012) 
and are critical for the presence of thermal and mechanical hypersensitivity in persistent 
pain states through activation of descending pathways (Nichols et al., 1999, Suzuki et al., 
2002). Indeed, descending pathways which arise from structures such as the 
periaqueductal grey (PAG), the rostral anterior cingulate cortex (rACC) and the 
rostroventral medulla (RVM) project to the spinal cord can both facilitate and inhibit 
spinal nociceptive processing (Figure 1.12). Descending serotonergic pathways which 
synapse onto spinal 5-HT3, and some other 5-HT, receptors are thought to primarily 
promote pain (Svensson et al., 2006, Geranton et al., 2008) though other 5-HT 
mechanisms in the spinal cord contribute to pain inhibition (Ossipov et al., 2010, Song et 
al., 2011). Descending noradrenergic pathways are primarily inhibitory and act on α2 
adrenoreceptors in the dorsal horn (Ossipov et al., 2010) while dopaminergic pathways 
can be both pro and anti-nociceptive and can contribute to the transition to chronic pain 
through activation of D1/D5 receptors (Kim et al., 2015). The balance of descending spinal 
pathways is therefore critical for normal pain processing while the plasticity of these 
pathways is hugely influential on the processing of pathological pain. 
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Figure 1.12 Central pain circuitry. Nociceptive inputs to the dorsal horn of the spinal cord 
synapse onto second order spinal neurons which project to corticothalamic structures as 
well as nuclei such as the RVM and PAG. Descending pathways also project to, and arise 
from, these nuclei and can both facilitate and inhibit pain signalling. (Taken from Ossipov 
et al. (2010)). 
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1.4 Transient Receptor Potential (TRP) channels 
The transient receptor potential family of ion channels is a structurally homologous 
superfamily of cation channels which are highly conserved across many species. TRP 
channels can be subdivided into families TRPA, C, M, ML, N, P and V according to their 
amino acid sequences and are implicated in a variety of sensory functions. The first TRP 
channel was identified in Drosophila where a mutant form of the channel responded 
transiently to a light stimulus resulting in a decreased Ca2+ influx (Hardie and Minke, 
1992). Subsequently identified TRP channels have also been associated with roles in 
many sensory functions. 
TRP channels consist of six transmembrane domains which form tetramers around a 
nonselective cation pore (Figure 1.13). TRPs are all non-selective cation channels, though 
some exhibit selectivity for Ca2+ over Na+. Each family of channels have distinguishing 
patterns of domains expressed at the intracellular C and N terminals and display great 
diversity in expression, activation and function. TRP channels are believed to show a 
huge amount of functional redundancy which may be explained by their role in processes 
vital for survival.  
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Figure 1.13 TRP channels consist of six transmembrane domains, however other defining 
features at the N and C termini vary between subfamilies (Adapted from Eijkelkamp et 
al. (2013))  
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1.4.1 TRP channel expression in sensory neurons 
Many TRP channels are expressed in DRG neurons and are significant contributors to the 
functional properties of different neuronal populations. TRPV1 serves a marker for a 
subset of small diameter, unmyelinated fibres which express the TrkA receptor and is first 
detected at E12.5 (Hjerling-Leffler et al., 2007). TRPA1 and TRPM8 expression occurs 
later as these classes of neurons derive from the TRPV1 positive population. TRPA1 is 
expressed in a portion of TRPV1 positive neurons while TRPM8 is only found in 
capsaicin insensitive neurons which are neither peptidergic nor IB4 positive. 
Interestingly, it is more highly expressed in the trigeminal ganglia than the DRG 
(McKemy et al., 2002). TRPV3 is coexpressed with TRPV1 though TRPV2 overlaps less 
with TRPV1, predominantly being expressed in medium and large diameter neurons 
(Caterina et al., 1999, Smith et al., 2002). TRPV4 is expressed in small diameter fibres 
and is found at high levels in the trigeminal ganglia (Liedtke et al., 2000, Facer et al., 
2007) while TRPP2 transcript is the most highly expressed of the TRP channels at all 
levels of sensory ganglia (Vandewauw et al., 2013). All of the functional TRPC channels 
are found in primary sensory neurons (Table 1.1) and are some of the most highly 
expressed in the mammalian nervous system (Elg et al., 2007). TRPC1 is expressed in 
myelinated and unmyelinated, IB4 negative fibres, in particular large diameter neurons. 
TRPC3 is one of the most abundantly expressed TRPC channels in the cell bodies of 
primary afferent neurons and is found in most TRPV1 negative cells (Elg et al., 2007, 
Quick et al., 2012). In addition, TRPC5 has been found to be localised to small and 
medium diameter sensory neurons in the periphery (Zimmermann et al., 2011) while 
TRPC6 is expressed in most DRG neurons (Quick et al., 2012). 
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TRP 
channel 
Sensory neuron expression References 
TRPA1 Peptidergic small- and medium-diameter 
Neurons 
(Story et al., 2003, Vandewauw et al., 
2013) 
TRPC1 
TRPC3 
TRPC4 
TRPC5 
TRPC6 
TRPC7 
Predominantly large diameter neurons 
Predominantly small diameter neurons 
Nociceptors and non-nociceptors 
Small diameter TG and DRG neurons  
Most DRG neurons 
(Staaf et al., 2009a) 
(Quick et al., 2012) 
(Buniel et al., 2003) 
(Gomis et al., 2008) 
(Quick et al., 2012) 
(Elg et al., 2007) 
TRPM2 
TRPM3 
TRPM4 
TRPM6 
TRPM7 
TRPM8 
 
 
     Rostrocaudal distribution in sensory neurons 
 
 
Small diameter non-peptidergic neurons; higher 
expression in TG than DRG 
 
 
      (Vandewauw et al., 2013) 
 
 
(McKemy et al., 2002, Peier et al., 
2002a) 
TRPML1 Rostrocaudal distribution in sensory neurons (Vandewauw et al., 2013) 
TRPP2 Rostrocaudal distribution in sensory neurons (Vandewauw et al., 2013) 
TRPV1 
TRPV2 
TRPV3 
TRPV4 
Peptidergic small and medium-diameter  neurons  
Medium and small diameter neurons 
Peptidergic small and medium-diameter  neurons  
TG and small and medium diameter neurons  
(Caterina et al., 1997) 
(Caterina et al., 1999) 
(Smith et al., 2002) 
(Liedtke et al., 2000, Facer et al., 2007) 
Table 1.1 TRP channel expression in sensory neurons. 
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1.4.2 TRP channel structure and heteromer formation 
Recently, the atomic structure of TRPV1 was examined with cryo-electron microscopy. 
Liao et al. (2013) and Cao et al. (2013) showed that the structure of TRPV1 is comparable 
to that of voltage gated ion channels. The channel is arranged as a tetrameric structure 
around a pore which is formed by transmembrane segments S5 and S6 and a pore loop 
while the voltage sensing residues are replaced by aromatic residues which are proposed 
to impart stability onto the ion channel (Liao et al., 2013). They found that the TRP 
domain is positioned to allow interaction with the S4-S5 transmembrane domains and a 
helix located near to the S1 transmembrane domains and suggest this allows modulation 
of conformation of the ion channel pore (Liao et al., 2013). In contrast to voltage gated 
ion channels, TRPV1 is believed to exhibit a dual gating system; it is proposed that a pore 
helix mediates this complex mechanism by allowing coupling between these gates (Cao 
et al., 2013). This development in the understanding of TRPV1 channel structure will 
likely aid understanding of the structure and mechanisms of activation of other TRP 
channel families. 
Despite the atomic structure of TRP channels only recently being confirmed, it has been 
known for some time that these channels can function in homomeric and heteromeric 
complexes. Indeed, the tetrameric structure of TRP channels allows different 
combinations of proteins to form around a pore and their structural homology means that 
there is promiscuity with TRP channels forming heteromers within subfamilies as well as 
between subfamilies. For example, TRPC1 is believed to heteromultimerise with all other 
TRPC channels (Storch et al., 2012) as well as channels from other subfamilies, such as 
TRPP2 (Kobori et al., 2009) and TRPV4 (Ma et al., 2011). Indeed, homomers 
overexpressed in vitro fail to exhibit currents suggesting that alone, TRPC1 cannot form 
functional channels (Storch et al., 2012). Other heteromeric complexes also show 
different functional properties than homomeric forms of their constituent proteins. For 
example, TRPC4 and TRPC5 when in complex with TRPC1 exhibit a different current-
voltage relationship than when expressed as homomeric channels (Clapham, 2003). 
TRPC5 in HEK293 cells is activated by temperatures below 37oC whereas expression of 
TRPC1 and TRPC5 heteromers did not induce the same current changes in response to 
cold (Zimmermann et al., 2011). Additionally, when in complex with TRPC1, TRPV4 
exhibits altered electrophysiological properties and Ca2+ permeability than when 
expressed as a homomeric channel (Ma et al., 2011). This structural promiscuity conveys 
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huge functional diversity to TRP channels but also makes dissecting out their individual 
contributions to sensory function particularly complex.  
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1.4.3 TRP channels in Mechanosensation 
TRP channels have been widely linked to a role in mechanosensation. In C.elegans, the 
TRP family isoform osm-9 is required for normal mechanosensory responses to nose 
touch (Colbert et al., 1997). The NOMPC (no mechanoreceptor potential C) gene in 
Drosophila encodes a channel which is expressed in mechanosensitive bristles. Flies 
expressing the NOMPC mutation have reduced sensitivity to touch shown by a decrease 
in mechanosensitive currents in these mechanosensory end organs (Kernan et al., 1994, 
Walker et al., 2000). Furthermore, interfering with the normal function of a vertebrate 
orthologue of the NOMPC channel was subsequently found to induce deafness and 
vestibular deficits in zebrafish which occurred as a result of altered mechanotransduction 
in hair cells (Sidi et al., 2003). Additionally, TRPY, the yeast TRP channel, is sensitive 
to osmotic pressure (Christensen and Corey, 2007). 
TRPA1 has also been implicated in mechanosensation. Drosophila larvae lacking 
expression of the TRPA1 homologue, painless, are insensitive to noxious mechanical 
stimuli (Tracey et al., 2003) while Kwan et al. (2006) found TRPA1 null mice exhibit an 
attenuated response to high-force innocuous and noxious mechanical stimuli. Slowly and 
intermediately adapting currents are associated with noxious mechanosensation and are 
absent from small diameter, non peptidergic DRG fibres taken from TRPA1 null mice 
(Vilceanu and Stucky, 2010, Brierley et al., 2011). Inflammatory and neuropathic models 
have indicated a complex role for TRPA1 in mechanical hypersensitivity. For example, 
mechanical hyperalgesia induced by mustard oil, CFA and SNL has been shown to be 
TRPA1 dependent (Petrus et al., 2007, Eid et al., 2008, Perin-Martins et al., 2013). 
However, contention over the role of TRPA1 in mechanosensation arose from other 
findings which suggest no alteration in the mechanical thresholds of TRPA1 knockout 
mice (Bautista et al., 2006) and that nerve injury induced mechanical allodynia was not 
resolved by antisense oligonucleotides against TRPA1 (Obata et al., 2005). Another 
reason that TRPA1 was a favourable candidate for primary mechanotransduction was the 
finding that it is expressed in mechanosensory hair cells in the inner ear and is blocked 
by a number of blockers of mechanically induced currents including gadolinium, 
amiloride and ruthenium red (Nagata et al., 2005). Subsequently however, this idea was 
challenged by the finding that TRPA1 null mice have unimpaired hearing (Kwan et al., 
2006). Differently designed gene knockouts, experimental approaches and use of single 
or mixed sex mice have been proposed as possible explanations for the discrepancies in 
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these TRPA1 studies. Importantly, heterologously expressed TRPA1 is not sufficient to 
confer mechanical sensitivity (Vilceanu and Stucky, 2010) leading to suggestions that 
TRPA1 may have an indirect role in mechanosensation. For example, one group propose 
it may regulate mechanical hyperalgesia rather than acute mechanical sensitivity (Petrus 
et al., 2007) or may only confer mechanical sensitivity to a certain subset of fibres 
(Brierley et al., 2011). Similarly, it is possible that TRPA1 alone is not sufficient to 
produce mechanically activated currents in non-neuronal cell lines, as has been reported 
for other TRP proteins believed to contribute to mechanosensation (Quick et al., 2012). 
Although TRPA1 may not be a primary mechanotransducer it is interesting to note that 
human Familial Episodic Pain Syndrome, generated by a point mutation in TRPA1 leads 
to the onset of cold evoked mechanical pain as a result of increased basal channel activity 
(Kremeyer et al., 2010).  
TRPV1 has been linked to roles in mechanical hypersensitivity in inflammatory and 
neuropathic pain conditions (Kanai et al., 2005). TRPV4 does not respond to stretching 
of the membrane in vitro and thus may not be gated by mechanical stimulation (Strotmann 
et al., 2000) however it does appear to be involved in mediating sensitivity to high 
threshold stimuli in mice (Suzuki et al., 2003). It is expressed in the DRG and in terminals 
of mechanosensory neurons (Suzuki et al., 2003) and also seems to mediate mechanical 
hypersensitivity in inflammatory and neuropathic pain states (Alessandri-Haber et al., 
2008). Furthermore, TRPV4 is frequently coexpressed with TRPC1 and TRPC6 in DRG 
and it has been proposed that they may act in concert to mediate these changes in 
hypersensitivity (Alessandri-Haber et al., 2009).  
Many members of the TRPC subfamily are implicated in mechanosensation in both 
cutaneous and other systems. TRPC1 null animals show a decrease in sensitivity to 
innocuous mechanical stimuli and sensory neurons in culture show a reduction of SA Aβ 
fibre firing in response to mechanical stimuli (Garrison et al., 2012). TRPC1, along with 
a number of other TRP channels, is expressed in Merkel cells where they have a role in 
mechanically induced Ca2+ influx (Haeberle et al., 2008). When both TRPC3 and TRPC6 
are deleted together, mice display attenuated sensitivity to light touch as well as a 
reduction in mechanically activated, RA currents in cultured DRG (Quick et al., 
2012).Vascular smooth muscle tone is believed to rely on mechanical sensitivity of 
TRPC6 while it also has mechanosensory roles in sensing glomerular pressure in the 
kidney where members of the TRPP family are also implicated in mechanosensory 
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function (Dietrich et al., 2005, Huber et al., 2006, Spassova et al., 2006, Christensen and 
Corey, 2007). The role of TRPC channels in mechanosensation is discussed further in 
section 4.2.1. 
In spite of the substantial evidence that TRP channels play a role in mechanosensation, 
their function as a pore forming, directly mechanosensitive ion channel has only recently 
been shown. In C.elegans, TRP-4 (a member of the NOMPC/TRPN subfamily) exhibits 
a rapid onset, mechanically activated current. A point mutation in the pore encoding 
region of the channel is able to alter its ion selectivity providing convincing evidence that 
the channel itself forms a pore subunit (Kang et al., 2010).  
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1.4.4 TRP channels and pain 
As well as a role in mechanosensation TRP channels have critical roles in physiological 
and pathological pain sensation. 
One of the most widely studied TRP channels, TRPV1 was identified as a capsaicin 
sensitive ion channel which also responds to noxious thermal stimuli (temperatures >43 
°C) and low pH (Caterina et al., 1997, Caterina et al., 2000). However, its role in sensing 
noxious heat was called into question when it was shown that while TRPV1 KO mice 
lose sensitivity to capsaicin and low pH, they exhibit limited alteration in acute noxious 
heat sensitivity (Caterina et al., 2000, Davis et al., 2000, Woodbury et al., 2004). TRPV2 
is also activated by temperatures above 52oC in vitro (Caterina et al., 1999), although 
82% of heat-sensitive neurons in TRPV1 null mice do not express TRPV2 suggesting that 
the retained sensitivity to noxious heat is also independent of TRPV2 (Woodbury et al., 
2004). In vitro, TRPV3 and TRPV4 produced currents at temperatures of 33–39 °C and 
25–34 °C, respectively though neither single nor double TRPV3/TRPV4 KO mice 
showed total loss of noxious thermal sensitivity (Liedtke et al., 2000, Peier et al., 2002b, 
Smith et al., 2002, Xu et al., 2002, Huang et al., 2011). Diphtheria toxin mediated ablation 
of TRPV1-positive sensory neurons does, however, abolish responses to noxious heat and 
thermal hyperalgesia showing this subset of neurons is critical for heat sensing (Mishra 
et al., 2011). 
Although the role for TRPV channels in acute noxious thermal sensitivity in vivo is not 
conclusive, they play crucial roles in pathological conditions. TRPV1 null animals do not 
display inflammation induced thermal hyperalgesia (Caterina et al., 2000, Davis et al., 
2000). Also, elevated TRPV1 expression is seen in sensory neurons of the DRG and in 
lamina I and II of the spinal cord following tissue damage and inflammation (Amaya et 
al., 2003, Zhou et al., 2003, Luo et al., 2004). TRPV1 is also sensitised by pro-
inflammatory mediators; this leads to induction and maintenance of thermal hyperalgesia, 
via protein kinase A (PKA) and protein kinase C (PKC) dependent mechanisms. For 
example, PKA enhances gating and increases TRPV1 translocation to the membrane 
(Zhang et al., 2008) while PKC phosphorylates TRPV1 to lower its activation threshold 
and potentiate channel activity (Premkumar and Ahern, 2000, Vellani et al., 2001). Other 
inflammatory mediators act to increase TRPV1 activity allowing it to contribute to 
nociceptor sensitisation in pathological conditions. These include prostaglandins, for 
example PGE2 and PGI2 which reduce the thermal threshold of TRPV1 to ~35 °C 
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(Moriyama et al., 2005), chemokines (Zhang et al., 2005a, Zhang et al., 2005b), 5‐ HT 
(Loyd et al., 2011), phosphoinositides (Zhuang et al., 2004) and bradykinin (Ferreira et 
al., 2004). TRPV1 expression is downregulated in damaged neurons following nerve 
injury and upregulated in surrounding, undamaged neurons (Hudson et al., 2001, Fukuoka 
et al., 2002). TRPV1 expression is also reduced in human diabetic and motor neuropathies 
(Lauria et al., 2006, Facer et al., 2007). NGF acts on TRPV1 in a number of ways 
including upregulation of its transcription, increased TRPV1 phosphorylation and 
increase translation and transport of TRPV1 to the periphery (Ji et al., 2002) which 
contributes to and maintains thermal hyperalgesia in both inflammatory and neuropathic 
conditions.  
In addition to TRPV1, other TRPV channels play a role in inflammatory and neuropathic 
pain conditions. TRPV4 is sensitised by ATP (Phelps et al., 2010) which contributes to 
the inflammatory response. Although loss of TRPV3 function reportedly does not affect 
thermal hyperalgesia in vivo (Moqrich et al., 2005), other studies have found that TRPV3 
activation in keratinocytes leads to release of prostaglandins and causes increased 
sensitivity to acute noxious heat and thermal hyperalgesia in a TRPV1‐ independent 
manner (Huang et al., 2008) and that TRPV3 expression is seen in intact nerves after 
injury (Facer et al., 2007). 
Cold hyperalgesia is a symptom of diseases such as rheumatoid arthritis (Jahanshahi et 
al., 1989), and cold allodynia is a common feature of many neuropathic pain states 
including those caused by traumatic nerve injury and post-herpetic neuralgia (Jorum et 
al., 2003). Under physiological conditions, the threshold for noxious cold, as distinct from 
innocuous cool, is considered to occur at temperatures <15 °C. Two TRP channels, 
TRPM8 and TRPA1 both contribute to transduction of cool and cold stimuli.  
TRPM8 is sensitive to menthol (a cooling compound) and cold, with a threshold of 
~25°C, and is activated by temperatures encompassing the innocuous cool and noxious 
cold range(McKemy et al., 2002, Peier et al., 2002a) Though TRPM8 has an established 
role for the channel in detection of innocuous cooling its role in detection of noxious 
stimuli is more controversial as two groups found loss of TRPM8 function in vivo did not 
alter cold sensitivity (Bautista et al., 2007, Dhaka et al., 2007) while two others report 
decreased cold sensitivity in the absence of TRPM8 (Colburn et al., 2007, Gentry et al., 
2010). Because TRPV1 is expressed in neurons expressing TRPM8 during development 
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but TRPV1 is subsequently downregulated, toxin mediated ablation of TRPV1 containing 
sensory neurons also caused ablation of TRPM8 and caused abolition of responses to 
acute noxious cold (Mishra et al., 2011). In neuropathic pain models, TRPM8 is critical 
for cold allodynia evoked by cooling compounds such as acetone (Colburn et al., 2007, 
Caspani et al., 2009) though nerve injury induced changes in TRPM8 expression are 
controversial (Proudfoot et al., 2006, Caspani et al., 2009) and menthol induced cold 
hypersensitivity is mediated by TRPA1, not TRPM8 (Gentry et al., 2010). 
TRPA1 was first suggested as a noxious cold sensor as it has an activation threshold of 
17oC when expressed heterologously which is close to the cold temperature considered 
to be painful and it is co-expressed with TRPV1 in nociceptive neurons (Story et al., 
2003). Contention over the role of TRPA1 in acute cold sensation has arisen from 
behavioural studies in TRPA1 KO mice. Some groups, including Kwan et al. (2006), 
observed a decrease in cold sensitivity while others, such as Bautista et al. (2006), did not 
observe any changes in cold sensitivity at the behavioural or electrophysiological level. 
A number of explanations have attempted to resolve this contention, for example that 
different techniques of cold assessment (Gentry et al., 2010) and experimental setup 
(Kwan et al. found a greater deficit in the response of female mice while Bautista et al. 
only used males) are responsible for the conflict. The design of the gene knockout has 
also been suggested as a potential source of variability. TRPA1 ‘null’ mice used by both 
groups are thought to express a truncated form of the protein, it has been suggested that 
this truncated form may exert an effect on other implicated channels, thus affecting the 
phenotype of the null mice (Foulkes and Wood, 2007). It has also been suggested that 
rather than being directly activated by cold, TRPA1 is activated by a rise in intracellular 
Ca2+ which is induced by cold (Zurborg et al., 2007) though it was subsequently shown 
that TRPA1 could be activated by cold in the absence of both intra‐  and extracellular 
Ca2+ (Karashima et al., 2009). 
In pathological conditions, genetic and pharmacological disruption of TRPA1 function 
reduces cold hypersensitivity (Stucky et al., 2009, del Camino et al., 2010, Gentry et al., 
2010). This includes rodent models of neuropathic and inflammatory pain; for example 
TRPA1 activation is responsible for the pain behaviour produced in the first phase of the 
Formalin test by neuronal excitation (Macpherson et al., 2007). As well as this, rodent 
models of neuropathic pain have shown that damaged neurons display a reduction in 
TRPA1 expression while expression is increased in intact neurons (Obata et al., 2005, 
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Katsura et al., 2006, Caspani et al., 2009). TRPA1 does not confer cold sensitivity to HEK 
cells, despite producing allyl isothiocyanate (AITC) induced currents, however in both 
HEK cells and cultured sensory neurons, agonist and inflammatory agent evoked TRPA1 
currents are markedly potentiated in the presence of even mild cooling (del Camino et al., 
2010). Together, this data provides convincing evidence that TRPA1 is necessary for cold 
hypersensitivity in pathological conditions though its role as an acute noxious cold sensor 
requires more investigation. 
Importantly, it has been shown that a small population of cold sensitive neurons does not 
respond to menthol or AITC suggesting TRPM8 and TRPA1 independent mechanisms of 
cold sensitivity (Babes et al., 2004). This may also provide some explanation for the 
discordance between results from single channel animal KO studies.  
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1.5 Acid sensing ion channels 
Acid sensing ion channels (ASICs) are a family of voltage-independent, ligand gated ion 
channels which are constituents of the amiloride-sensitive degenerin/epithelial sodium 
(DEG/ENaC) channel family. They are highly conserved across evolution, are widely 
expressed in the nervous system, form homomeric and heteromeric complexes and, much 
like TRP channels, have diverse roles in sensory functions. 
Encoded by ACCN (amiloride sensitive cation channel) genes 1-4, there are six ‘major’ 
ASICs; ASIC1a, ASIC1b, ASIC2a, ASIC2b, ASIC3 and ASIC4. ASIC1a and b are 
alternative splice products of ACCN2; ASIC2a and b are alternative splice products of 
ACCN1. Another protein, ASIC5, or BASIC, is amiloride sensitive but only shares low 
sequence homology with other ASICs (Schaefer et al., 2000, Lin et al., 2015b). ASICs 
show high sequence homology and form trimeric complexes; each constituent protein 
consists of two transmembrane domains, cytosolic N and C termini and large, 
multidomain extracellular regions. The trimeric structure of ASICs (Figure 1.14) was 
confirmed when the crystal structure of the chicken ASIC1 protein was resolved (Jasti et 
al., 2007). The transmembrane domains of ASIC subunits are crucial; their interactions 
with surrounding lipids and each other provides stability to the channel while they also 
define the interior of the pore and TM2 contributes to its ion selectivity (Jasti et al., 2007, 
Gonzales et al., 2009). The expression pattern, biophysical properties and functional roles 
of ASICs vary greatly and are examined in brief below. 
 
Figure 1.14 The trimeric structure of ASICs was confirmed through resolution of the 
crystal structure of chicken ASIC1 (Modified from Wemmie et al. (2013)).  
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1.5.1 ASIC expression 
ASICs are expressed in neuronal and non-neuronal tissue including in the cell bodies and 
peripheral terminals of primary sensory neurons and mechanosensory end organs. 
ASIC1a is localised to a subset of TRPV1 positive neurons, whereas ASIC1b has specific 
expression and ASIC3 preferential expression in the peripheral nervous system. ASIC1, 
2 and 3 are all found in large and small diameter DRG neurons (Table 1.2). ASIC1, 2 and 
3 are also expressed in cell bodies of the trigeminal ganglia (Rahman et al., 2011).  
In hairy skin, ASIC2a and ASIC3 are expressed in lanceolate endings surrounding the 
guard hair follicles (Price et al., 2000, Price et al., 2001) while in glabrous skin, ASIC2 
and ASIC3 are present in Meissner corpuscles. Both of these mechanosensory end organs 
are associated with RA mechanoreceptors. In addition, ASIC3 appears to be present in 
Merkel cell complexes and free nerve endings associated with the SA mechanically 
activated current (Price et al., 2001). Expression of ASIC3 in rodents is primarily 
restricted to sensory ganglia and while some expression has been reported in the spinal 
cord (Baron et al., 2008), in humans ASIC3 is highly expressed in both spinal cord and 
brain (Delaunay et al., 2012). ASIC4 was originally cloned from a DRG cDNA library 
and was found in large diameter fibres (Akopian et al., 2000, Usoskin et al., 2015), though 
reports of ASIC4 expression in sensory ganglia are contested (Lin et al., 2015a) (see 
section 7.2.1).  
In the central nervous system, ASIC1a, ASIC2 and ASIC4 are all broadly expressed in 
regions including the spinal cord, cerebellum, amygdala and hippocampus (Table 1.2) in 
both homomeric and heteromeric forms. ASIC4 expression in cerebellum is increased in 
adult compared to newborn rats while its expression in spinal cord is downregulated after 
birth (Akopian et al., 2000); the highest expression of ASIC4 however is observed in the 
pituitary gland (Lin et al., 2015a).  
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ASIC Tissue expression Reference 
ASIC1a DRG; TG; nodose ganglia Waldmann et al. (1997b) (rat); Rahman et al. 
(2011); Walder et al. (2010); Page et al. 
(2004); Alvarez de la Rosa et al. (2002) (rat) 
Spinal cord Wu et al. (2004) (rat); Baron et al. (2008) 
(mouse) 
Brain Waldmann et al. (1997b) (human; rat); 
Alvarez de la Rosa et al. (2003) (mouse) 
ASIC1b DRG; TG; nodose ganglia Page et al. (2004) (mouse); Page et al. (2005) 
(mouse); Rahman et al. (2011) ; Alvarez de la 
Rosa et al. (2002) (rat) 
ASIC2a DRG; TG; nodose ganglia Page et al. (2005) (mouse); Price et al. (2000) 
(mouse); Cano14 (human); Alvarez de la Rosa 
et al. (2002) (rat) 
Mechanosensory end organs (Cabo et al., 2015) (human) 
Spinal cord (Wu et al., 2004)(rat); (Baron et al., 2008) 
(mouse) 
Brain (Price et al., 2000) (mouse); (Roza et al., 
2004) (mouse) 
ASIC2b DRG; TG; nodose ganglia (Page et al., 2005) (mouse); (Alvarez de la 
Rosa et al., 2002) (rat) 
Spinal cord (Wu et al., 2004)(rat); (Baron et al., 2008) 
(mouse) 
Brain (Roza et al., 2004) (mouse) 
ASIC3 DRG; TG; nodose ganglia (Page et al., 2005) (mouse); (Price et al., 2001) 
(mouse); (Chen et al., 2002) (mouse); 
(Alvarez de la Rosa et al., 2002)(rat); (Sluka et 
al., 2003) (mouse); (Waldmann et al., 
1997a)(rat) 
Mechanosensory end organs (Price et al., 2001) (mouse); 
Spinal cord (Baron et al., 2008) (mouse); (Delaunay et al., 
2012) (human) 
Brain (Delaunay et al., 2012) (human) 
ASIC4 Brain (regions include: 
amygdala, striatum, 
hippocampus, cerebellum) 
(Lin et al., 2015a) (mouse); (Grunder et al., 
2000) (rat); (Akopian et al., 2000) (rat) 
Pituitary gland (Lin et al., 2015a) (mouse) 
Spinal cord (Lin et al., 2015a)(mouse); (Grunder et al., 
2000) (rat); (Akopian et al., 2000) (rat) 
DRG (Akopian et al., 2000) (rat; low levels); 
(Alvarez de la Rosa et al., 2002)(rat);  
Vestibular system (Grunder et al., 2000) (rat) 
Table 1.2 ASIC subunit expression patterns. 
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1.5.2 Biophysical properties of ASICs 
An excess of protons (H+) is found in conditions such as inflammation, ischaemia and at 
the synaptic cleft following release of neurotransmitter. Proton gated currents in the 
nervous system are heterogeneous and mediated by TRPV1 (Bevan and Yeats, 1991) and 
ASICs which form homomeric and heteromeric complexes. The description of proton 
gated currents in sensory neurons by Krishtal and Pidoplichko (1981) was followed in 
1997 (Waldmann et al.) by the cloning of the first ASIC, shown to produce a proton gated 
current which was selective for Na+ ions. All ASICs, excluding ASIC2b and ASIC4 
(Lingueglia et al., 1997), are gated by protons; it has recently been suggested that it is 
likely ASICs bind more than one proton during activation and that many ASIC residues 
are involved in binding protons (Grunder and Pusch, 2015). The large extracellular 
domain of ASICs contains a negatively charged cavity containing carboxyl-carboxylate 
groups which allow proton binding in low pH conditions (Jasti et al., 2007). Proton 
binding is thought to cause movement of the disulphide rich region, also in the 
extracellular loop, leading to rotation of the transmembrane domains to open the 
activation gate (Jasti et al., 2007, Gonzales et al., 2009). Sustained exposure to low pH 
can cause ASICs to desensitise through movement of the transmembrane domains that 
form a desensitisation gate (Gonzales et al., 2009). Desensitisation occurs over a period 
of hundreds of milliseconds to seconds, depending on the subunit involved (Table 1.3). 
ASIC3, however, does not fully desensitise (Waldmann et al., 1997a) and ASIC1a 
homomers exhibit the phenomenon of tachyphylaxis (Chen and Grunder, 2007, Li et al., 
2012), though this sustained desensitisation after repeated activation requires strong 
acidification so may not play a major role in physiological activation (Grunder and Pusch, 
2015). 
ASIC subunits show different cation selectivity with most subunits preferentially 
conducting Na+ and only ASIC1a showing Ca2+ permeability. Heterologous expression 
systems have been used to identify the characteristic currents produced by ASIC 
homomeric and heteromeric complexes, which has led to a better understanding of the 
contributions of different ASIC subunits in vivo (Figure 1.15). In particular, the functional 
properties of many heteromeric complexes have been linked to physiological roles in the 
nervous system that cannot be accounted for by homomeric complexes alone.  
ASIC1a is activated by a rapid drop in pH (<1ms) to below 6.9 and produces a transient, 
rapidly desensitising inward current which is slow to recover (Waldmann et al., 1997b). 
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Similar to ASIC1a, ASIC1b produces an amiloride sensitive, rapidly activating and 
desensitising current at pH5.9 (Chen et al., 1998, Sutherland et al., 2001); it is permeable 
to Na+ and K+ but its human orthologue is additionally permeable to Ca2+ (Hoagland et 
al., 2010). ASIC2a is activated at a much lower pH than ASIC1a or ASIC3 and has slower 
inactivation kinetics (Lingueglia et al., 1997). When expressed alone, ASIC2b is 
insensitive to protons though it can form heteromeric complexes with ASIC2a where it 
produces a non-selective slowly inactivating current, not seen with ASIC2a expression 
alone (Lingueglia et al., 1997). ASIC2b also forms functional heteromeric complexes 
with ASIC3. As well as producing a Na+ selective transient current, ASIC3 exhibits a 
sustained current which is not inhibited by amiloride (Waldmann et al., 1997a). When 
expressed as a homomer, this current is Na+ selective, though when coexpressed with 
ASIC2b, the sustained current appears to be non-selective which is consistent with the 
sustained current seen in sensory neurons. This sustained current is likely to be key to 
acid sensitivity in the periphery where pH decreases slowly and over a sustained period 
in inflammation and ischaemia (Grunder and Pusch, 2015). Importantly, this current is 
also able to sensitise neurons to other stimuli (Deval et al., 2003) while the transient 
currents of ASIC1 and ASIC3 are sufficient to depolarise sensory neurons (Mamet et al., 
2002, Deval and Lingueglia, 2015).  
ASIC1a also forms functional heteromeric complexes with ASIC2a and 2b (Bassilana et 
al., 1997, Sherwood et al., 2011, Bartoi et al., 2014). Proton gated currents in hippocampal 
neurons are consistent with the properties of ASIC1a/2a heteromers (Askwith et al., 2004) 
as well as ASIC1a/2b complexes which also appear to mediate neuronal cell death in CNS 
neurons (Sherwood et al., 2011). The ratio of ASIC1a/2a subunits in heteromeric 
complexes is believed to regulate their function in CNS neurons (Jones et al., 2004, Li et 
al., 2010); ASIC1a/2a complexes can form in a stoichiometry of 2:1 or 1:2 and do so in 
cells also expressing functional homomeric channels (Bartoi et al., 2014). It has been 
suggested that the ASIC1a/2a complex is less proton sensitive than ASIC1a homomers in 
order to prevent sustained desensitisation in the presence of continued acidification 
(Baron et al., 2008). Clearly, the heteromerisation of ASIC subunits confers functional 
diversity and allows fine tuning of their biophysical properties; as such, understanding 
their subunit interactions has, and continues, to elucidate more about the physiological 
roles of ASICs.  
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Figure 1.15 Currents produced by ASIC subunits expressed in COS cells vary by subunit 
as does ion selectivity. Expression of multiple subunits likely leads to formation of 
heteromeric channels with different characteristics to their component homomers. Taken 
from Voilley (2004)). 
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ASIC 
Ion 
permeability 
Activation 
pH 
τactivation 
(ms at pH 
6.0) 
τdesensitisation (s) 
τrecovery    (s, 
at pH 7.4) 
References 
ASIC1a Na+>Ca2+>K+ 6.4-6.6 6-13 1.2-3.5 13 
(Waldmann et 
al., 1997b); 
(Sutherland et 
al., 2001); 
(Bartoi et al., 
2014); 
(Yermolaieva 
et al., 2004) 
ASIC1b 
Na+, K+ (Ca2+ 
human 
orthologue) 
5.9  1.7 5.9 
(Chen et al., 
1998); 
(Sutherland et 
al., 2001); 
(Hoagland et 
al., 2010) 
ASIC2a Na+ 4.5-5.5  3.15  
(Lingueglia et 
al., 1997); 
(Bartoi et al., 
2014) 
ASIC2b - - - - - 
(Lingueglia et 
al., 1997) 
ASIC3 Na+>K+ 
6.5-6.7 
(transient); ≤4 
(sustained) 
<5 0.3 0.4-0.6 
(Waldmann et 
al., 1997a); 
(Sutherland et 
al., 2001) 
ASIC4 - - - - - 
(Akopian et 
al., 2000) 
ASIC1a/2a Na+, K+ 4.8-5.4  0.6-0.9 0.4-0.6 
(Bassilana et 
al., 1997); 
(Bartoi et al., 
2014) 
ASIC1a/2b Na+, K+, Ca2+ 6.4  2.6  
(Sherwood et 
al., 2011) 
ASIC3/2b Non selective 6.5    
(Lingueglia et 
al., 1997) 
Table 1.3 Biophysical properties of ASICs. 
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1.5.3 ASICs in mechanosensation 
The mec-4 and mec-10 members of the family of DEG/ENaC channels contribute to a 
complex that transduces touch in C.elegans (Goodman et al., 2002, Chalfie, 2009). 
Mutations in these proteins alter ion selectivity of the channel complex showing that these 
channels are pore forming subunits (O'Hagan et al., 2005). These orthologues of 
mammalian ASICs are vital for production of normal mechanically activated currents and 
behavioural responses to touch. Stomatin-like protein3 is needed for normal touch 
sensation and associates with and blocks the currents produced by ASIC2a, ASIC2b and 
ASIC3 (Wetzel et al., 2007). These findings, along with ASIC structure, expression in 
mechanosensory structures, and early knockout data showing impaired mechanosensory 
function in vivo indicated that ASICs may be potentially interesting candidate 
mechanotransducers. 
An ASIC3 knockout mouse showed increased sensitivity to light touch but decreased 
responses to noxious pinch stimuli (Price et al., 2001) while impairing the function of 
ASIC2 in the firing of RA mechanosensitive fibres produced conflicting data (Price et al., 
2000, Roza et al., 2004). In light of the heteromerisation of ASICs, some groups have 
investigated their function in combination. For example, a model which inactivated all 
native neuronal ASIC currents through expression of a dominant negative ASIC3 subunit 
found heightened sensitivity to cutaneous mechanical stimuli (Mogil et al., 2005). 
Similarly, an ASIC1a, ASIC2 and ASIC3 triple KO mouse showed an increased 
sensitivity to stimulation with von Frey fibres (Kang et al., 2012). Altogether these data 
indicated that ASICs may negatively regulate mechanosensation. 
Electrophysiological properties of mechanosensitive fibres in ASIC null mice have also 
highlighted ASIC mediated changes in mechanosensitivity but which conflict with some 
of the behavioural findings. Though ASIC1a, ASIC2, ASIC3 triple KOs display increased 
spike frequency in response to mechanical stimulation (Kang et al., 2012) in the absence 
of just ASIC2, RA and SA MA currents were decreased (Price et al., 2000) while the 
absence of ASIC1a produced no changes and lack of ASIC3 caused decreased A 
mechanoreceptor firing but an increase in RA currents (Chen and Wong, 2013). 
Furthermore, Drew et al. (2004) found that cultured DRGs from ASIC2 and ASIC3 null 
mice did not show any difference in mechanically induced currents compared to wild 
types. In agreement with this, it was found that ASIC1a, ASIC2 and ASIC3 single KO 
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mice show no changes in acute mechanosensation (Roza et al., 2004, Staniland and 
McMahon, 2009). 
It has been suggested that while ASICs may not be involved in cutaneous 
mechanosensation, their presence in deep tissues may be more important. For example, 
ASIC2 appears to play a role in mechanosensitivity associated with the baroreflex (Lu et 
al., 2009) and it may also have a role in the viscera (Roza et al., 2004, Page et al., 2005). 
Loss of ASIC1a produces an increase in visceral mechanosensitivity while loss of ASIC3 
decreases mechanical sensitivity in a subset of visceral afferents (Page et al., 2004, Roza 
et al., 2004, Jones et al., 2005, Page et al., 2005).  
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1.5.4 ASICs in pain 
Protons are a feature of inflammation and countless animal and human studies have 
shown that administration of acidic stimuli leads to pain (Wemmie et al., 2013); 
understanding the contribution of ASICs is therefore particularly important to develop a 
better understanding of mechanisms involved in pain and inflammation.  
In DRG neurons, acid evoked currents can be produced in vitro in capsaicin sensitive and 
insensitive neurons and can lead to neuron depolarisation (Bevan and Yeats, 1991, Steen 
et al., 1992, Leffler et al., 2006). Indeed, proton sensitivity of DRG neurons involves 
activity of TRPV1 (Bevan and Yeats, 1991, Tominaga et al., 1998) but amiloride, a 
blocker of ASICs, reduces pain in inflammatory conditions (Waldmann et al., 1997b) 
while NSAIDs such as ibuprofen and aspirin inhibit proton induced currents 
independently of TRPV1 (Voilley et al., 2001) suggesting proton induced ASIC currents 
also contribute to nociceptive function in sensory neurons. Proton-gated currents are still 
present in rat DRG neurons in the presence of TRPV1 agonist, capsazepine and these 
currents are inhibited by administration of morphine (Cai et al., 2014). In humans, 
cutaneous acid infusion produced pain shown to be dependent on both ASICs and TRPV1 
(Jones et al., 2004) while another study found that amiloride but not capsazepine block 
currents evoked by mildly acidic pH (Ugawa et al., 2002) suggesting the contribution of 
these channels to acid sensation may be pH dependent. Importantly, TRPV1 requires pH 
<6 for activation but cutaneous nociceptors can be activated by a drop to just pH6.9. 
Moreover, in muscle tissue, a drop in pH from 7.4 to 7.0 can be sufficient to induce 
persistent neuronal activity, suggesting TRPV1 is unlikely to be the sole mediator of acid 
evoked currents in nociceptive neurons (Issberner et al., 1996, Ugawa et al., 2002). 
Though TRPV1 plays an important role in acid evoked nociception, there is a great deal 
of evidence that ASICs are critical as well. 
Inflammatory mediators such as NGF, BDNF and 5-HT promote upregulation of ASIC 
transcription. It has also been shown that NGF-mediated-increase in ASIC3 levels leads 
to an increase in the proportion of cells expressing ASICs, increased ASIC3 current 
amplitude, and ultimately to increased neuronal excitability (Mamet et al., 2002). In 
addition to changes in sensory neurons, expression of ASIC1a and ASIC2a is increased 
in the spinal cord after peripheral inflammation (Wu et al., 2004).  Dorsal horn neurons 
produce acid evoked currents which are independent of capsaicin and appear to be 
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mediated by ASIC1a with ASIC2a and ASIC2b contributing to some of the current types 
produced, likely through heteromer formation (Baron et al., 2008). 
Animal models have been used to investigate the effect of disrupting ASIC function on 
cutaneous and deep tissue acute and inflammatory pain in vivo. Since ASIC3 produces a 
sustained current which is thought to be critical for the pain resulting from tissue acidosis 
(Waldmann et al., 1997a), it has been particularly well studied in animal models with 
sometimes conflicting results. While some groups report loss of ASIC3 function leads to 
a decrease in acid sensitivity and a decrease in heat sensitivity (Price et al., 2001) others 
have found hypersensitivity to acidic, thermal and mechanical stimuli (Chen et al., 2002). 
Yen et al. (2009) and Deval et al. (2008) found ASIC3 siRNA mediated knockdown and 
ASIC3 KO attenuated inflammatory thermal and mechanical hypersensitivity. Another 
investigation of single KO of ASIC1, ASIC2 and ASIC3 showed unimpaired acute and 
inflammatory sensitivity in all groups (Staniland and McMahon, 2009). Disrupting the 
function of all acid evoked, neuronal ASIC currents through expression of a dominant 
negative ASIC3 subunit produced hypersensitivity to a number of inflammatory visceral 
and cutaneous insults as well as acute, noxious mechanical but not thermal stimuli (Mogil 
et al., 2005). Two models of neuropathic pain produced mechanical and thermal 
hypersensitivity which was reversed by treatment with the ASIC1a blocker, Psalmotoxin1 
(PcTx1) through activation of endogenous enkephalins (Mazzuca et al., 2007). On the 
other hand, ASIC3 KO mice showed an increase in sensitivity to dynamic mechanical 
stimuli in neuropathic conditions (Borzan et al., 2010). Clearly, the role for ASICs in 
cutaneous mechanosensation is complex, though the use of specific toxins and synthetic 
peptides which bind to ASICs have gone some way to elucidating more about the way 
these channels may be activated and thus contribute to nociception. 
It has been suggested that through their large, extracellular domain, ASICs may have 
ligands other than protons which lead to pain sensation or that may increase their 
sensitivity to protons. For example, a small synthetic molecule, 2-guanidine-4-
methylquinazoline (GMQ), binds to ASIC3 outside of its H+ binding site (Figure 1.16) 
and when injected in vivo, causes pain behaviour which is not observed in ASIC3 
knockout mice (Yu et al., 2010). Agmatine, an endogenous polyamide, also produced this 
pain behaviour acting through the same ligand binding site. Its activity was potentiated 
by mild acidosis and coadministration of Agmatine with other inflammatory mediators 
augments pain behaviour produced by inflammatory mediators alone (Li et al., 2010). 
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Importantly, these molecules produce sustained activation of ASIC3, as opposed to the 
transient currents produced by low pH, which may indicate a mechanism for the long 
term effects of ASICs in painful conditions (Yu et al., 2010, Wemmie et al., 2013). 
Similarly, hind paw injection of a snake venom, MitTx (Micrurus tener tener) produces 
pain behaviour in WT but not ASIC1a KO mice and to a lesser degree in ASIC3 KO mice 
while in vitro, this venom selectively produces persistent activation of ASIC1a, ASIC1b 
and ASIC3 and enhances the proton efficacy of ASIC2a (Bohlen et al., 2011, Wemmie et 
al., 2013). It is possible, therefore, that endogenous ligands of ASICs potentiate their 
sensitivity to protons allowing their activation at physiologically relevant pH; for 
example, through binding of polyamines such as agmatine, which accumulate in 
inflammatory conditions (Yu et al., 2010). Also, Deval et al. (2008) argue that in the 
presence of arachidonic acid, ASIC3 can be activated at physiological pH, 7.4. Indeed, 
arachidonic acid and hyperosmolarity are both features of inflammatory conditions and 
synergistically reduce the pH dependence of ASIC3 in rat DRG and can activate the 
channel at physiologically relevant levels (Deval et al., 2008). 
Deep tissue pain in structures such as muscles, joints and viscera is a huge clinical 
problem (Sikandar and Dickenson, 2012). ASICs are expressed in peripheral sensory 
neurons which innervate skeletal muscle (Gautam and Benson, 2013); interestingly, 
evidence suggests that ASIC1 and ASIC3 may contribute differentially to deep tissue 
pain. In a model of chronic muscle pain, the development of secondary mechanical 
hyperalgesia is ASIC3, but not ASIC1, dependent (Sluka et al., 2003, Sluka et al., 2007). 
Similarly, joint and muscle inflammation produces secondary mechanical hyperalgesia of 
the paw which is ASIC3 dependent, while primary mechanical hyperalgesia at the site of 
inflammation was shown to be mediated by ASIC1 (Ikeuchi et al., 2008, Walder et al., 
2010). ASIC3 mRNA is upregulated in fibres innervating muscle (Walder et al., 2010) 
though ASIC3 was shown to be necessary for the development rather than the 
maintenance of mechanical hyperalgesia (Karczewski et al., 2010, Chen et al., 2014). In 
a human study of patients with inflammatory bowel conditions, ASIC expression was 
upregulated in the intestine compared to patients with uninflamed viscera (Yiangou et al., 
2001), while animal models showed the importance of ASIC1 and ASIC3 in mediating 
mechanical hypersensitivity in inflammatory conditions (Jones et al., 2005, Staniland and 
McMahon, 2009). Acidosis in cancer tumour microenvironment is believed to contribute 
to pain though the role of ASICs in this mechanism is still incompletely understood (Sluka 
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et al., 2009, Damaghi et al., 2013). For example, ASIC1a and ASIC1b mRNA was 
upregulated in a rodent model of cancer induced bone pain (Nagae et al., 2007) while 
conversely, ASIC2 upregulation was shown to attenuate migration of glioma cells (Vila-
Carriles et al., 2006, Damaghi et al., 2013). ASIC3 is also implicated in pain associated 
with cardiac ischaemia (Sutherland et al., 2001). Clearly there is an important role for 
ASICs in pain sensitivity in normal as well as pathological states though a better 
understanding of the nociceptive signalling mechanisms of these channels in the nervous 
system would be beneficial to the understanding of pain processing and potentially to the 
search for more effective analgesic targets. 
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Figure 1.16 Synthetic (GMQ) and naturally occurring (MitTx; Mambalgin-1) agonists 
and antagonists of ASICs demonstrate proton independent mechanisms of ASIC 
activation and have helped elucidate more about the roles of ASICs in pain. Pro-algesic 
agents such as Arachidonic Acid (AA) have also been identified as modulators of ASICs 
in inflammatory conditions. (Modified from Wemmie et al. (2013)). 
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1.6 Annexin A6 
In this thesis, we identify a novel role for Annexin A6 in regulation of mechanosensation. 
Annexins are a superfamily of Ca2+-dependent, phospholipid-binding proteins which are 
involved in diverse functional processes. They are highly evolutionarily conserved; 
vertebrate annexins are denoted by an A in their name (for example, Annexin A6) while 
classes B-E refer to invertebrate, unicellular and plant orthologues.  
The annexin ‘core’ consists of four homologous domains made up of approximately 70 
amino acids which pack around a hydrophilic hole and form a convex surface which binds 
Ca2+. Resolution of the crystal structure of vertebrate annexins showed that these domains 
are arranged into a bent disc shape. The homologous repeat domains are critical in 
allowing annexins to bind to Ca2+ and phospholipids while the N terminal domains of 
these proteins, which are much more diverse, are believed to be important for conferring 
function to individual annexins as well as mediating stability, and protein interactions 
(Moss et al., 1992, Turnay et al., 2005, Lizarbe et al., 2013).  
Annexin A6 is unique among vertebrate annexins in having eight, rather than four, 
homologous domains. The resolution of the ANXA6 crystal structure showed that these 
domains form two core lobes connected by a 40 amino acid loop (Benz et al., 1996, Avila-
Sakar et al., 1998). The two lobes are perpendicular to one another but upon membrane 
binding they reorientate themselves such that they are coplanar with the membrane (Benz 
et al., 1996, Kawasaki et al., 1996). Two such conformations of membrane bound 
ANXA6 have been reported; in one, both lobes have their convex surface facing the 
membrane while in the other, the lobes are closer together and only one has the convex 
side facing the membrane while the other lobe is flipped such that the convex surface 
faces away from the membrane (Avila-Sakar et al., 2000). It has been suggested that the 
flexibility of ANXA6 and its orientation to the membrane is regulated by phosphorylation 
of specific residues and may be critical for its role in membrane fusion and vesicle 
aggregation (Benz et al., 1996, Freye-Minks et al., 2003). 
Anxa6, previously known as p68, calelectrin and protein III (Moss et al., 1992) is a 
compound gene which appears to derive from Annexin A5 and Annexin A10 being 
spliced together, early in evolution. Expression of ANXA6 is restricted to specific tissues 
and cell types. In both rat and mouse, ANXA6 is expressed in large and small diameter 
sensory neurons and at low levels in Schwann cells but not in other types of glial cells in 
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the DRG (Naciff et al., 1996a, Naciff et al., 1996b). It is highly expressed at the plasma 
membrane of these neurons and in intracellular regions consistent with association of 
ANXA6 with the endoplasmic reticulum (Naciff et al., 1996a, Naciff et al., 1996b). In the 
spinal cord, ANXA6 is distributed rostrocaudally, primarily in the cell bodies, axons and 
dendrites of motor neurons. In cultured neurons taken from DRG and spinal cord, 
ANXA6 has been shown to suppress K+ conductance as well as decreasing Ca2+ current 
in sensory neurons (Naciff et al., 1996a) though a clear understanding of the function of 
ANXA6 in nervous tissue has yet to be resolved. 
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1.7 Voltage gated sodium channels 
The family of mammalian voltage-gated sodium channels consist of nine alpha subunits, 
Nav1.1-1.9, encoded by the genes SCN1A-5A and SCN8A-11A. Beta subunits of voltage 
gated sodium channels associate with the alpha subunits acting to anchor and localise the 
channels (Figure 1.17). Voltage gated sodium channels allow flux of Na+ into the cell, 
producing the depolarising upstroke of the action potential. Neuronally expressed sodium 
channels in peripheral sensory neurons have crucial roles in pain and mechanosensation.  
Nav1.3, 1.7, 1.8 and 1.9 are preferentially expressed in the peripheral nervous system. 
Nav1.3 is more highly expressed during embryonic development than in adult nervous 
system, and Nav1.3 null animals have normal pain sensitivity (Nassar et al., 2006) though 
in pathological conditions it is upregulated in DRG (Black et al., 2004) and spinal cord 
(Waxman et al., 1994).  
Nav1.7 is expressed in sensory and sympathetic neurons as well as the thalamus and 
olfactory bulb. In humans, a nonsense mutation mapped to SCN9A, the gene encoding 
Nav1.7, produced  total insensitivity to pain and anosmia while leaving other sensory 
modalities unaffected (Cox et al., 2006), subsequently, other loss of function mutations 
have also been mapped to Nav1.7 which cause pain insensitivity. Paroxysmal extreme 
pain disorder (PEPD) (Fertleman et al., 2006) and primary erythermalgia (Yang et al., 
2004, Drenth et al., 2005) are conditions characterised by severe, ongoing pain which 
occurs in the absence of a stimulus as a result of gain of function mutations in SCN9A. 
Mice lacking functional expression of Nav1.7 in sensory neurons show decreased thermal 
and mechanical sensitivity and significantly reduced inflammatory hypersensitivity 
(Nassar et al., 2004) while impairing the function of Nav1.7 in sensory and sympathetic 
neurons leads to loss of mechanical allodynia produced by specific models of neuropathic 
pain (Minett et al., 2012). Interestingly, Nav1.7 KO mice develop comparable mechanical 
and cold hypersensitivity to WT in some models of neuropathic pain as well as in models 
of cancer induced bone pain (Minett et al., 2014b). 
Nav1.8 is selectively expressed in a population of small diameter fibres in dorsal root and 
trigeminal ganglia (Akopian et al., 1996). It produces a TTX resistant, slowly inactivating 
current and is crucial in the upstroke of the action potential and repetitive firing of neurons 
in which it is expressed. Its role in some thermal and mechanical sensitivity in acute and 
inflammatory conditions (Akopian et al., 1999) has been shown through the use of KO 
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mice which show normal behavioural responses to all other stimuli. Ablation of the 
Nav1.8 positive population of sensory neurons leads to almost total insensitivity to cold 
and noxious mechanical pain (Abrahamsen et al., 2008).  
Nav1.9 is responsible for production of the persistent current in peripheral sensory 
neurons (Ostman et al., 2008) and the hyperexcitibility of those neurons in inflammatory 
conditions. Loss of Nav1.9 leads to a loss of mechanical and thermal hypersensitivity in 
inflammatory conditions (Lolignier et al., 2011). Nav1.9 is also critical for normal cold 
sensitivity in physiological and pathological conditions including as a result of oxaliplatin 
induced neuropathic pain (Lolignier et al., 2015a) which is a problem in up to 90% of 
people treated with this chemotherapeutic agent (Kiernan, 2007). 
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Figure 1.17 The primary structure of voltage gated sodium channels. There are 9 α-
subunits in the family of VGSCs; all consist of four homologous domains (DI-DIV) each 
of which has six transmembrane segments (S1–S6). The S4 segment of each domain 
contains positive charge while the linker that connects S5 and S6 forms the external pore 
and selectivity filter. The β-subunits associate with the α-subunits acting to anchor and 
localise the channels. (Taken from (Benarroch, 2007).  
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1.8 Targeted gene deletion strategies in transgenic mice 
1.8.1 Cre/loxP system 
The Cre/lox recombination system allows selective modification of gene expression. In 
order to create a gene knockout, the gene of interest is flanked by 2 loxP sites (red 
triangles; Figure 1.18), derived from Bacteriophage P1 (Sternberg et al., 1981, Sauer and 
Henderson, 1988), which are 34 base pairs in length: 
ATAACTTCGTATAGCATACATTATACGAAGTTAT. The central 8bp sequence, 
(5’-GCATACAT-3’) where recombination occurs, is flanked by 13bp inverted repeat 
sequences. The recombination occurs in the presence of a Cre enzyme which is under the 
control of a promoter of interest. The promoter can be ubiquitous, tissue specific or under 
the control of an inducible system which allows selectivity in the spatial or temporal 
modification of gene expression. In cells where the Cre recombinase is expressed, the 
floxed sequence is excised and removed while one loxP site remains in the targeting 
allele; in tissues not expressing Cre, gene expression is unaffected. 
 
Figure 1.18 The Cre-loxP system allows selective modification of gene expression (red 
arrows, loxP sites). 
 
1.8.2 Flp/FRT system 
The Flp /FRT system works in a similar way to the Cre/loxP system. The flippase 
recombination target (FRT) sites flank the gene of interest and the flippase (Flp) 
recombinase enzyme, from the Saccharomyces cerevisiae yeast (Dymecki, 1996), acts to 
excise the gene of interest at these FRT sites: 
GAAGTTCCTATTCTCTAGAAAGTATAGGAACTTC.  
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2 Aims of this project 
The aim of this thesis is to use transgenic techniques to investigate the contribution of 
candidate mechanosensors to touch and pain in physiological and pathological conditions. 
 First, mice with knockout of multiple TRPC channels are used to investigate their 
role in mechanosensation with a particular focus on TRPC1, TRPC3, TRPC5 and 
TRPC6. TRPC3 and TRPC6 are expressed in a subpopulation of sensory neurons 
which are known to be responsible for sensitivity to mechanical stimuli 
(Abrahamsen et al., 2008) and have been shown to have a combined role in 
innocuous, but not noxious, mechanosensation (Quick et al., 2012). TRP channel 
are believed to show functional redundancy and their known protein interactions 
are vast. As such, we hypothesised that additional TRPC channels may work in 
combination with TRPC3 and TRPC6 to mediate innocuous mechanosensation. 
TRPC1 and TRPC5 are expressed in DRG, have demonstrable roles in 
mechanosensation (Gomis et al., 2008, Garrison et al., 2012) and are known to 
interact with TRPC3 and TRPC6. Using a novel multiple knockout approach, we 
aimed to minimise the effects of functional redundancy by studying TRPC1, 
TRPC3, TRPC5 and TRPC6 quadruple KO mice and elucidate a combinatorial 
role for these TRPC channels in innocuous mechanosensation where monogenic 
studies may have failed. 
 Next, we use a multiple knockout approach to investigate whether TRP channels 
which have roles in mechanosensation contribute to mechanical hypersensitivity 
in Osteoarthritis. Mechanical hypersensitivity is a key clinical feature of 
Osteoarthritis and is poorly understood. Although TRPA1 and TRPV1 have been 
implicated in Osteoarthritis induced pain in pharmacological studies and 
inhibitors of these channels have been tested in preclinical and clinical trials, there 
is some contention over whether these channels do, in fact, play any role in OA 
pain. Although TRPC3 and TRPC6 have established roles in mechanosensation, 
there is no evidence arguing for or against a role in OA induced mechanical 
hypersensitivity. As all of these channels are viable candidates for such a role, we 
hypothesised that their contribution to mechanical hypersensitivity may be 
elucidated most effectively using multiple knockout mice. This novel transgenic 
approach aimed to minimise the influence of characteristics such as functional 
redundancy and heteromerisation and provide insight into the roles of TRP 
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channels in Osteoarthritis pain where pharmacological approaches have produced 
complex and sometimes conflicting findings. 
 Using a combination of gene knockout and gene therapy approaches, the role of 
Annexin A6 in mechanosensation is reported. Mechanically activated currents can 
be classified according to their adaptation profiles and the recent discovery of 
Piezo2 as a transducer of rapidly adapting currents was a huge step towards a 
better understanding of this sensory modality. In spite of this, little is known about 
the protein(s) responsible for the slowly adapting, mechanically activated current 
which is produced by high threshold mechanical stimulation and is associated 
with noxious mechanosensation. NMB-1 is a peptide which selectively blocks the 
slowly adapting current. We identified Annexin A6 as an NMB-1 binding partner 
and found it is also present in a subpopulation of sensory neurons which are 
known to be responsible for sensitivity to mechanical stimuli (Abrahamsen et al., 
2008). After identifying Annexin A6 as a strong mechanotransduction candidate, 
we performed behavioural assessment of global knockout mice and found they 
were hypersensitive to noxious mechanical stimuli. Subsequently, we 
hypothesised that Annexin A6 may in fact be a negative regulator of noxious 
mechanosensation and used electrophysiological and behavioural assessment to 
determine the effect of Annexin A6 overexpression on mechanosensation. 
 Finally, an ASIC4 knockout mouse is used to determine whether this poorly 
understood protein has a role in pain or mechanosensation. ASICs have been 
widely studied as potential contributors to mechanosensation and pain though the 
resulting evidence has provided conflicting insight into the roles these channels 
may be playing. The function of ASIC4 is poorly understood, however in vitro 
studies suggested that it may be involved in the regulation of other ASICs. We 
hypothesised that if ASIC4 also regulates other ASICs in vivo, it may be indirectly 
involved in regulating mechanosensation or sensitivity to other noxious stimuli. 
As such, we characterised the expression of ASIC4 in nervous tissue and 
performed behavioural assessment of the sensory function of a novel, global 
ASIC4 knockout mouse. 
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3 Materials and Methods 
3.1 Molecular Biology 
3.1.1 DNA extraction for genotyping 
Ear tissue samples were taken from mice and digested in 30µl lysis buffer for 60 minutes 
at 55oC then for 5 minutes at 95oC to inactivate Proteinase K. Samples were vortexed, 
spun down and stored at -20oC. 
 
 
 
 
 
 
 
 
 
 
 
 
1µl 19.7mg/ml Proteinase K (Roche) added per 499µl Lysis Buffer. 
Samples were then used to check gene expression with appropriate primers for each gene 
of interest. 
  
Component Volume (ml) 
10X GB 3.60 
25% TritonX-100 0.72 
β-Mercaptoethanol 0.36 
H2O 31.32 
Total 36.00 
Table 3.1 Ear Lysis Buffer reagents 
Component Volume (ml) 
1.5M Tris pH8.8 4.47 
1.0M Ammonium Sulphate 1.66 
1.0M Magnesium Chloride 0.67 
H2O 3.20 
Total 10.00 
Table 3.2 10X GB buffer reagents 
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3.1.2 Polymerase chain reaction for genotyping 
The following components were added to 0.2ml tubes and set up for PCR. A typical 
reaction consisted of: 
11µl Dreamtaq PCR Mastermix (Thermo Scientific) 
11µl H2O 
1µl each primer (10µM) 
1ng template DNA 
(Dreamtaq contains all components necessary for PCR, dNTPs, Taq, buffer) 
 
Samples were then subject to PCR in conditions appropriate for Dreamtaq and specific 
for each primer set. A typical programme is given below: 
Initial denaturation, 95oC for 2 minutes; 
The next 3 steps were cycled 30 times: 
Denaturation, 95oC for 30 seconds; 
Annealing, 55-65oC for 30 seconds (determined from Tm of primers-5oC); 
Extension, 72oC for 30 seconds; 
Final extension, 72oC for 5 minutes 
 
3.1.3 Gel electrophoresis 
Samples were run on a 1% agarose gel to separate bands by size. Gels were prepared by 
dissolving 0.5g agarose (Sigma) per 50ml 1X TAE buffer (40mM Tris-acetate, 1mM 
EDTA). Ethidium bromide (EtBr) was added (0.5μg/ml) and the gel was set. 5µl of an 
appropriate molecular weight marker was run alongside samples in each gel. Samples 
were run for 45 minutes at 100 volts to separate bands which were visualised using a 
Biodoc System. 
3.1.4 RNA extraction 
Animals were culled according to Home Office protocols and DRGs were dissected onto 
ice and stored at 4oC in RNAlater. DRGs were immersed in 0.8ml Trizol and 
homogenised for 3 x 10seconds using a MINILYS benchtop homogeniser (Peqlab).  
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RNA extraction was then performed using an RNEasy Minelute Cleanup Kit (QIAgen). 
Samples were passed through a Qiashredder mini column and spun at 13,000rpm; the 
supernatant was removed and, with 2/10th of the volume of chloroform, was added to a 
phase lock gel tube. The sample was spun at 13,000rpm for 15 minutes at 4oC. The 
resulting colourless, aqueous layer was added to an equal volume of 70% ethanol (in 
DEPC H2O) and spun for 15 seconds in an RNeasy MinElute spin column. Following 
application of a wash buffer to the column membrane, 80µl DNase I in an RNase free 
RDD buffer was added and incubated at RT for 15 minutes to digest genomic DNA. Wash 
buffer was applied to the column membrane, followed by 80% ethanol. The column was 
spun for 15 seconds at 13,000rpm both times and placed in a new 2ml collection tube for 
each step. Once the membrane was dried by spinning, 12µl nuclease free water was 
applied and the column spun for 2 minutes at 13,000rpm to elute the RNA. RNA 
concentration (ng/µl) was checked using a Nanodrop spectrophotometer (Thermo 
Scientific) and RNA was stored at -80oC. 
3.1.5 cDNA synthesis 
The following components were incubated at 25oC for 5 minutes and then at 42oC for 30 
minutes followed by a reverse transcriptase heat inactivation step at 85oC for 5 minutes. 
All reagents were obtained from the iScript cDNA synthesis kit (BioRad). cDNA was 
stored at -20oC.  
 
 
3.1.6 Agarose gel extraction and DNA sequence analysis 
gDNA and cDNA samples which required sequence confirmation were amplified using 
protocols listed above. Next, samples were run on a 1% agarose gel and excised using a 
scalpel before being excised with a Qiagen gel extraction kit. Briefly, the gel fragment 
Component Quantity 
RNA 1 µg 
Random Primers 2µl 
Reverse Transcriptase 1µl 
5x iScript Select Reaction Mix 4µl 
Nuclease Free H2O Volume adjusted as necessary 
Table 3.3 cDNA synthesis reagents 
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was put in a 1.5ml Eppendorf, weighed and dissolved in 3x gel volume (1mg gel~1µl) of 
solubilisation buffer at 50oC for 10mins. 1 gel volume of isopropanol was added to the 
sample which was then applied to a spin column and centrifuged. 750µl wash buffer was 
passed through the membrane and spun before another 1min spin to remove residual 
buffer. DNA was eluted in 50µl elution buffer and centrifuged for 1min and the 
concentration measured using a Nanodrop spectrophotometer (Thermo Scientific). 
Samples were sent to Source Bioscience (Cambridge) for Sanger sequencing. Results 
were analysed using SnapGene viewer software and sequence alignments performed 
using NCBI nucleotide BLAST. 
3.1.7 Reverse transcription polymerase chain reaction (RT-PCR) 
RT-PCR was used to confirm gene knockout in RNA which was isolated from DRG 
samples and reverse transcribed into cDNA as described above. Primers were designed 
to target exon-exon junctions of cDNA sequences.  A typical PCR protocol was used, as 
outlined above. The resulting products were run on an agarose gel alongside a 
housekeeping gene control, GAPDH to ensure the cDNA sample and PCR reaction 
worked. 
3.1.8 Quantitative RT-PCR 
In order to detect levels of gene expression in different tissues, RNA was isolated from 
tissue samples and reverse transcribed into cDNA as described above. Reactions were 
performed in triplicate on a 96-well reaction plate in 20μl volume using Bio-Rad SYBR 
Green Supermix. Reactions were run using a Biorad Real-Time PCR Detection System. 
A typical programme was:- 
Denaturation at 95ºC for 3 min 
The next 3 steps were cycled 40 times: 
Denaturation at 95 ºC for 30 seconds 
Annealing at 60 ºC for 30 seconds 
Extension at 72 ºC for 30 seconds 
Melt curve to check for one specific product 
Results were normalised to GAPDH expression levels and analysed using the 2−ΔΔCt 
method (Livak and Schmittgen, 2001). 
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3.2 Immunohistochemistry 
3.2.1 Tissue collection 
Animals were administered sodium pentobarbitone via intraperitoneal (i.p.) injection 
(150mg/kg) to induce terminal anaesthesia. They were then transcardially perfused with 
0.1 M phosphate buffered saline (PBS) with 0.01μl/1000 ml heparin followed by 4% PFA 
in PBS for 5-10 minutes. Tissues were dissected and post-fixed for 2 h in 4% PFA and 
transferred to 30% w/v sucrose in 0.1 M PBS at 4°C overnight. Tissues were then 
mounted in OCT medium and stored at ‐ 80 °C. 
3.2.2 Sectioning 
Tissues were sectioned using a Cryostat and mounted onto Superfrost Plus slides (Thermo 
Scientific). DRG were sectioned at 10µm thickness and spinal cord at 30µm thickness. 
Slides were dried for 2 hours at RT then stored at -20oC. 
3.2.3 Immunostaining 
Tissue was removed from -80oC and dried at 4oC for 30 mins then at RT for 120 mins. 
Slides were washed with 1xPBS containing 0.3% Triton X-100 (PBST) for 3 x 5 mins 
then with PBST containing 10% goat serum (blocking buffer) for 60 mins at RT. Primary 
antibodies (Table 3.4) were applied to the slides, diluted in blocking buffer, and left at 
4oC overnight. Slides were then washed for 3 x 10 mins in PBST before secondary 
antibodies, diluted in blocking buffer (Table 3.4), were applied for 2 hours at RT. 
Secondary antibodies were removed by washing in PBST for 3 x 10 mins. The slides were 
dried at RT in the dark and then mounted with Vectashield mounting medium and a 
coverslip before being sealed and stored in the dark. 
3.2.4 Analysis 
After drying, sections were imaged using a Leica SP5 confocal microscope or Leica 
DMRB microscope with Hamamatsu ORCA-R2 digital camera and HCImage software. 
Images were processed using EMBL ImageJ software using global adjustments in 
brightness and contrast. 
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3.3 Western blotting 
3.3.1 Tissue preparation 
Animals were culled according to Home Office protocols and tissues were dissected onto 
dry ice and homogenized for 90 seconds with Precellys ceramic beads (Peqlab) in ~300µl 
modified RIPA buffer. Cell lysates were incubated for 1hr shaking on ice. Following a 
final homogenisation step, samples were centrifuged for 8 minutes at 14,000 RPM at 4oC. 
3.3.2 Protein quantification 
Samples were prepared using the bicinchoninic acid (BCA) kit (Thermo Scientific) 
according to manufacturer’s instructions and compared to 5 standards of bovine serum 
albumin (BSA) from 0µg/µl to 2µg/µl. Briefly, protein samples were made up to dilution 
factors of 1, 2, 5 and 10 using 1ml solution A and 20µl solution B. Samples and standards 
were incubated at 37oC for 30 minutes. Standards were analysed using a Nanodrop 
spectrophotometer (Thermo Scientific) to produce a standard curve which allowed 
quantification of sample concentrations. 
3.3.3 SDS-PAGE 
3X loading buffer (NEB; 187.5mM Tris-HCl, 6% w/v SDS, 30% glycerol) with 1ml DTT 
(1.25M) was added to the protein samples and denatured at 95oC for 5 mins. 20-60µg 
protein was loaded onto a Mini-PROTEAN TGX Stain-Free precast gels (4-12% 
Gradient, Bio-Rad) alongside a Spectra Multicolor High Range Protein ladder (Thermo 
Scientific) in 1X running buffer (10X stock; 30.3g Tris Base, 144g glycine, 10g SDS at 
pH 8.3) and run for 15 minutes at 120V and then 45 minutes at 100V. 
3.3.4 Wet transfer 
Immobilin-P membranes (Millipore) were activated with Methanol. Proteins were 
transferred onto the membrane in 1X ice cold transfer buffer (10X Stock Transfer Buffer, 
30g Tris base, 144g glycine in 1L dH2O) for 1 hour at 100V. 
3.3.5 Blocking and antibody incubation 
Membranes were incubated in blocking solution (1x PBST; 10X PBS stock (Gibco) 
pH7.5, 0.1% Tween 20 (Sigma); 5% Marvel) for 2 hours at RT and then at 4oC overnight 
in primary antibody (Table 3.4) and blocking solution. For peptide control samples, 
primary antibody was pre-incubated with peptide antigen at RT for 30 minutes with 
shaking. 
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Membranes were washed 4 times in 1X PBST before incubation with horse radish 
peroxidase (HRP) conjugated secondary antibodies (Table 3.4) in blocking buffer (1x 
PBST with 2.5% Marvel) for 90 minutes at room temperature with shaking. Membranes 
were washed 4 times in 1X PBST. Protein was incubated with Pierce ECL 
chemiluminescent substrate (Thermo Scientific) for 1 minute before visualisation on X-
ray films (GE healthcare) using an X-ray film developer. 
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3.4 Antibodies 
 
  
Experiment 
Primary 
Antibody 
Dilution Company 
Secondary 
Antibody 
Dilution Company 
WB 
anti-
ASIC1 
1:600 Alomone 
ECL anti-
Guinea pig 
HRP 
conjugated 
IgG (from 
goat) 
1:16000 
GE Life 
sciences 
WB 
anti-
ASIC4 
1:200 Alomone 
ECL anti-
Rabbit HRP 
conjugated 
IgG (from 
donkey) 
1:16000 
GE Life 
sciences 
WB anti-βactin 1:1000 
Santa 
Cruz 
ECL anti-
Mouse HRP 
conjugated 
IgG (from 
sheep) 
1:16000 Abcam 
WB anti-GFP 1:200 Abcam 
ECL anti-
Rabbit HRP 
conjugated 
IgG (from 
donkey) 
1:2000 Abcam 
WB 
anti-
Anxa6 
1:400 Abcam 
ECL anti-
Rabbit HRP 
conjugated 
IgG (from 
donkey) 
1:2000 Abcam 
IHC 
 
anti-
Peripherin 
1:200 Sigma 
Alexa Fluor 
594 
conjugated 
goat anti-
mouse IgG 
1:1000 
Life 
technologies 
IHC anti-GFP 1:2000 Abcam 
Alexa Fluor 
488 
conjugated 
goat anti-
rabbit IgG 
1:1000 Abcam 
IHC 
 
anti-IB4 1:500 Sigma 
Alexa Fluor 
568 
Streptavidin 
conjugates 
1:1000 
Life 
technologies 
Table 3.4 Antibodies used for Western Blot (WB) and Immunohistochemistry (IHC) 
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3.5 Behavioural testing 
Animals were acclimatised for an appropriate amount of time for each test. Tests 
determined to be painful were performed on different groups of animals where possible. 
Mice were used at 6-12 weeks old and 5-8 weeks old for hearing tests.  
3.5.1 Von Frey 
von Frey testing is a behavioural paradigm designed to investigate sensitivity to an 
innocuous mechanical stimulus. A set of 20 nylon hairs of weights ranging from 0.008g 
– 300g were used to apply pressure to the plantar surface of the paw. A hair of 0.4g was 
always used first. von Frey testing was performed using the up-down method (Chaplan et 
al., 1994) to determine the 50% paw withdrawal threshold. This involved applying a von 
Frey filament to the paw; if a positive response was obtained, a filament of lesser force 
was applied next but if no response was seen a filament of greater strength was applied. 
This was continued until 6 responses were obtained with a positive response consisting 
of lifting, flinching or licking of the paw during or immediately after stimulus application. 
In order to complete the test, animals were kept in a mesh bottomed enclosure in which 
they were acclimatised for at least 60 minutes prior to testing.  
The same technique was used when testing mechanical threshold on the hairy skin of the 
abdomen. Since glabrous and hairy skin receive different sensory innervation, both types 
of skin were investigated in order to determine whether deletion of TRP channels may 
have an effect on mechanical threshold in either or both types of skin. 
3.5.2 Cotton Swab test 
The cotton swab test is a different measure of innocuous sensitivity than the up-down von 
Frey technique. It is a dynamic stimulus; a cotton swab puffed out to 15mm diameter (3x 
normal size) was moved across the glabrous skin of the paw in a ~1 second sweep as 
described by Garrison et al. (2012). The cotton swab stimulus was applied 5 times to each 
animal with a break of ≥60 seconds and the number of responses was recorded to produce 
a score out of 5. 
3.5.3 Randall Selitto 
The Randall Selitto test is used to assess the noxious mechanical pain threshold and was 
used on the tail and paw of animals. The test designed by Randall and Selitto (1957, as 
cited in Minett (2011)) and modified by Takesue et al. (1969) involves application of a 
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blunt probe to a surface (paw or tail) with increasing pressure until the animal exhibits a 
painful response. Such signs include struggling, withdrawal of tail or paw or vocalisation. 
The test was repeated 3 times for each animal. 
When testing the tail, animals were restrained in a clear plastic tube with an 
acclimatisation period of approximately 5 minutes while for testing the paw, animals were 
restrained through holding the scruff of the neck in such a way that a response could still 
be observed. 
3.5.4 Hargreaves 
The Hargreaves test, originally designed to assess thermal nociception in inflammatory 
pain states (Hargreaves et al., 1988), was used to assess spinal reflex responses to noxious 
thermal stimulation. Animals were acclimatised in an enclosure with a glass base for a 
minimum of 60 minutes. A radiant heat light source was applied to the plantar surface of 
the hind paw with a cut off time of 30 seconds. The stimulus was stopped when a painful 
response was observed (licking, lifting or shaking the paw) and the latency to paw 
withdrawal (in seconds) was recorded. Three recordings were made from each animal and 
an average taken.  
3.5.5 Hot Plate 
The hot plate test is designed to test responses to noxious thermal stimuli but unlike the 
Hargreaves test, it is believed to involve supraspinal mechanisms (Chapman et al., 1985). 
Prior to testing, mice were acclimatised on the unheated plate. Once heated to the desired 
temperature, mice were placed on the plate and the time until the first distinctive pain 
behaviour (licking or shaking of hind paw) was recorded, at which point mice were 
removed from the plate. Temperatures used were 50oC and 55oC (±0.2oC) according to 
the initial description of the technique by Macdonald et al. (1946) and amended by Eddy 
and Leimbach (1953) with testing for each temperature performed in separate sessions.  
3.5.6 Thermal Place Preference 
Cold sensitivity tests provide insight into sensitivity of animals to noxious cold 
temperatures. It is suggested that temperatures <15oC can be considered to be at a noxious 
level of cold. For this project, cold sensitivity was assessed using a place preference set 
up. Two adjacent plates (a test plate and second plate) were held at 20oC while animals 
were allowed to explore for 120 seconds. The temperature of the test plate was then 
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dropped to 4oC and animals explored for a further 120 seconds. In both trials, animals 
were placed onto the test plate (in order that they were exposed to the cold temperature) 
and the time spent on the test plate was recorded. The test plate and second plate were 
switched in order that environmental effects did not bias the time spent on the test plate. 
3.5.7 Rotarod 
The accelerating rotarod test was used as a measure of motor coordination (Jones and 
Roberts 1967). Mice were placed onto a rotarod machine turning at 6 rpm. This speed 
was maintained for 30 seconds to allow animals to acclimatise. Time spent on the rotarod 
was recorded from the end of this period at which point the speed was increased from 
6rpm to 40 rpm on a 3 minute ramp with a cut-off point of 5 minutes from the start of 
acceleration. The timer was stopped when animals fell from the rotarod or made 3 full 
rotations within a 10 second period. This was repeated 3 times per animal. 
3.5.8 Swim Test 
The forced swim test was, in this case, used as a measure of vestibular function. Although 
this test can be used to investigate many different faculties, applying simple parameters 
allow it to be used as a means of studying vestibular function while unaffected by 
proprioceptive inputs seen in other tests performed on a solid surface. The test was 
initially designed by Porsolt et al. (1978) and since has frequently been used to monitor 
vestibular deficits in rodents (Gray et al., 1988, Kaiser et al., 2001, Burne et al., 2006). A 
protocol similar to that performed by Can et al. (2012) was employed. 
Animals were placed in a 15cm deep water bath which was maintained at 23-25oC and 
allowed to swim for 1 minute. They were then removed and dried in heated chamber. The 
test was recorded and analysed in slow motion using Realtime player software and the 
number of times the head of the animal was submerged under water was recorded. 
3.5.9 Trunk Curl Test 
The trunk curl test acts as a crude measure of vestibular function. Each animal is held in 
the air by the tail 5 cm away from a horizontal surface for 5 seconds. A wildtype mouse 
should demonstrate a reaching movement towards the horizontal surface, whereas 
animals with vestibular deficits are inclined to curl towards the abdomen (Hardisty-
Hughes et al., 2010). A scoring system was used to quantify this; if the mouse reached its 
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forelimbs towards the surface, it received a score of 1. If the mouse curled towards the 
abdomen, it received a score of 0. A partial curl received a score of 0.5. 
3.5.10 Auditory testing 
3.5.10.1 Click Box 
The click box test was performed to investigate hearing function. Animals were put in 
individual enclosures and allowed to acclimatise for 60 minutes. The device was held 
20cm above each animal and an 89dbSPL click with a frequency of 19.5 kHz was emitted. 
The Preyer reflex response is the response of a wild type mouse to such a sound and 
involves the ears moving flat against the back (Jero et al., 2001). The test was recorded 
and analysed in slow motion using Realtime player software. If the response was 
observed, a score of 1 was given; for no response a score of 0 was given and for a partial 
response, a score of 0.5 was given. All animals were tested with 3 consecutive clicks, 
separated by a period of at least 5 seconds. 
3.5.10.2 Auditory Brainstem Response recordings 
Performed by Dr. Ruth Taylor 
Mice were anaesthetised and an active electrode placed between the ears at the vertex 
with a reference electrode at the mastoid and a ground electrode at the tail. Tone pip 
stimuli of 8, 12, 24, 32 and 40 kHz were applied at varying sound pressure levels to allow 
determination of the threshold (dB) required to elicit a response. (Protocol as previously 
reported (Quick et al., 2012) and, this time, provided and implemented by Dr Ruth Taylor, 
UCL Ear Institute). C57BL/6 mice have been shown to develop early onset hearing loss 
(Henry and Chole, 1980), so mice were used between the ages of 4 and 8 weeks of age. 
3.5.10.3 Mechano-electrical Transducer Current recordings 
Performed by Terri Desmonds 
Mechano-electrical transducer (MET) currents were recorded from outer hair cells in 
cultured cochlea from early postnatal animals (~P2) using whole-cell patch clamp. A fluid 
jet was used to generate a 45 Hz sinusoidal force with a driver voltage (DV) amplitude of 
40V. The holding potential of -84mV was stepped in 20 mV increments from -164 mV 
to +96 mV.  (Protocol as previously reported (Quick et al., 2012) and, this time, provided 
and implemented by Terri Desmonds, University of Sussex).  
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3.5.11 Inflammatory pain models 
3.5.11.1 Formalin Test 
The Formalin test was first modified for mice in order to provide a model of continuous, 
moderate pain which allowed non-invasive assessment of pain behaviour (Hunskaar et 
al., 1985). Animals were acclimatised to a Perspex box for at least 1 hour prior to testing 
when a 20µl intraplantar injection of 5% Formalin was given in the hind paw. Animals 
were observed for the next 60 minutes and the time spent licking, shaking or biting the 
affected paw was measured in five minute blocks.  
The test involves an early acute phase, which is believed to involve direct activation of C 
fibres via TRPA1 (Tjolsen et al., 1992, McNamara et al., 2007) and occurs around 5-10 
minutes after injection. The second, inflammatory phase begins around 20 minutes after 
injection and believed to result from the action of prostaglandins and other inflammatory 
mediators as well as spinally mediated changes (Dubuisson and Dennis, 1977, Hunskaar 
and Hole, 1987, Tjolsen et al., 1992). 
3.5.11.2 CFA 
Complete Freund’s Adjuvant (CFA) injection is used as a model of lasting inflammatory 
hypersensitivity to both thermal and mechanical stimuli and is a well-established model 
for use in mice (Larson et al., 1986). It causes sustained thermal and mechanical 
hyperalgesia which are linked to TNFα release in the periphery (Cunha et al., 1992) as 
well as spinal changes such as increased density of postsynaptic NMDA receptors (Yang 
et al., 2009). 
Animals received a single, intraplantar injection of 20µl of 100% CFA (Sigma) and were 
tested for mechanical and thermal hypersensitivity using the von Frey up-down method 
and the Hargreaves test, respectively for up to 14 days. 
3.5.12 Model of chronic muscle pain 
Mice received an injection of 20µl of pH 4 acidic saline into the gastrocnemius muscle 
on days 0 and mechanical hypersensitivity was analysed by von Frey stimulation on the 
ipsilateral and contralateral paw using the up-down method and using a static weight 
bearing machine to assess weight distribution over the hind paws. This model has been 
shown to induce chronic mechanical hypersensitivity in the absence of tissue damage 
(Sluka et al., 2001), unlike comparable administration of inflammatory stimuli. 
 93 
 
3.5.13 Model of visceral pain and referred hypersensitivity 
0.1% w/v capsaicin was dissolved in 10% ethanol, 10% Tween80 and 80% saline and 
50µl was administered into the colon using a synthetic cannula, 4cm long and 0.61mm 
diameter according to the protocol designed by (Laird et al., 2001). Animals were then 
filmed for 20 minutes after administration of capsaicin to allow analysis of visceral pain. 
Pain behaviours were analysed using Realtime player and counted when behaviours 
including pressing the abdomen onto the floor of the holding box, licking or biting the 
abdomen and stretching or retracting the abdomen were observed. Subsequently 10 
applications of a 0.16g von Frey filament to the abdomen and the number of responses 
were counted. The hair was applied for 1–2 s to the abdomen with an inter-stimulus 
interval of 10 s. Responses included licking or biting the abdomen at the site of 
stimulation, arching the abdomen away from the site of stimulation or jumping. 
3.5.14 Induction of Arthritis 
The monosodium iodoacetate model of Osteoarthritis was first described by Kalbhen 
(1987) (as cited in (Combe et al., 2004)) and has been widely used in rats to produce 
symptoms allied to OA in humans. These include cartilage degradation, synovial 
inflammation, osteoclast formation and ultimately bone remodelling. This model, though 
beginning to be used in mice (Harvey and Dickenson, 2009), has been less thoroughly 
investigated than in rats. We therefore began by doing a dose-response study and 
proceeded using a dose of 0.5mg Sodium Iodoacetate (Sigma) dissolved in 5µl sterile 
0.9% Saline (Sigma) injected intra-articularly into the knee joint of each animal. Pain 
behaviour was assessed by stimulation with von Frey filaments using the up-down 
method and using a static weight bearing machine to assess weight distribution over the 
hind paws. 
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3.6 Gene therapy 
3.6.1.1 AAV production and purification 
Performed by Dr Julie Tordo 
The human Annexin A6 gene was cloned into two different serotypes of adeno associated 
virus (AAV), 6 and X. The gene was inserted downstream of an IRES-eGFP construct to 
allow subsequent observation of transduced neurons.  
To produce recombinant AAV (rAAV) vectors, cells were transiently co-transfected with 
two plasmids: the plasmid containing the transgene flanked by the inverted terminal 
repeat (ITRs) of AAV2, and a helper plasmid that provides the excised AAV-specific 
genes rep and cap in trans and the adenovirus helper functions necessary for virion 
formation. To produce AAV6 or AAVx recombinant vectors, the specific capsid gene 
(cap) of each virus was inserted into the helper plasmid.  
To produce recombinant AAV virions, 5x108 HEK293T cells were seeded per cell factory 
(CF10). 14 to 18 hours later, the cells were double transfected with the ITR-containing 
plasmid pAAV-CMV-AnxA6-IRES-GFP, and either of the helper plasmids to produce 
AAV6 or AAVx-CMV-AnxA6-IRES-GFP vectors. The cells were harvested after 72 
hours of incubation at 37°C by centrifugating the media and cells; The supernatant was 
removed and kept for further treatment, and the cell pellets were resuspended in lysis 
buffer (150mM NaCl, 50mM Tris pH8.5). The cell pellets were then lysed by 4 cycles of 
freeze and thaw to release the virus, where each cycle consists of 30 minutes at -80°C 
followed by 30 minutes at 37°C. After the last thaw the lysate was treated with benzonase 
and incubated at 37° for 30 minutes. The lysate was then spun at 4000 rpm for 30 minutes 
for clarification and the resulting supernatant was filtered. The cell culture supernatant 
was also harvested and precipitated by adding 31.3 g ammonium sulfate salt per 100 ml 
of collected media supernatant. After shaking to dissolve the salts, the supernatant was 
incubated for 30 minutes on ice then spun for 30 minutes at 8300 g. The resulting pellet 
was resuspended in lysis buffer, treated with benzonase, clarified by centrifugation and 
filtered.  
The recombinant AAV virus preparations were purified by FPLC using the ÄKTApurifier 
chromatography system (GE Healthcare) and an AVB sepharose affinity column (buffer 
A: PBS, pH 8; buffer B: 0.5M glycine, pH2.7). The collected fractions were then dialysed 
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against PBS overnight. For mice injections, the virus samples had to be concentrated as 
only limited volumes of vectors can be injected in vivo. We then performed real time 
quantitative PCR and SDS polyacrylamide gel electrophoresis (SDS-PAGE) assays to 
assess the viral genomes titers and capsids titers, respectively, of the concentrated vectors. 
The vectors were then titer-matched before injection.  
3.6.1.2 Real-time Quantitative PCR analysis 
Performed by Dr Julie Tordo 
The number of genome copies of AAV in the viral stock was determined by quantitative 
PCR (qPCR) using primers targeted to the GFP transgene; GFP forward (5’ GAC GGC 
AAC ATC CTG GGGCAC AAG 3’) and GFP reverse (5’ CGG TCA CGA ACT C 3’). 
qPCRs were performed in a master mix solution containing SYBR Green PCR master 
mix with MgCl2 (Applied Biosystems), forward and reverse GFP primers, Reference 
Dye, and dH2O. Samples were added into each well of a 384-well plate and each 
condition was assayed in duplicate. The PCR conditions consist of an initial denaturation 
step at 94°C for 5 min followed by 40 cycles of denaturation at 94°C for 10 sec, annealing 
at 60°C for 20 sec, and extension at 72°C for 40 sec.  
3.6.1.3 SDS-PAGE 
Performed by Dr Julie Tordo 
Protein samples were electrophoresed on a polyacrylamide gel in the presence of SDS, 
and stained using Sypro Ruby Stain.  
12% polyacrylamide gels were loaded with various dilutions of viral samples, along with 
bovine serum albumin at quantities ranging from 500ng to 62.5ng to realise a standard 
curve. Each sample was mixed with 6x loading buffer and heated for 5 minutes at 95°C 
prior to loading. The gels were run at 110V in 1x Tris-glycine buffer until the loading dye 
exited the bottom of the gel. The gel was then immersed and agitated in fixing solution 
(50% ethanol, 15% (v/v) acetic acid in ultrapure water) twice for 10 minutes before 
immersion and agitation in ultrapure water for 5 minutes. An overnight stain of the gel 
was then performed with Sypro Ruby Stain (Pierce Biotechnology) following 
manufacturer’s instructions.  
 96 
 
3.6.1.4 Administration of viral vectors 
A viral titre of 5x1012VP/ml was administered intrathecally to mice at the sixth lumbar 
level, following an intravenous injection of 25% Mannitol. Pre-treatment with mannitol 
has been shown to increase viral transduction into primary sensory neurons (Vulchanova 
et al., 2010).  
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3.7 Patch clamp electrophysiology 
Performed by Dr. Stéphane Lolignier 
3.7.1.1 Culture and transfection of dorsal root ganglia 
Immediately after CO2 euthanasia, DRG were removed from 6-12 week old mice and 
digested for 35 min at 37°C in Ca2+- and Mg2+-free Hanks’ balanced salt solution (HBSS) 
containing 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 10 mM 
glucose, 5 mg/ml collagenase type XI and 10 mg/ml dispase. After digestion, DRG were 
gently triturated in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% 
qualified foetal bovine serum (FBS) using fire-polished glass Pasteur pipettes. When 
required, neurons were electroporated using the Neon Transfection System (Life 
Technologies) according to the supplier’s recommendations, in 10 µl tips and with 0.6 µg 
plasmid per reaction, applying 2 x 20 ms pulses of 1100 V. Cells were plated on poly-L-
lysine and laminin coated dishes, in DMEM containing 10% FBS and 125 ng/ml 7S nerve 
growth factor (NGF). Neurons were kept at 37°C in 5% CO2 and used for patch clamp 
studies the two following days, or at 48 ± 4 h for electroporated neurons. 
3.7.1.2 Patch clamp recordings 
Small (< 30 pF) or large (> 30 pF) DRG neurons whose soma were not in contact with 
those of other neurons, and who were displaying clear fluorescent signal when 
transfection was performed, were selected for electrophysiological recordings. Patch 
pipettes were pulled from borosilicate glass capillaries using a PC-10 puller (Narishige 
Group) and had a resistance of 1.5-3.5MΩ. The pipette solution contained (in mM): 125 
CsCl, 4.8 CaCl2, 1 MgCl2, 4 MgATP, 0.4 Na2GTP, 10 ethylene glycol tetraacetic acid 
(EGTA) and 10 HEPES (pH: 7.4 with CsOH; osmolarity: 310 mOsm with sucrose). The 
bath solution contained (in mM): 132 NaCl, 3 KCl, 2.5 CaCl2, 1 MgCl2, 10 glucose, 10 
HEPES (pH: 7.4 with NaOH; osmolarity: 310 mOsm with sucrose). Voltages were not 
corrected for junction potentials and recordings were performed at room temperature. 
Voltage and current clamp recordings were performed using a MultiClamp 200B 
amplifier and an Axon DigiData 1440A digitizer (Molecular Devices). Data were 
recorded and stored using Clampex 10 (Molecular Devices). Current recordings were 
low-pass filtered at 5 kHz and sampled at 20 kHz. Capacity transients were cancelled; 
however, series resistances were not compensated. Holding command was set at -70 mV 
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before and during mechanical stimulation. Off-line analysis and fits were performed using 
Clampfit 10 (Axon Instruments, Molecular Devices Inc.). 
3.7.1.3 Mechanical stimulation and analysis 
Mechanical stimulation of cell bodies was achieved using a heat-polished glass pipette 
(tip diameter of approximately 2 µm) controlled by a piezo-electric crystal drive (Burleigh 
LSS-3000) and placed above the centre of the cell soma at an angle of 70° to the surface 
of the dish. The probe was positioned so that a 10 µm movement did not visibly contact 
the cell but that an 11 µm movement, considered as a 1 µm stimulus, produced an 
observable membrane deflection. The probe was moved at a speed of 1 µm/ms. 250 ms 
mechanical steps were applied every 10 s in 1 µm increments. 
Currents were characterized as a function of the signal given by the highest stimulation 
intensity applied before the seal was lost. Cells were considered as non-responding when 
no current > 20 pA was observed with a 12 µm stimulus. Responding cells were then 
classified regarding to the adaptation kinetics of their currents. Rapidly adapting currents 
had a decay kinetic that was best described by a bi-exponential fit. Intermediately 
adapting currents had a decay kinetic that was best described by a mono-exponential fit. 
Slowly adapting currents showed minimal decay (< 20%) during the 250ms stimulation. 
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3.8 Statistical analysis 
Data were analysed using Graphpad Prism 6. Student’s unpaired t tests were used to 
compare groups or one or two-way ANOVA with post-hoc tests, where appropriate. If 
data could not be assumed to be normally distributed or did not satisfy the Shapiro-Wilk 
normality test, non-parametric analysis was used; Mann Whitney or Kruskal Wallis with 
post hoc tests; are stated for each experiment where appropriate. Data are presented as 
Mean±SEM. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001 
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4 The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch 
and hearing 
4.1 Summary 
Transient receptor potential channels have diverse roles in mechanosensation. Recently, 
TRPC3 and TRPC6 have been shown to be necessary for normal touch and hearing as 
animals lacking functional expression of both channels show reduced innocuous 
mechanosensitivity and altered hearing and vestibular function. However, the fact that 
single knockout mice are apparently normal suggests that TRPC3 and TRPC6 together, 
contribute to mechanosensation. We have extended these studies to analyse deficits by 
additionally knocking out TRPC1 and TRPC5 in triple and quadruple knockout mice. 
TRPC1 and TRPC5 have both been shown to have roles in mechanosensation and stretch 
activation, respectively, and are coexpressed in sensory neurons with TRPC3 and TRPC6. 
We examined both touch and hearing in behavioural and electrophysiological assays, and 
provide evidence that triple and quadruple knockout mice have larger deficits than double 
knockout mice. Mechano-electrical transducer currents of cochlear outer hair cells were 
however normal. This suggests that TRPC1, TRPC3, TRPC5 and TRPC6 channels 
contribute to cutaneous and auditory mechanosensation in a combinatorial manner, but 
have no direct role in cochlear mechanotransduction. 
4.2 Introduction 
4.2.1 TRPC channels 
The classical or canonical family of TRP channels, known as TRPCs, were the first family 
of TRP channels to be identified (Wes et al., 1995). The seven members of the 
mammalian TRPC family can be subdivided into groups according to amino acid 
sequence homology; TRPC1; TRPC3/6/7; TRPC4/5 and TRPC2. The latter acts as a 
pseudogene in humans but has a role in pheromone sensing in rodents (Montell, 2005). 
Characteristics of the family include 3 to 4 ankyrin repeats located near to the N terminus 
and a TRP domain located close to the C terminus. Of particular interest to this study are 
canonical TRP channels 1, 3, 5 and 6 due to their known roles in mechanosensory 
function, their known interactions and their coexpression in DRG neurons. 
Canonical TRP channels exhibit low levels of expression early in development but their 
increase in expression levels aligns, temporally, with the gain of sensory functions (Elg 
et al., 2007). TRPC3 is the most highly expressed of the TRPC channels in tissues such 
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as the brain, skeletal muscle and heart and is also expressed in the kidney, pancreas and 
lung (Kunert-Keil et al., 2006). In addition, TRPC1, TRPC5 and TRPC6 are expressed in 
the brain, with TRPC6 found at particularly high levels in the Purkinje cells of the 
cerebellum (Kunert-Keil et al., 2006) and TRPC5 in growth cones of the hippocampus 
(Table 4.1) (Clapham, 2003). In the DRG, TRPC1, TRPC3 and TRPC6 are the most 
abundantly expressed TRPC subunits and their expression has been observed in most 
sensory neurons in adult mice (Elg et al., 2007, Quick et al., 2012). In addition, TRPC5 
has been found to be localised to small and medium diameter sensory neurons (Table 4.1) 
(Zimmermann et al., 2011). A single cell RNA sequencing study also determined a non-
peptidergic subset of neurons which express all four TRPC subunits (Usoskin et al., 2015) 
meaning there is substantial potential for interaction between different combinations of 
these TRPC subunits. Additionally, all TRPC channels are found within the inner ear 
(Takumida and Anniko, 2009). As this study investigates the roles of TRPC channels 
using global KO mice, the expression of these channels must be taken into account. 
The function of TRPC channels in sensory systems has been widely investigated and 
many TRPC channels have been implicated in roles in mechanosensation. An 
understanding of their mechanisms of activation is an integral part of this (Table 4.1). 
TRPC1 is believed to be a store operated channel which is activated as a result of 
depletion of intracellular Ca2+ (Wes et al., 1995, Zitt et al., 1996). Much evidence suggests 
TRPC3 functions as a receptor activated channel (McKay et al., 2000, Venkatachalam et 
al., 2001) linked to the presence of the phosphotidylinositol bisphosphate (PIP2) 
metabolite, diacylglycerol (DAG) (Trebak et al., 2003a) though other studies have 
indicated that it functions as a store operated channel (Vazquez et al., 2001). Subsequently 
it was proposed that the activation mechanism of TRPC3 may be dependent on its 
expression levels; low levels of expression allow it to function as a store operated channel 
while at higher levels of expression it is coupled to receptor activation (Vazquez et al., 
2003). Functionally distinct splice variants of TRPC3 have also been identified 
suggesting potentially even greater diversity in the mechanisms of activation of this 
channel (Kim et al., 2012a). TRPC5 is also considered to be activated by receptor 
coupling (Okada et al., 1998) and is sensitive to intracellular Ca2+ levels (Blair et al., 
2009). Like TRPC3, TRPC6 has been shown to be activated by DAG in a Protein Kinase 
C independent manner and independently of intracellular Ca2+ stores and PIP2 metabolite 
inositol trisphosphate (IP3) (Hofmann et al., 1999, Trebak et al., 2003b). For example, it 
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is believed to contribute to mechanosensory function in the cardiovascular system 
indirectly though activation of the Angiotensin II (AT1) receptor (Saleh et al., 2006). 
TRPC3 shows significantly higher levels of basal activity than TRPC6 owing to different 
levels of N terminal glycosylation (Dietrich et al., 2003) however that both can be 
activated by DAG which is also involved in activity of stretch activated channels further 
highlights their potential relevance to mechanosensory function. It has been proposed that 
the process of DAG production from the breakdown of PIP2 can lead to membrane stress 
which is comparable to stretch and that this is potentially a mechanism by which DAG 
sensitive TRPC channels could be sensitive to mechanical force (Hardie and Franze, 
2012). 
More recently, it has been suggested that TRPC3 and TRPC6 may also be subject to more 
direct regulation by PIP2 independent of DAG (Lemonnier et al., 2008, Imai et al., 2012). 
Interestingly, Hardie and Franze showed that exposure to light evoked PLC-mediated 
contractions of the lipid membrane in photoreceptor cells of Drosophila. When 
mechanosensitive channels were expressed in these cells, they were activated by these 
contractions suggesting lipid mediated mechanical gating of TRP channels in sensory 
function (Hardie and Franze, 2012, Rohacs, 2013). The complexities of the mechanisms 
of channel activation for TRPC channels are somewhat difficult to define. This is 
complicated further by the fact that many in vitro investigations may not accurately mimic 
behaviour of the native forms of the channels. Crucially, the ability of TRPC channels to 
form functional heteromers which, evidence suggests, do not necessarily behave in the 
same way as homomeric channels (Clapham, 2003) adds to the difficulty of dissecting 
out the mechanisms of action and function of each TRPC channel subunit. This has been 
shown to be true in the case of TRPC3 and TRPC6 in mechanosensation. 
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Table 4.1 Properties of canonical TRP channels. TRP-protein interactions are also 
mapped in the TRIP database (Shin et al., 2011, Shin et al., 2012). 
  
TRPC 
Channel 
Mechanism of 
Activation (proposed) 
Expression 
Selectivity 
PNa : PCa 
Evidence of heteromerisation 
TRPC1 Store operated channel 
Heart, brain, 
kidney, DRG 
Non 
selective 
TRPC3 (Liu et al., 2005) 
TRPC5 (Strubing et al., 2001)  
TRPC6 
TRPV4 (Ma et al., 2011)  
TRPP2 (Kobori et al., 2009) 
TRPC2 
Store operated channel, 
DAG 
Vomeronasal 
organ, testis 
2.7 TRPC6 
TRPC3 
Store operated channel, 
DAG 
Brain, kidney, 
lung, pancreas, 
DRG 
1.6 
TRPC1 (Liu et al., 2005, Yuan et al., 
2007) 
TRPC6 (Hofmann et al., 2002) 
TRPC7 (Hofmann et al., 2002) 
TRPC4 Store operated channel 
Brain, 
endothelia, 
adrenal gland, 
retina, DRG 
7 
TRPC1 (Shin et al., 2011) 
TRPC3 (Shin et al., 2011) 
TRPC5 (Shin et al., 2011) 
TRPC6 (Shin et al., 2011) 
TRPC5 
Store operated channel, 
DAG 
Brain, kidney, 
liver, TG, 
DRG 
9.5 TRPC1 (Strubing et al., 2001) 
TRPC6 DAG 
Brain, lung, 
heart, DRG 
5 
TRPC3 (Hofmann et al., 2002) 
TRPC4 (Yuan et al., 2007) 
TRPC7 (Hofmann et al., 2002) 
TRPC7 
Store operated channel, 
DAG 
Eye, heart, 
lung 
1.9-5 
TRPC1 (Shin et al., 2011) 
TRPC3 (Shin et al., 2011) 
TRPC5 (Shin et al., 2011) 
TRPC6 (Shin et al., 2011) 
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TRPC3 and TRPC6, which are known to heteromerise (Hofmann et al., 2002), came to 
light as potential cutaneous mechanosensors as a result of their expression in a subset of 
sensory neurons which are necessary for normal mechanosensation (Abrahamsen et al., 
2008). Knockout mice were created with global deletion of either TRPC3 or TRPC6 or 
both genes. It was shown that mice with global deletion of both TRPC3 and TRPC6 
(double knockouts; DKO) have attenuated innocuous mechanosensitivity which is 
reflected by a decrease in RA mechanically activated currents in DRG neurons taken from 
DKO mice (Quick et al., 2012). In the past, other potential mechanotransducers have lost 
favour as they lacked a role in transduction of auditory stimuli in the cochlea. In contrast 
to this, the previous data also suggested that DKO animals had a high frequency hearing 
deficit. Interestingly, when expressed heterologously, TRPC3 with or without TRPC6 is 
able to confer mechanosensitivity to ND-C cells but not HEK cells. ND-C cells are a 
sensory neuron derived cell line which display a slight endogenous mechanosensitivity 
(Rugiero and Wood, 2009). The context dependent ability of TRPC3 and TRPC6 to 
confer mechanosensitivity to cell lines suggests that these channels are, alone, insufficient 
to form a primary mechanotransduction complex. For example, Piezo2 produces a robust 
RA mechanically activated current in both Neuro2A and HEK293 cells (Coste et al., 
2010). This, combined with the knowledge that TRPC channels interact with each other 
to produce functional heteromeric complexes (Table 4.1) led us to investigate the effect 
of knocking out additional TRPC channels, TRPC1 and TRPC5. Both of these channels 
are expressed in sensory neurons and are able to form heteromers with other TRPC 
channels. Moreover both in vivo and in vitro evidence suggests they are capable of 
contributing to mechanosensory function, for example TRPC1 confers sensitivity to 
osmotically induced membrane stretch in cultured DRG neurons (Staaf et al., 2009a) 
while TRPC5 is also sensitive to this in HEK293 cells (Gomis et al., 2008). TRPC5, in 
addition to TRPC6, is blocked by a tarantula toxin known to inhibit mechanosensitive 
channels (Spassova et al., 2006). TRPC1 KO mice show impaired responses to low 
threshold mechanical stimuli and a reduction in of firing of SA-Aβ and RA-Aδ fibres 
(Garrison et al., 2012). 
As well as taking into consideration the likelihood of TRPC heteromers influencing 
function, using mice with multiple TRPC channel knockout provides a way of minimising 
the effects of the likely compensatory upregulation of other TRPC channels. The 
importance of considering these factors has been demonstrated by Quick et al. (2012) in 
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behavioural phenotype analysis and by Dietrich et al. (2005) who showed that TRPC3 is 
upregulated in the smooth muscle cells of TRPC6 KO mice where both channels are 
involved in regulation of vascular smooth muscle tone. Finally, it is thought that TRPC1 
is not able to function as a homomeric channel (Storch et al., 2012), and is believed to 
require other channels to allow its translocation into the membrane (Hofmann et al., 2002) 
suggesting that the interaction between these TRPC subunits has potentially vast 
functional consequences. 
The data presented below use a novel multiple knockout approach to investigate the effect 
of TRPC1, TRPC3 and TRPC6 triple KO (TKO) and TRPC1, TRPC3, TRPC5 and 
TRPC6 quadruple KO (QKO) on mechanosensory function in vivo. Behavioural 
paradigms have been chosen to investigate the sensory function of these animals while 
electrophysiological recordings investigated mechanosensory function in the inner ear.  
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4.3 Results 
4.3.1 Gene knockout and breeding strategy of triple and quadruple knockout mice 
Triple and quadruple KO mice were generated on a mixed C57BL/6J:129SvEv 
background by combinatorial breeding of single KO alleles (TRPC1 (Dietrich et al., 
2007), TRPC3 (Hartmann et al., 2008), TRPC5 (Phelan et al., 2013), TRPC6 (Dietrich et 
al., 2005)) at the Comparative Medicine Branch of the NIEHS in North Carolina by Dr. 
J Abramowitz and Prof. L. Birnbaumer. 
Both TRPC1 and TRPC6 gene knockouts were created by interruption of an exon with a 
neomycin cassette (PGK-neo). In TRPC1, the cassette was placed in exon 8 downstream 
of an EcoRI site which is destroyed, leading to creation of a stop codon in the exon; while 
in the TRPC6 gene, exon 7 was replaced with the cassette. In both cases, the interrupted 
regions normally encode 86 amino acid long sequences which form transmembrane 
domains 4 and 5 and contribute to the pore domain of the channels (Figure 4.1).  
TRPC3 and TRPC5 gene knockouts were produced by global Cre recombinase mediated 
excision of floxed exons. Exon 7 of TRPC3 was flanked by loxP sites; the floxed mouse 
was crossed with a mouse expressing a Cre recombinase under the control of the Mox2 
promoter (which is ubiquitously expressed, early in development), potentially producing 
a truncated protein. In TRPC5, a mouse with floxed exon 5 was excised by crossing with 
a mouse expressing Cre recombinase under the control of the Sox-2 promoter (also 
expressed early in development). If a truncated protein is expressed, it would be lacking 
expression of the 5th and 6th transmembrane domains (Figure 4.1). 
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Figure 4.1 Construct designs for TRPC single KO mice which were bred together to 
produce multiple KOs. 
 
TRPC3 and TRPC6 double KO mice (also produced from single KOs) were crossed with 
C57BL/6J mice to generate heterozygous offspring. Heterozygotes were then bred 
together to produce WT and DKO mice which acted as controls for QKO mice. Though 
not littermate controls, these animals were age and sex matched as far as possible and 
produced on the same background. TKO mice were compared to TRPC1, 3, 6 
heterozygous mice which were produced by breeding TKO mice with C57BL/6J mice. 
Such controls were not an option for QKO mice as the TRPC5 gene is on the X 
chromosome so male mice can only be WT or KO for TRPC5. 
TRPC gene knockouts were confirmed through genotyping using PCR of genomic DNA 
isolated from ear samples of each mouse (Figure 4.2). Primers were used to identify WT, 
heterozygous or KO gene expression; primer sequences and band sizes are listed in the 
table below (Table 4.2). 
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Gene Primer Sequence (5’-3’) WT 
band 
size 
KO 
band 
size 
TRPC1 F GGGATGATTTGGTCAGACATTAAG 368 bp 250 bp 
TRPC1 R GTGTACCTAACATCAACCATGGTAC 
TRPC1 R1 TGGATGTGGAATGTGTGCGAGGC 
TRPC3 F2 GAATCCACCTGCTTACAACCATGTG 800 bp 300 bp 
TRPC3 R GGTGGAGGTAACACACAGCTAAGCC 
TRPC5 R GGATGTTGGCTCTGTGAAACAATGACTC 2.3 Kb 450 bp 
TRPC5 F2 AGCTAACAGTATCCCTAAGTGATCC 
TRPC6 3 CAGATCATCTCTGAAGGTCTTTATGC 234 bp N/A 
TRPC6 4 TGTGAATGCTTCATTCTGTTTTGCGCC 
TRPC6 1 ACGAGACTAGTGAGACGTGCTACTTCC N/A 339 bp 
TRPC6 2 GGGTTTAATGTCTGTATCACTAAAGCCTCC 
Table 4.2 Genotyping primers for TRPC channels 
 
 
Figure 4.2 PCR genotyping was performed to identify WT, DKO, TKO and QKO mice. 
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4.3.2 Mice with global deletion of multiple TRPC channels develop normally 
Mice with TRPC1, 3, 6 and TRPC1, 3, 5, 6 deletions develop normally to adulthood, are 
born in average litter sizes and exhibit largely normal health. At 6 weeks old, there was 
no significant difference in the mass of the animals (Figure 4.3); WT=20.30g±1.77g; 
DKO=21.47g±1.38g; QKO =24.36g±1.58g; TKO=22.58g±1.22g; Het=21.64g±1.08g 
(p>0.05). 
 
Figure 4.3 Mass of animals at 6 weeks old Was not significantly different between groups 
(WT n=6; DKO n=9; QKO n=5; TKO n=6; TRPC Het n=9 Data are shown as Mean±SEM 
with one-way ANOVA).  
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4.3.3 Mice with global deletion of multiple TRPC channels have deficits in light touch 
sensitivity 
Previous work identified a combinatorial role for TRPC3 and TRPC6 in innocuous 
mechanosensation (Quick et al., 2012) shown by an increase in the paw withdrawal 
threshold (PWT) and a decrease in response frequency to stimulation with a cotton swab. 
We repeated these tests in QKO and TKO mice to determine whether these deficits were 
augmented by additional loss of TRPC1 and TRPC5. 
In the von Frey test QKO mice show an increase in PWT when compared to WT controls 
(effect of genotype, ANOVA p=0.004) (WT= 0.36g, QKO =0.69g; p=0.003). This is not, 
however, significantly different than the PWT of DKO mice (0.69g; p>0.05). TKO mice 
(0.55g) show a similar PWT to heterozygous controls (0.53g, p>0.05) though a Student’s 
t test showed a significant increase compared to WT mice (p=0.045) though no significant 
difference was observed when compared to DKO or QKO groups (p>0.05) (Figure 4.4a). 
Sensory innervation of hairy and glabrous skin is different. von Frey testing was 
performed on the hairy skin of the abdomen to allow comparison of this to the glabrous 
skin of the paw as phenotypic differences between these two skin types have been 
observed (Minett et al., 2014a). Though there was a trend towards KO groups showing 
less sensitivity to mechanical stimuli than control groups, this was not significant 
(p>0.05) (Figure 4.4b). 
Different mechanosensory end organs with different neuronal innervation are associated 
with responses to different stimulus modalities. As well as assessing innocuous 
mechanosensitivity using von Frey fibres, we used a dynamic cotton bud stimulus to 
investigate the roles of TRPC channels in mechanosensation. In the cotton swab test, the 
number of responses out of a total of five stimuli was counted. Data show there is a 
stepwise decrease in the response frequency from WT to DKO to QKO mice (scores 
2.83±0.31, 1.80±0.20 and 0.80±0.25, respectively) (Figure 4.4c). QKO mice showed a 
significant decrease in the percentage responses when compared to WT controls 
(genotype effect, Kruskal Wallis test p=0.004; QKO v. WT p=0.0006). TKO mice 
responded fewer times to cotton swab stimulation than heterozygous controls (Figure 
4.4c) (scores 1.13±0.40 and 2.60±0.27, respectively; p=0.01) and if compared to WT 
mice, their decrease in sensitivity is also significant (p=0.02; not shown on graph for 
clarity).  
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Figure 4.4 Innocuous mechanical sensitivity is impaired in multiple KO mice, demonstrated by 
an increase in PWT on the glabrous skin of the paw (a) though no change is observed on the 
hairy skin of the abdomen (b) and a decrease in the number of responses to a cotton swab stimulus 
(c) (von Frey paw: WT n=9; DKO n=10; QKO n=10; TKO n=8; TRPC Het n=9; von Frey 
abdomen: n=6 per group; cotton swab: WT n=6; DKO n=10; QKO n=10; TKO n=8; TRPC Het 
n=10 Data are shown as Mean±SEM with one-way ANOVA and Tukey post-hoc test (a,b) and 
Kruskal Wallis with Dunn’s post hoc test (b) *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
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4.3.4 Mice with global deletion of multiple TRPC channels show normal responses 
to noxious mechanical stimuli 
Sensitivity to noxious mechanical stimuli is assessed using Randall Selitto equipment 
applied to the paw or the tail. As some groups have reported that a phenotype is only 
produced using one of these tests, both paw and tail responses have been assessed (Minett 
et al., 2014a).  
The force at which QKO animals responded to noxious mechanical stimulation on the tail 
(173.5g±4.72g) was comparable to WT (165.42g±3.90g) and DKO (159.25g±4.64g) 
animals (p>0.05) (Figure 4.5a). Heterozygous and TKO mice also showed no significant 
difference in responses with the force required to elicit withdrawal as 170.42g±4.93g 
and162.08g±4.93g, respectively (p>0.05) (Figure 4.5a). 
Similarly, the force required to elicit a response when stimulating the paw was consistent 
between groups; WT 98.26g±5.17g, DKO 101.71g±4.63g, QKO 100.13g±3.87g and 
TKO 94.46g±3.81g compared to heterozygotes 105.18g±6.35g (p>0.05) (Figure 4.5b). 
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Figure 4.5 Noxious mechanosensation is unimpaired in all groups. Sensitivity was tested 
using Randall-Selitto apparatus applied to the tail (a) and to the paw (c) (R-S tail: WT 
n=6; DKO n=10; QKO n=10; TKO n=6; TRPC Het n=6; R-S paw: WT n=6; DKO n=10; 
QKO n=10; TKO n=9; TRPC Het n=7 Data are shown as Mean±SEM with one-way 
ANOVA).  
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4.3.5 Mice with global deletion of multiple TRPC channels show normal responses 
to thermal stimuli 
Exposure to a radiant heat source in the Hargreaves test indicated no difference in heat 
sensitivity between genotypes. The latency to a nocifensive response was 18.12s±1.62s 
for WT, 17.42s±1.09s for DKO, 16.81s±0.61s for QKO and 18.53s±1.81s and 
15.66s±0.89s for TKO and heterozygous controls, respectively (Figure 4.6a). There was 
no significant difference between test groups and their controls. While the Hargreaves 
test is believed to be primarily a test of spinal reflex responses, it is suggested that the hot 
plate test involves some supraspinal mechanisms (Chapman et al., 1985, Minett, 2011); 
since these mice have global deletion of TRPC channels comparing these assessment 
types is important. However, consistent with the Hargreaves test results, responses in the 
hot plate test were not significantly different between groups. At 50oC the latency to 
response times were WT=33.37s±3.48s; DKO=39.78s±1.97s; QKO=33.08s±1.86s; 
TKO=36.05s±2.65; Het=40.02s±2.01s and at 55oC, WT=19.78s±2.00s; 
DKO=16.97s±0.52s; QKO=12.77s±0.72s; TKO=14.80s±1.11s and Het =15.18s±1.37s 
(Figure 4.6b). 
A place preference set up was used to assess cold sensitivity; a baseline recording was 
taken with both plates set at 20oC for 2 minutes before one plate was dropped to 4oC for 
another 2 minutes. QKO mice spent 8.61%±6.17% of the time on the 4oC test plate 
compared to 47.22%±10.49% time spent on the same plate when held at 20oC (Figure 
4.6c). TKO mice spent 15.42%±10.72% of the time on the noxious cold (4oC) test plate 
compared to 61.67% time spent on the test plate at 20oC (Figure 4.6c). The time spent on 
the test plate when held at a noxious cold temperature (4oC) was not significantly different 
between groups (WT=9.028%±5.35%; DKO=15.28%±6.17%; Het 15.83s±8.56s).   
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Figure 4.6 Thermosensation is unimpaired in all groups shown by comparable responses to a latent 
heat stimulus (a), a hot plate test (b) and a noxious cold place preference test (c) (All tests, n=6 per 
group Data are shown as Mean±SEM with two-way ANOVA (a, b, c). 
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4.3.6 Mice with global deletion of multiple TRPC channels show some deficits in 
vestibular function 
In the forced swim test, an increase in the number of head submerges was seen in QKO 
animals compared to WT animals (scores of 3.17 and 0.50, respectively; p=0.11) though 
this change was less pronounced than that seen in DKO mice (genotype effect Kruskal 
Wallis test, p=0.0005; WT v. DKO p=0.002; DKO v. QKO p>0.05) (Figure 4.7a). TKO 
mice also showed an average of 4.33 head submerges compared to the 0.83 seen in 
heterozygous controls (p=0.04) suggesting impaired vestibular function in TRPC 
multiple KO mice. 
In the trunk curl test, scores were attributed to each mouse according to a basic scoring 
system which assesses vestibular function. WT mice scored 0.75±0.11; DKO, 0.33±0.11; 
QKO, 0.33±0.11 (genotype effect Kruskal Wallis test, p=0.003; WT v DKO and v QKO 
p>0.05) while TKO scored 0.10±0.10 compared to the heterozygotes score 0.67±0.11 
(p=0.01) (Figure 4.7b).  
These findings suggest some deficit in the normal vestibular function of all the groups of 
knockout animals. However, the time taken to fall from an accelerating rotarod was 
similar in all groups with latencies of 181.6s±10.70s, WT; 181.60s±21.99s, DKO; 
202.80s±26.13s; 204.70s±24.77s, QKO; 202.80s±26.13s, TKO and 202.4s±29.07s, 
heterozygotes (Figure 4.7c). Although the rotarod test can be used to investigate 
vestibular function, other studies have found that the test does not always correlate with 
the alterations in vestibular deficits presented by other relevant tests (Minasyan et al., 
2009, Quick et al., 2012).  
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Figure 4.7 Vestibular function is impaired in TRPC KO mice. The number of head submerges 
in a swim test (a). Trunk curl test score (b). Latency to fall from an accelerating rotarod is 
unimpaired in KO mice (c). (Swim test n=6 per group; Trunk curl: WT, DKO, QKO, TRPC Het 
n=6 per group; TKO n=5; Rotarod WT n=6; DKO n=7; QKO n=6; TKO n=6; TRPC Het n=9. 
Data are shown as Mean±SEM with Kruskal Wallis with Dunn’s post hoc test (a,b) and one-way 
ANOVA (c) *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001). 
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4.3.7 Mice with global deletion of multiple TRPC channels have some hearing 
deficits 
Auditory brainstem response (ABR) recordings were performed by Dr Ruth Taylor (UCL 
Ear Institute) 
A calibrated click box was used for a crude assessment of auditory function; the normal 
Preyer reflex response it provokes was assessed in multiple KO animals. QKO animals 
responded with an average score of 0.31±0.12 compared to 0.75±0.06 in WT and 
0.53±0.14 in DKO (Figure 4.8a). The mean TKO response score was 0.47±0.11 compared 
with 0.86±0.04 in heterozygous controls (Figure 4.8b). The difference between WT and 
QKO animals was found to be significant (genotype effect Kruskal Wallis test, p=0.03; 
p=0.04) and when compared to the TKO score of 0.47, there is a clear downward trend 
with deletion of each additional gene. The TKO score was also significantly reduced 
compared to the heterozygote score of 0.86 (p=0.02). Nonetheless, all genotypes 
maintained some responses showing hearing at this frequency was not completely 
abolished.  
Recordings from the brainstem were taken in response to stimuli at a range of frequencies. 
TKO mice were compared to WT and heterozygous controls and showed an elevated 
threshold in response to frequencies of 24 kHz (TKO 46dB±3.23dB; Het 
30.00dB±6.89dB) and 32 kHz (TKO 68.50dB±3.25dB; WT 54.17dB±5.39dB) though 
these were not significant. Also at the highest frequency of 40kHZ, responses of all 
groups were seen at similar thresholds (~70DbSPL) (Figure 4.8d). These values can be 
considered unexpectedly high for WT animals.  
Separately tested QKOs were compared to DKO and WT mice and showed a much higher 
threshold for a response at all frequencies tested over 24kHz. (genotype effect ANOVA, 
p=0.0002; 24kHz, QKO v. WT p=0.004; QKO v. DKO p=0.002; 32kHz, QKO v. WT 
p<0.0001; QKO v. DKO p<0.0001; 40kHz, QKO v. WT p<0.0001; QKO v. DKO 
p=0.0006). A higher response threshold was also seen in QKO animals upon stimulation 
with a low frequency stimulus of 8kHz (WT, 25.83dB±4.17dB; DKO, 32.22dB±2.90dB; 
QKO, 50.00dB±5.70dB; QKO v. WT p=0.004; QKO v. DKO p=0.03) (Figure 4.8c). 
Altogether, these data substantiate the finding that loss of function of multiple TRPC 
channels leads to impaired hearing function and suggests that deletion of each additional 
TRP channel is able to augment this sensory deficit.   
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Figure 4.8 Impaired hearing in QKO and TKO mice (a) compared to controls shown by 
a decrease in Preyer reflex response score and higher threshold responses to auditory pip-
tone stimuli in Auditory Brainstem Response recordings in QKO mice compared to DKO 
and WT (b) and in TKO mice compared to TRPC Het and WT mice (c). (a) WT, DKO, 
QKO, TKO n=6 per group; TRPC Het n=5 (b) WT n=6; DKO n=9; QKO n=5; (c) WT 
n=6 TKO n=10; TRPC Het n=5. Data are shown as Mean±SEM with Kruskal Wallis with 
Dunn’s post hoc test (a) and two-way ANOVA and Tukey post-hoc test (b,c) *p<0.05; 
**p<0.01; ***p<0.001; ****p<0.0001 (in b,c *denotes significance compared to WT; # 
denotes significance compared to DKO)). 
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4.3.8 Mice with global deletion of multiple TRPC channels show normal mechano-
electrical transduction currents in the outer hair cells of the cochlea 
This work was performed by Terri Desmonds (University of Sussex) 
Mechano-electrical transducer (MET) currents recorded from outer hair cells of the 
cochlea are evoked by sinusoidal force stimuli. These currents are of normal amplitude 
in cells taken from the apical end of the cochlea which responds to low frequency sounds 
and at the basal end which is responsive to high frequency sounds in all genotypes. 
Previously, reduced amplitude currents were observed in basal coil hair cells, though 
these traces show that multiple KO animals exhibit the same features as WT mice (Figure 
4.9). These features include current reversal near to 0mV and small numbers of channels 
open at rest which increase with each depolarisation as a result of reduced Ca2+-dependent 
adaptation. Whereas attenuation of the current amplitude may indicate impaired cochlear 
mechanotransduction, these currents demonstrate that this is not the case in multiple KO 
animals and that, therefore, TRPC channels are not direct mechanotransducers in the 
cochlea. 
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(c) (d) 
(e) (f) 
(g) (h) 
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Figure 4.9 Representative MET current recording from the apical and basal coil (AC and 
BC, respectively) of control (a, b) and QKO mice (e,f) and from the basal coil of DKO 
(c) and TKO (d) mice . Current-voltage curves averaged from (g) 16 mid-basal coil 
control OHCs, 4 mid-basal coil TRPC1/TRPC3/TRPC6 TKO OHCs (h) 5 mid-apical WT 
OHCs, 4 mid-basal WT OHCs, 3 mid-apical QKO OHCs; 2 mid-basal QKO OHCs and 
3 mid-basal DKO OHCs. 
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4.4 Discussion 
The aim of this work was to characterise the sensory function of mice with global deletion 
of multiple members of the canonical subfamily of TRP channels. Previous work showed 
that global deletion of both TRPC3 and TRPC6 attenuates sensitivity to innocuous 
mechanical stimuli and impairs hearing and vestibular function (Quick et al., 2012). No 
such phenotype was observed in mice with global deletion of only one of these genes, 
therefore it seems that TRPC channels may have a combinatorial role in mediating 
specific sensory functions. As TRP channels are known to heteromultimerise and are 
believed to show functional redundancy, the development of these multiple knockout 
animals provided a novel approach to investigating the combined roles of the TRPC 
channels where monogenic studies may have been unsatisfactory. We pursued this line 
of investigation by characterising the sensory function of TRPC1, TRPC3 and TRPC6 
triple KO and TRPC1, TRPC3, TRPC5 and TRPC6 quadruple KO mice and observed 
that additional KO of TRPC1 and TRPC5 in addition to TRPC3 and TRPC6 augments 
specific sensory deficits. 
4.4.1 TRPC channels are required for normal sensitivity to innocuous mechanical 
stimuli 
Sensitivity to innocuous mechanical stimuli is impaired in TKO and QKO mice. QKO 
mice show an increase in paw withdrawal threshold compared to WT controls in the von 
Frey test. Interestingly, this hyposensitive phenotype is not augmented compared to DKO 
mice. The threshold of TKO animals is comparable to heterozygous controls however, 
although it is not significant, it does appear to be higher than the WT threshold. The cotton 
swab test provides a different means of assessing sensitivity to mechanical stimuli as it 
an unequivocally light touch stimulus which is dynamic and thus has different qualities 
to stimulation with punctate von Frey fibres. In this test, there was a decrease in touch 
sensitivity which appears to be augmented in a stepwise manner by deletion of each 
additional channel, suggesting a combinatorial role for these channels in light touch 
sensitivity.  
Based on the existing knowledge of a role for TRPC1 in light touch mechanosensation 
and TRPC5 in stretch activation in other physiological systems we hypothesised that 
additional deletion of these TRPC channels may augment the phenotype seen in DKO 
mice. As such, the fact that we did not see such a change in the von Frey test is perhaps 
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surprising, however in the cotton swab test, we observed a stepwise decrease in the 
response score with each additional gene knockout. Garrison et al. (2012) identified a 
similar issue in mice lacking TRPC1. The responses of these mice to suprathreshold 
mechanical stimuli were unchanged when compared to controls but the percentage 
responses to sub threshold stimuli, including a cotton swab and low threshold von Frey 
fibres, were attenuated. Different subsets of sensory neurons are responsible for specific 
sub-modalities, for example a specific subset of C-LTMR fibres are believed to be 
responsible for responses to pleasant touch (Loken et al., 2009), while activation of 
different mechanosensory end organs by different stimulus qualities leads to activation of 
different combinations of primary afferent neurons. As such, it is possible that the 
different nature of these assays may involve TRPC channels expressed in different subsets 
of sensory neurons. Indeed, single cell RNA sequencing identified one subset of neurons 
which expresses all of the four TRPC subunits and many others that expressed two or 
three (Usoskin et al., 2015); it may be that by knocking out all four, we are interfering 
with multiple, distinct mechanosensory mechanisms. Importantly, TRPC1 KO mice 
showed unimpaired firing in SA-Aβ mechanoreceptors (Garrison et al., 2012) whereas 
we previously identified a loss of RA currents in TRPC3 and TRPC6 DKO mice (Quick 
et al., 2012) which substantiates this hypothesis. As such, it could be that the different 
stimulus qualities of the cotton swab test compare to the von Frey fibres means that there 
is more of a role for large diameter fibres in responses to this particular stimulus type. 
Also, TRPC1 but not TRPC6 is believed to contribute to mechanically activated Ca2+ 
influx in Merkel cells (Haeberle et al., 2008) so it is possible that differential TRPC 
channel expression in mechanosensory end organs means multiple TRPC KO mice have 
altered mechanotransduction in multiple neuronal subtypes and also mechanosensory end 
organs. As such, one potential interpretation of this data is that by knocking out TRPC1, 
TRPC3, TRPC5 and TRPC6 we are affecting mechanosensory processing in multiple 
ways and that the behavioural assessment we have performed is indicative of an 
augmented deficit in a specific mechanosensory sub-modality. In order to determine 
whether this is the case, electrophysiological characterisation of TKO and QKO neurons 
would need to be performed. Both mechanoclamp stimulation of cultured DRG and 
recording from the ex-vivo skin-saphenous nerve preparation would allow a better 
indication of the way in which multiple TRPC channel KOs have altered the properties 
of mechanosensitive fibres. 
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In spite of the expression of TRPC3 and TRPC6 in Nav1.8 expressing nociceptive neurons 
(Abrahamsen et al., 2008), sensitivity to noxious mechanical stimuli were normal in our 
multiple KO mice. TRPC5 is also expressed in some small diameter neurons 
(Zimmermann et al., 2011) but is also found in some large diameter neurons where 
TRPC1 is also expressed. Garrison et al. (2012) showed that there was no alteration in 
the behaviour of TRPC1 knockout animals in response to noxious mechanical stimuli, 
nor was there any change in the firing properties of C and Aδ nociceptors. Alessandri-
Haber et al. (2009) found antisense oligonucleotides knockdown of TRPC1 and TRPC6 
did not alter baseline responses to Randall-Selitto testing. Together, these are consistent 
with the conclusion that these channels do not play a significant role in noxious 
mechanical sensitivity and substantiate a modality specific role for TRPC channels in 
mediating sensitivity to innocuous, and not noxious, mechanical stimuli. 
Sensitivity to acute noxious heat stimuli is unaltered in all groups which is consistent with 
previous findings about members of the TRPC subfamily of channels (Garrison et al., 
2012, Quick et al., 2012). Interestingly, TRPC5 has been linked to a role in cold sensing; 
when expressed in HEK293 cells, currents were induced by temperatures 25-37oC. 
However these currents were not inducible in TRPC1/5 heteromers and TRPC5 null mice 
did not display any changes in behavioural responses to cold (Zimmermann et al., 2011). 
In the current study, QKO animals (the only group which lack TRPC5 expression) 
exhibited normal responses to cold. In light of the findings mentioned above, it may be 
interesting to look at responses of these animals to cool temperatures within the 25-37oC 
range which induced currents in the heterologously expressed channels. Alternatively, it 
may also be indicative of TRPC5 functioning cooperatively with other TRP channels 
which are linked to a role in cold sensitivity. Further investigation into the roles of these 
channels, for example through electrophysiological characterisation of KO sensory 
neurons, may elucidate more about the sensory functions of these channels. 
4.4.2 TRPC channels indirectly contribute to auditory and vestibular function 
It has been suggested that cutaneous mechanotransduction complexes and complexes of 
the inner ear are likely to have a common identity as loading of FM1-43, a styryl dye 
which is taken up by mechanosensitive channels in the cochlea, is inhibited by NMB-1, 
the peptide which blocks mechanically activated SA currents in sensory neurons (Gale et 
al., 2001, Drew et al., 2007). Previous work indicated a role for TRPC3 and TRPC6 in 
hearing and vestibular function (Quick et al., 2012). These new data support this 
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suggestion and also implicate TRPC1 and TRPC5 in normal hearing function as ABR 
thresholds are higher in QKO mice than control mice. 
In order to determine whether the observed hearing deficits in TRPC multiple KO mice 
are the result of altered mechanotransduction in the cochlea, mechano-electrical 
transducer (MET) currents were recorded from cultured OHCs. As the amplitude of the 
currents produced by mechanotransduction complexes in the hair cells were comparable 
in all KO groups to WT, it is unlikely that TRPC1, TRPC3, TRPC5 or TRPC6 are directly 
involved in auditory mechanotransduction. Instead, it is likely that the loss of TRPC 
channel function affects the auditory process downstream of the MET channel, though it 
is possible that function is impaired elsewhere in the cochlea. Indeed, since vestibular 
function is also impaired, it is likely that mechanosensory processing in the inner ear is 
altered by loss of function of these TRPC subunits. However, in order to identify the way 
in which TRPC channel deletion alters this mechanosensory processing, more in depth 
behavioural and electrophysiological phenotyping would need to be performed. 
4.4.3 A role for TRPC channels in mechanosensation 
The role of TRPC channels in sensory function is not clear cut. The characterisation of 
mice with multiple TRPC channels knocked out is beneficial as these channels are known 
to heteromultimerise and are believed to show functional redundancy. As a result, animals 
with a single null gene may have a masked phenotype if other channels are able to 
compensate for the loss of function of the affected channel. Through using mice with loss 
of function of multiple TRPC channels, this is likely to have been avoided to some extent. 
However, the fact that mice used in the current study have a deletion of these channels 
from birth means other changes may have occurred outside of the TRPC family to 
compensate for these mechanisms. Moreover, the fact that these channels are deleted 
globally suggests that sensory phenotypes may be affected by changes outside of sensory 
neurons; TRPC channels are expressed in keratinocytes (Tu et al., 2005), for example, 
which are believed to contribute to mechanosensation (Lumpkin et al., 2010). Though 
current understanding of the role of keratinocytes in mechanosensation is limited, there 
is evidence that these cells respond to mechanical stress (Tsutsumi et al., 2009). TRPV 
channels are expressed in keratinocytes and have been shown to mediate responses to 
stretch stimuli and noxious thermal stimuli in these cells (Huang et al., 2008, Mihara et 
al., 2011). It has been suggested that sensory transduction through keratinocytes may lead 
to neuronal activation through release of mediators such as prostaglandins and ATP 
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(Huang et al., 2008, Mihara et al., 2011). In addition, Merkel cells, another form of 
epidermal cell, have recently been shown to have a direct role in mechanosensation where 
they are sites of mechanotransduction (Maksimovic et al., 2014). It is therefore possible 
that the role we observe for TRPC channels in mechanosensation could be partly due to 
their expression in keratinocytes. Indeed, teasing out the contribution of epidermal cells 
and neurons is difficult, however a conditional KO approach, as was used to determine 
the role of Piezo2 in Merkel cells, may elucidate further whether epidermally expressed 
TRPC channels contribute to innocuous mechanosensation.  
Unimpaired responses to other stimuli such as noxious heat in the Hargreaves test suggest 
that reflex responses are unimpaired. This is despite the known ‘moonwalker’ phenotype 
produced in TRPC3 knockout mice (Becker et al., 2009) though normal performance in 
the rotarod test also suggests these animals have unimpaired motor coordination.  
Indeed, a conditional deletion of these channels may be a more reliable way of 
investigating the role of these channels in primary afferent neurons while an inducible 
knockout model may avoid compensation of loss of function by other mechanisms. There 
are, therefore, many ways in which this work could be expanded to tease apart the roles 
for these channels in sensory function.  
Although this study does not provide evidence that TRPC channels are directly gated by 
mechanical force they may instead be involved more indirectly in mechanosensitivity. 
The mammalian transient receptor potential channel-interacting protein (TRIP) database 
identifies a total of 276 protein interaction partners for TRPC1, TRPC3, TRPC5 and 
TRPC6 (Shin et al., 2011, Shin et al., 2012). Of these, a number have been linked to roles 
in mechanosensation. For example, Orai1 interacts with TRPC1, TRPC3 and TRPC6 and 
mediates stretch sensitivity in cardiomyocytes (Volkers et al., 2012). Phospholipases are 
also activated by stretch in a number of sensory systems and, as discussed earlier are 
linked to activation of a number of TRPC channels. Moreover, evidence already exists to 
suggest that TRPC channel activation occurs downstream of other mechanosensitive 
proteins. For example, Mederos y Schnitzler et al. (2008) found that ligand independent 
activation of Gq protein coupled receptors by membrane stretch activate PIP2 and 
subsequently cause release of DAG which is able to induce cation currents through 
TRPC6 leading to membrane depolarisation in HEK cells. TRPC channel contribution to 
mechanosensitivity in the kidney has also been linked to interactions with other proteins 
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(Huber et al., 2006). The idea that TRPC channel interactions are critical for their role in 
mechanosensation is supported by previous work which showed that their 
mechanosensory function is context dependent (Quick et al., 2012). When expressed in 
neuronally derived cell lines, TRPC3 and TRPC6 produce mechanically activated 
currents though they are unable to confer mechanosensitivity to non-neuronal cell lines.  
This new data suggests that the role of TRPC channels in the inner ear are indirect as 
transducer currents in the cochlea are unimpaired. They are, however, critical for 
cutaneous touch sensation and appear to function combinatorially in their contribution to 
specific elements of innocuous mechanosensation. The huge and diverse range of TRPC 
channel interactions indicate that it is likely that they act as part of a bigger 
mechanosensory complex to contribute to or coordinate cutaneous mechanosensation and 
serves to highlight the potentially complex roles these channels may be playing in 
mechanosensation but also provides an interesting route to identifying other constituents 
of mechanotransduction complexes. 
4.4.4 Future work 
The work presented shows TRPC channels have a modality specific role in innocuous 
mechanosensation. DRG neurons taken from TRPC3 and TRPC6 showed a selective loss 
of RA mechanically activated currents and a corresponding increase in the proportion of 
non-responding neurons (Quick et al., 2012). In order to better understand the 
contributions of TRPC1 and TRPC5 to mechanosensory function, it is necessary to 
determine the changes in electrophysiological properties of sensory neurons. This would 
include patch clamp recording of multiple KO DRG neurons with mechanical stimulation 
to determine whether additional KO of TRPC1 and TRPC5 alters any other mechanically 
activated current type and if any other changes in neuronal properties are observed. 
TRPC3 and TRPC6 only confer mechanosensitivity to a neuronally derived cell line, 
while Piezo2, a bone fide primary mechanotransducer is able to produce currents in HEK 
cells. First, it would be interesting to transfect TRPCs 1, 3, 5 and 6 into HEK cells and 
investigate whether, together, these channels are able to confer mechanosensitivity to this 
cell line. Indeed, pursuing the idea that TRPC channel interactions may lead to 
information about the identity of mechanotransduction complex means that it may be 
useful to investigate the effect of coexpressing TRPC interacting proteins with TRPC 
channels in non-mechanosensitive cell lines. This could be prioritised by beginning with 
proteins with mechanosensory roles already identified.  
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Evidence which implicates TRPC channels in neuronal sensitisation in pathological 
conditions is increasing (Sisignano et al., 2014). For example TRPC channels 1 and 6 
have a role in mediating mechanical hyperalgesia in inflammatory conditions despite not 
contributing to the nociceptive threshold in uninjured neurons (Alessandri-Haber et al., 
2009) while TRPC3 and TRPC5 are downregulated in an SNI model of neuropathic pain 
(Staaf et al., 2009b). TRPC3 knockdown attenuates nociceptor sensitisation induced by 
inflammatory mediators (Alkhani et al., 2014). This suggests that characterising 
inflammatory and neuropathic pain induced mechanical hypersensitivity in TKO and 
QKO may elucidate more roles for these channels in mechanosensory function. Indeed, 
TRPC3 and TRPC6 are expressed in a subset of small diameter fibres which express RA 
mechanically activated currents; a subset of neurons with these qualities are integral to 
the development of mechanical hypersensitivity (Seal et al., 2009). Moreover, low 
threshold mechanotransduction complexes have been implicated in neuropathy induced 
mechanical allodynia (Eijkelkamp et al., 2013a). As such, there is potential that the 
combinatorial mechanosensory function of TRPC channels may extend to pathological 
pain conditions. 
There are, therefore a number of ways in which this work could be developed to better 
understand the contribution of TRPC channels to mechanosensory function. 
 
 
(See Appendix A (Sexton et al., 2015) for related article). 
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5 The role of TRP channels in mechanical hypersensitivity in 
Osteoarthritis 
5.1 Summary 
Osteoarthritis is a debilitating condition which is increasingly prevalent with old age and 
is predicted to affect 130 million people worldwide by 2050. Pain is the predominant 
clinical symptom however the relationship between joint damage and pain is unclear. 
Existing analgesic therapies often provide incomplete pain relief and, with chronic 
administration, are associated with adverse effects. As such a better understanding of the 
mechanisms responsible for pain in OA is required for the development of more effective 
analgesics. Transient receptor potential ion channels have established roles in pain and 
mechanosensation in physiological and pathological conditions. We hypothesised that 
putative mechanosensory TRP channels, TRPC3, TRPC6, TRPA1 and TRPV1 may 
contribute to mechanical hypersensitivity in OA. Pharmacological studies have produced 
conflicting data regarding the roles of TRPA1 and TRPV1 in OA pain so by using 
transgenic approaches we hoped to confirm whether these channels do indeed contribute 
to OA induced mechanical hypersensitivity. However we find that only TRPA1 has any 
role in mechanical hypersensitivity in OA suggesting that pharmacological agents 
targeting TRPA1 which are currently involved in clinical trials may be successful in 
conferring some analgesia to patients in OA. Importantly however, we found that TRPA1 
does not play a role in the referred hypersensitivity seen in the paw. A role for TRPC3 
and TRPC6 in OA pain has not been investigated, however these channels are expressed 
in a subpopulation of sensory neurons required for mechanical and inflammatory pain 
and have demonstrable roles in innocuous mechanosensation. Using unique multiple KO 
mice, we hoped to determine whether these channels play a role in mechanical 
hypersensitivity in OA however we found that both single and double TRPC3 and TRPC6 
knockout mice display normal hypersensitivity after injection of MIA. Mechanisms 
responsible for pain in OA are poorly understood; this multiple knockout approach 
therefore provides a novel insight into the role of key pain mediators in OA. 
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5.2 Introduction 
5.2.1 Osteoarthritis 
Osteoarthritis (OA) is a chronic, degenerative joint disease which the World Health 
Organisation estimate affects 9.6% men and 18% women over the age of 60, worldwide 
(WHO, 2013).  
OA has a severe impact on quality of life; a recent survey by ArthritisCare (2010) found 
the majority of respondents reported experiencing ‘severe levels of pain on a regular 
basis’. Indeed, musculoskeletal conditions, of which OA is one of the most common, are 
the largest single cause of work loss in Europe (EUMUSC) and in the UK alone, an 
estimated 9.3 million working days were lost through work related musculoskeletal 
disorders in 2009/10 (HSE, 2010). It is estimated that OA alone leads to 164,000 hip and 
knee replacements in the UK per year and costs the NHS at least £1 billion per year 
(ArthritisResearchUK, 2011). 
Prevalence of OA increases with age. The UN estimates that the ageing population means 
that by 2050, people over the age of 60 will account for 20% of the world’s population of 
whom 15%, or an estimated 130 million people, will have symptomatic OA (WHO, 
2013). 
Many complex pathological changes occur in OA (Wieland et al., 2005, Suri and Walsh, 
2012) beginning with progressive loss of articular cartilage, most commonly in joints 
such as the knees and hips. Normally, this cartilage is responsible for uptake and release 
of synovial fluid during load bearing movements. Loss of cartilage in OA leads to 
production of inflammatory mediators and changes in the subchondral bone such as 
sclerosis and the development of osteophytes. OA also entails inflammation and 
thickening of the synovium, leading to production of excess synovial fluid whilst the 
capsule thickens and contracts. Changes in the composition of the cartilage, such as a loss 
of proteoglycans, can lead to vascular and neuronal invasion of the cartilage. Increased 
osteoclast activity can result in replacement of the subchondral bone marrow with 
fibrovascular tissue such as macrophages, which also produce inflammatory mediators. 
In late stages of the disease these changes can, together, lead to severe bone malformation 
and remodelling (Figure 5.1).  
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The predominant clinical feature of OA is pain though presenting symptoms also include 
stiffness, crepitus, swelling and limitation of movement (ArthritisCare, 2010, Davis et al., 
2010). Pain in OA has a strong mechanical component and can be triggered by specific 
activities such as climbing the stairs; in early stages of the disease, this pain can be 
relieved by rest. As the disease progresses pain becomes more constant, with reports of 
spontaneous as well as evoked pain, and neuropathic-like symptoms can develop 
(Hochman et al., 2011). These include sensations of pins and needles and burning and 
deficits in vibration sensation and proprioception. 
Despite its high incidence and well characterised pathology, the relationship between 
joint damage and pain is not completely understood. Cartilage degradation is a 
characteristic feature of OA but cartilage is an aneural tissue while other structures such 
as the synovium and subchondral bone are much more highly innervated (Saito and 
Koshino, 2000, Hunter et al., 2013) but their damage produces widely varying levels of 
pain (Hunter et al., 2008). Similarly, a metastudy suggests that pain is not a useful 
indicator of the degree of joint damage in OA of the knee (Bedson and Croft, 2008). 
Moreover, although total joint replacement is often the last resort for patients suffering, 
some patients still report pain after surgery (Wylde et al., 2011). 
Currently, OA treatments are symptomatic; first line therapies include recommending 
lifestyle changes, such as weight loss given the risk factor of obesity, and a number of 
pharmacological interventions (NICE-Clinical-Guidelines-177, 2014). These include 
administration of NSAIDs such as aspirin, and other cyclooxygenase inhibitors, as well 
as opioids and antidepressants such as SNRIs. These drugs only provide pain relief in a 
subset of patients; a meta-analysis estimated the effect size for NSAIDs in treating OA of 
the knee as ‘small to moderate’ (Bjordal et al., 2004). Undesirable side effects are also 
problematic, particularly as these drugs are often administered chronically to OA patients 
(Wolfe et al., 1999). New classes of drugs have attempted to target different mechanisms 
underlying pain in OA. Tanezumab is a humanised monoclonal antibody which targets 
nerve growth factor (NGF) and produced significant analgesia in phase II and phase III 
clinical trials of patients with OA of the knee (Lane et al., 2010, Wood, 2010, Brown et 
al., 2012). Adverse effects in these patients including an increased need for total joint 
replacement means the safety of this class of drugs is yet to be resolved. Pain relief in OA 
therefore represents a huge unmet clinical need.   
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Figure 5.1 Changes present in the osteoarthritic joint. (a) In a healthy joint, cartilage is 
healthy, aneural and avascular while in an osteoarthritic joint (b) cartilage degradation 
can ultimately lead to bone remodelling while synovial inflammation and thickening of 
the capsule also occur. Taken from (Wieland et al., 2005). 
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5.2.2 Monosodium Iodoacetate model of Osteoarthritis  
Animal models of OA aim to mimic disease pathology. In order to produce results which 
can be translated to the human condition, it is vital that the models accurately reflect the 
histological and pain phenotype observed in OA. 
The monosodium iodoacetate (MIA) model is well established in rats and is beginning to 
be used in transgenic mice (Harvey and Dickenson, 2009). It is a rapid onset, chemical 
model involving a single intraarticular injection of sodium iodoacetate, which acts 
through inhibition of glycolysis to cause chondrocyte degradation. The pathological 
changes associated with MIA injection have been well characterised. In the first days after 
MIA injection, there is a loss of proteoglycans (Fernihough et al., 2004), while cartilage 
degradation is visible by day 14 (Fernihough et al., 2004, Mapp et al., 2013). Persistent 
synovial inflammation, which is sensitive to NSAIDs (Fernihough et al., 2004), is also 
reported for as long as 49 days after MIA injection (Mapp et al., 2013) though other 
studies report that this inflammation subsides after day 7 (Guzman et al., 2003). In later 
stages of the MIA model, degradation of the subchondral bone, an increase in osteoclasts 
and ultimately, bone remodelling occur (Guzman et al., 2003, Fernihough et al., 2004, 
Mapp et al., 2013). Dose-dependent changes consistent with neuropathic pain have also 
been reported (Thakur et al., 2012) and gabapentin, which is often used as a first line 
therapy for neuropathic pain, has been shown to reverse MIA induced tactile allodynia 
but not mechanical hyperalgesia (Fernihough et al., 2004).  
The MIA model produces robust pain behaviours which transpire from an early stage. 
Hypersensitivity is restricted to the affected limb with no contralateral changes occurring; 
thermal sensitivity is also unaltered (Harvey and Dickenson, 2009). Both primary and 
secondary mechanical hypersensitivity are present at an early stage in the MIA model 
(Fernihough et al., 2004). Assessing pain behaviour in the MIA model in rodents 
predominantly relies on the use of tactile stimulation of the paw on the affected limb and 
assessment of weight distribution of affected and unaffected limbs (Fernihough et al., 
2004, Neugebauer et al., 2007, Harvey and Dickenson, 2009). In rats, many more pain 
outcomes have been used including grip strength and vocalisation in response to knee 
bend, though using these to produce reliable and reproducible data in mice has proved 
difficult. The use of von Frey hairs applied to the plantar surface of the hind paw of 
rodents is an established and reliable means of assessing mechanical hypersensitivity, 
although it is important to note that measurement of hind paw mechanical sensitivity in a 
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model of knee OA relates to a measure of secondary hyperalgesia (given that the primary 
site of injury is not being directly assessed). Indeed this contributes to the translational 
value of OA models that produces secondary changes, as referred pain is commonly 
reported in OA patients as a result of central sensitisation (Bajaj et al., 2001). Using an 
incapacitance meter to assess weight distribution arguably also provides clinically 
relevant means of assessing hypersensitivity as patients with OA often exhibit 
compensatory behaviours to limit joint loading and have altered joint biomechanics which 
can affect their gait (Malfait et al., 2013). High doses of MIA produce weight bearing 
asymmetry in rats (Fernihough et al., 2004) though at lower doses reports vary in the 
significance of these changes (Thakur et al., 2012, Mapp et al., 2013, Yu et al., 2013, 
Rahman et al., 2015). Used in combination, these behavioural assessments of pain 
outcomes provide a more rounded insight into the development and maintenance of 
mechanical hypersensitivity in OA. 
The MIA model produces histological changes which are consistent with some of the 
changes seen in human OA, it also induces rapid onset pain behaviour and therefore 
provides a useful means of assessing the mechanisms responsible for OA pain 
(Fernihough et al., 2005).Although the MIA model has been best characterised in rats, 
applying the model to mice provides the opportunity to investigate the molecular 
mechanisms contributing to OA induced pain using transgenic approaches.  
Although the role for transduction channels in OA has been investigated using 
pharmacological inhibitors which have produced complex and sometimes conflicting 
findings (McGaraughty et al., 2010, Okun et al., 2012), there is little literature using 
transgenic alteration of gene expression to study the role of putative mechanosensory TRP 
channels in mechanical hypersensitivity in OA. We use a multiple KO approach to reduce 
the influence of functional redundancy which TRP channels are believed to exhibit and 
to investigate the potential combinatorial role of TRP channels in mechanical 
hypersensitivity in OA. 
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5.3 Results 
5.3.1 Dose-response study for induction of pain behaviour with MIA 
This work was performed together with Dr Stéphane Lolignier and Dr Ana Paula Luiz 
Although the MIA model is widely used, other studies report a wide range of doses. A 
brief literature search indicates in rats, doses from 0.1mg to 4.8mg per knee are used while 
in mice, there are similar levels of variability. For the current study, three doses of MIA 
were tested and the pain behaviour they produced was monitored over 14 days (effect of 
dose ANOVA, p=0.005). 0.2mg MIA produced a significant reduction in 50% paw 
withdrawal threshold at day 7 (p=0.02) but by day 14 this hypersensitivity was beginning 
to resolve (p=0.21). The 0.5mg and 0.75g doses both produced significant 
hypersensitivity that was maintained for 2 weeks (Day 7, p=0.001 and 0.03, respectively; 
Day 14, p=0.001 and 0.02, respectively) (Figure 5.2a). Subsequent experiments were 
performed using 0.5mg MIA in 5µl 0.9% saline in order to use the lowest dose that 
produces sustained hypersensitivity and reproducible pain behaviours. 
In line with other reports, we observed development of weight bearing asymmetry, but 
unlike observations in rat studies, this phenotype present at day 7 was largely resolved by 
day 14 (Figure 5.2b). No alteration in thermal sensitivity was observed in the Hargreaves 
test following administration of 0.2mg MIA (Figure 5.2d), and motor coordination was 
not significantly altered at any time point after administration of 0.5mg MIA (Figure 
5.2c), consistent with reports of MIA use in C57BL/6 mice (Harvey and Dickenson, 
2009). After confirming no changes in thermal sensitivity arose from the study and that 
motor coordination was unimpaired, subsequent experiments were analysed using the von 
Frey and weight bearing tests enabling us to focus specifically on changes in mechanical 
sensitivity in OA. 
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Figure 5.2 Dose-dependent pain behaviour following intra-articular injection of MIA. 
Three doses of MIA were tested using von Frey assessment over 14 days. Both 0.5mg 
and 0.75 mg produced lasting hypersensitivity so were used for subsequent experiments. 
(b) A weight bearing asymmetry was present at day 7 but resolved by day 14. No changes 
in motor coordination (d) or thermal sensitivity in the Hargreaves test (c) were observed 
following administration of 0.5mg and 0.2mg MIA, respectively. (Dose response trial, 
n=5 per group. Data shown as Mean±SEM with one way ANOVA with Tukey post-hoc 
test. Weight bearing test, n=6; Hargreaves test n=3; Rotarod test n=9. Data shown as 
Mean±SEM with one-way ANOVA with Dunnett’s post-hoc test). 
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5.3.2 TRPC3 and TRPC6 knockout animals develop mechanical hypersensitivity 
following injection of MIA 
This work was performed together with Louisa Townson 
TRPC3 and TRPC6 are, together, required for normal touch sensitivity and contribute to 
RA mechanically activated currents in a subset of sensory neurons. As a result of this 
important role in mechanosensation, we hypothesised that they may have contribute to 
mechanical hypersensitivity in OA. In order to investigate this, TRPC3 single KO, 
TRPC6 single KO and TRPC3, TRPC6 DKO animals were compared to WT mice 
following administration of 0.5mg MIA. A decrease in 50% withdrawal threshold at day 
7 was significant in all groups compared to baseline (MIA treatment effect, ANOVA 
p<0.0001; WT 0.43g±0.08g to 0.18g±0.06g (p=0.002); TRPC3 SKO 0.34g±0.07g to 
0.13g±0.03g (p=0.006); TRPC6 SKO 0.33g±0.04g to 0.15g±0.05g (p=0.04); TRPC3, 
TRPC6 DKO 0.52g±0.06g to 0.20g±0.05g (p=0.001)) (Figure 5.3a). There was no 
significant difference in withdrawal threshold between groups at any time point (p>0.05), 
though WTs showed a threshold of 0.12g and TRPC3 and TRPC6 double KO mice have 
a threshold of 0.24g. 
Similarly, although a weight bearing asymmetry was visible in all groups by day 7 (MIA 
treatment effect, ANOVA p<0.0001), it was beginning to resolve by day 14 in all groups 
(Figure 5.3b). That WT mice show resolution of this phenotype suggests that the changes 
are independent of the loss of function of TRPC3 and TRPC6. There was no difference 
between genotype groups at any time point. The weight bearing and von Frey data 
together suggest that TRPC3 and TRPC6 do not contribute to the development or 
maintenance of mechanical hypersensitivity in OA. 
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Figure 5.3 TRPC3 and TRPC6 do not contribute to mechanical hypersensitivity in OA. 
(a) von Frey withdrawal thresholds were significantly decreased compared to baseline in 
all groups. (b) a weight bearing asymmetry was present in all groups at day 7 but resolved 
by day 14. (n=10 per group; Data shown as Mean±SEM with two way ANOVA with 
Tukey post-hoc test).  
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5.3.3 TRPA1-TRPC3-TRPC6 triple knockout animals show partial attenuation in 
mechanical hypersensitivity following injection of MIA  
This work was performed together with Dr. Stéphane Lolignier 
TRPA1, TRPC3 and TRPC6 have all been implicated in mechanosensory roles and are 
co-expressed in some subsets of sensory neurons, allowing the potential for interaction, 
though TRPA1 is also found in an additional peptidergic subset (Usoskin et al., 2015). 
Although these channels are unlikely to be primary mechanotransducers, they all have 
established roles in mechanosensation. As a result of the functional redundancy which 
TRP channels are believed to exhibit, we considered that although inhibiting the function 
of TRPC3 and TRPC6 did not alter mechanical hypersensitivity produced by arthritis 
induction, additionally inhibiting the function of TRPA1 may. As such, we tested 
TRPA1-TRPC3-TRPC6 triple KO mice and compared them to TRPC3-TRPC6 double 
KO mice to determine whether these channels, together, have any role in mechanical 
hypersensitivity in Osteoarthritis.  
Both groups showed a significant decrease in withdrawal threshold from baseline to day 
7 (MIA treatment effect, ANOVA p<0.0001; TRPC3-TRPC6 double KO mice, p=0.001; 
TRPA1-TRPC3-TRPC6 triple KO mice, p=0.001 statistics not shown on graph for 
clarity) which was maintained for the duration of the experiment (Figure 5.4a). TRPC3-
TRPC6 DKO mice showed a slight weight bearing asymmetry at day 7 though this was 
not significant and returned to baseline distribution from day 14 for the duration of the 
experiment (Figure 5.4b). TRPA1-TRPC3-TRPC6 triple KO mice did not develop a 
significant weight bearing asymmetry at day 7 compared to baseline (p=0.82). There was 
no significant difference between genotype groups at any time point. 
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Figure 5.4 TRPA1 is required for the full manifestation of mechanical hypersensitivity in 
OA. (a) von Frey withdrawal thresholds were significantly decreased compared to 
baseline in all groups. (b) No significant weight bearing asymmetry was observed after 
MIA injection. (n=10 per group; Data shown as Mean±SEM with two way ANOVA with 
Tukey post-hoc test)  
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5.3.4 TRPA1- TRPV1 double knockout animals develop mechanical hypersensitivity 
following injection of MIA 
This work was performed together with Dr. Stéphane Lolignier 
TRPA1 and TRPV1 have both separately been linked to a role in mechanical 
hypersensitivity in pathological conditions and recent evidence shows that as well as 
being co-localised in sensory neurons, they are able to form functional heteromeric 
complexes (Salas et al., 2009). In order to pursue this, TRPA1 single KO, TRPV1 single 
KO and TRPA1, TRPV1 double KO mice were compared to WT animals in order to see 
the contribution of TRPA1 and TRPV1 alone and in combination in OA induced 
mechanical hypersensitivity.  
Assessment of mechanical hypersensitivity using von Frey hairs did not identify any 
difference between genotype groups at any time point, though all groups showed a 
significant reduction in withdrawal threshold at day 7 compared to baseline which was 
maintained for the duration of the experiment (WT 0.45g±0.03g to 0.28g±0.04g 
(p=0.002); TRPA1 KO 0.34g±0.07g to 0.13g±0.03g (p=0.006); TRPV1 SKO 
0.33g±0.04g to 0.15g±0.05g (p=0.04); TRPA1, TRPV1 DKO 0.52g±0.06g to 
0.20g±0.05g (p=0.001)) (Figure 5.5a). 
A weight bearing asymmetry was produced in WT, TRPV1 SKO and TRPA1, TRPV1 
DKO animals at day 7 but this was resolved back to baseline levels by day 14. 
Interestingly, TRPA1 KO mice did not develop a weight bearing asymmetry at any time 
point and this was significant, at day 7, compared to WT mice (p=0.01) (Figure 5.5b). 
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Figure 5.5 TRPA1 but not TRPV1 contributes to mechanical hypersensitivity in OA. (a) 
von Frey withdrawal thresholds were significantly decreased compared to baseline in all 
groups. (b) A weight bearing asymmetry did not develop in TRPA1 SKO mice but was 
present in all other groups. (WT, n=7; TRPA1 SKO, n=8; TRPV1 SKO, n=8, DKO, n=7; 
Data shown as Mean±SEM with two way ANOVA with Tukey post-hoc test). 
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5.4 Discussion 
The aim of the work in this chapter is to explore the role of TRP channels in OA. The 
MIA model of OA is a commonly used rodent model, partly due to its rapid onset and 
production of pain and joint pathology comparable to that seen in the human condition. 
We used this model to investigate whether putative mechanosensors in the family of TRP 
channels contribute to mechanical hypersensitivity in OA. 
5.4.1 MIA produces a weight bearing asymmetry and referred tactile hypersensitivity 
The MIA model is well characterised in rats in that it produces a unilateral, mechanical 
hypersensitivity which elicits a biphasic, dose-dependent weight bearing asymmetry. Its 
use in mice is less widely reported and the dose used in both of these groups is highly 
variable. We found that injection of 0.5mg MIA produced a lasting tactile hypersensitivity 
in the von Frey test as well as a phasic weight bearing asymmetry. Testing the distribution 
of weight on the hind paw is considered to be a useful measure as OA patients report pain 
on load bearing. In our experiments, weight bearing asymmetry was only visible 7 days 
after injection of MIA and was back to an equal distribution by day 14.  
Inflammation has been shown to be present in the early stages following injection of MIA 
though the length of time it is present has been debated with some groups suggesting it is 
attenuated after 7 days. Weight bearing asymmetry can be resolved by treatment with 
NSAIDs suggesting that early stage inflammation contributes to the phenotype (Bove et 
al., 2003). In rats, this measure produces a biphasic response where an initial asymmetry 
is resolved and then reappears around 7 days after administration of MIA. It is possible 
that a similar pattern is visible in mice, though assessments at time points between 
injection and 7 days would be needed to confirm this. After 7 days, the asymmetry 
remains in rats which is not what we observed in the current tests in mice. It is possible 
that the phenotype in the current work is resolved partially after day 7 as the dose is only 
sufficient to produce a short period of inflammation up to 7 days but becomes milder or 
absent by day 14. However it is also possible that if the inflammation is milder after 7 
days that the static weight bearing measurement is not sensitive enough to detect such a 
mild phenotype in mice. 
In line with other reports in C57BL/6 mice, thermal sensitivity was unaltered by MIA 
injection at all time points and motor coordination was also unimpaired (Harvey and 
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Dickenson, 2009). As such, in subsequent experiments only von Frey and weight bearing 
assessments were performed. 
5.4.2 TRPA1, but not TRPC3, TRPC6 or TRPV1, contributes to mechanical 
hypersensitivity in OA 
TRPC3 and TRPC6 are together necessary for normal touch sensation (Quick et al., 
2012). Though they are not primary mechanotransducers alone, they contribute to the RA 
currents displayed by a subset of small diameter neurons. TRPC6 has a demonstrable role 
in inflammatory mechanical hyperalgesia (Alessandri-Haber et al., 2009). Also, TRPC3 
and TRPC6 DKO mice show attenuated pain behaviours in the second phase of the 
formalin test and a partial attenuation of mechanical hypersensitivity evoked by 
carrageenan (Quick, 2011); altogether existing evidence makes them favourable 
candidates for a role in mechanical hypersensitivity in pathological conditions.  
The current data show that mice lacking functional expression of TRPC3, TRPC6 and 
both channels develop mechanical hypersensitivity to the same extent as WT controls. 
This suggests that the mechanosensory function of these channels does not contribute to 
the development or maintenance of mechanical hypersensitivity in OA. Although existing 
evidence implicates TRPC3 and TRPC6 in mechanical hyperalgesia in some models of 
inflammatory pain (see above), there is also evidence to argue against a role for these 
channels in pathological conditions. For example, DKO mice show normal allodynia 
following SNL surgery and develop hyperalgesia following CFA injection (Quick, 2011). 
Notably, the Nav1.8 positive population of sensory neurons, where TRPC3 in particular 
is expressed, are not needed for neuropathic pain (Abrahamsen et al., 2008).  
MIA has been shown to have a dose-dependent neuropathic component as it leads to 
upregulation of ATF-3, a marker of peripheral neuron injury, and produces a pain 
phenotype which is sensitive to gabapentin (Thakur et al., 2012). It is unlikely that the 
dose we are using has a neuropathic element as it is quite low, though this would need to 
be confirmed using histological or pharmacological analysis. Although other groups have 
reported a role for TRP channels in OA induced pain at specific doses of MIA, if this 
experiment was repeated at a higher dose it is unlikely our findings would change since 
TRPC3 and TRPC6 are unlikely to contribute to mechanical allodynia. It is therefore 
likely that, TRPC3 and TRPC6 play a selective role in mechanical hypersensitivity in 
other inflammatory conditions that may be unimportant in OA pain. Also, it is possible 
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that other mechanically activated TRP channels compensate for the loss of function of 
TRPC3 and TRPC6 allowing the hypersensitivity to remain in spite of their loss of 
function. 
TRPC3 is expressed throughout the DRG while TRPA1 and TRPC6 show slightly more 
restricted expression however Usoskin et al. (2015) identified four subsets of neurons 
expressing all three channels so there is potential interaction between TRPC3 and TRPC6 
with TRPA1 in the DRG. All of these channels contribute to mechanosensation in some 
way though they may contribute differentially. As such, knocking out TRPC3 and TRPC6 
is unlikely to completely impair pathways involving TRPA1 and it is possible that 
compensatory activity through TRPA1 pathways allows mechanical hypersensitivity to 
remain in the absence of functional TRPC3 and TRPC6. We used mice with deletion of 
TRPA1, TRPC3 and TRPC6 to reduce the effect of such functional redundancy and used 
TRPC3 and TRPC6 DKO mice as controls knowing that they alone were not refractory 
to mechanical hypersensitivity. The current data show that TKO mice do not develop a 
weight bearing asymmetry at any time point whereas DKO mice show a slight, non-
significant, decrease in the weight borne on the affected limb from 50.20%±2.12% down 
to 41.11%±2.33%.  
Though TRPA1 KO mice do not develop a weight bearing asymmetry, suggesting 
resistance to the development of some pain, they do display hypersensitivity in the von 
Frey test. The application of von Frey hairs to the paw, a site away from the affected joint 
is considered to be representative of a secondary hyperalgesia or referred pain, which is 
also a feature of the human condition. The von Frey test demonstrates that neither TRPA1, 
TRPC3 nor TRPC6 have a role in the referred hypersensitivity produced by OA. In a 
separate experiment, TRPA1 single KO mice were compared to WT, TRPV1 KO and 
TRPA1-TRPV1 DKO mice. TRPA1 KO mice did not develop a weight bearing 
asymmetry at day 7 while all other groups did. All groups developed a referred 
hypersensitivity, demonstrated by a sustained reduction in the withdrawal threshold of 
the paw. This latter experiment is important as it demonstrates that loss of function of 
TRPA1 alone is sufficient to prevent full manifestation of OA induced mechanical 
hypersensitivity. 
Existing data both supports and contests a role for TRPA1 in OA induced pain based on 
studies where pharmacological inhibitors, A-967079 and HC030031 are administered to 
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block TRPA1 (McGaraughty et al., 2010, Okun et al., 2012). The former compound, A-
967079 attenuates mechanical allodynia as well as reducing the responses of spinal 
neurons to noxious mechanical stimuli in rats (McGaraughty et al., 2010). However 
HC030031 does not resolve weight bearing asymmetry produced by high dose MIA 
(Okun et al., 2012). Okun et al. (2012) suggested that the differential findings may be 
explained by the fact that A-967079 had no effect on spontaneous firing of spinal neurons 
and that this activity contributes to the ongoing pain they see in the weight bearing test. 
They concluded therefore that TRPA1 blockade is insufficient to provide relief from 
ongoing pain in advanced OA. Such a conclusion is compatible with our findings that a 
relatively low dose of MIA can produce a weight bearing asymmetry which is attenuated 
by loss of TRPA1, yet the referred pain to the paw, which may be the result of changes 
in the CNS, is independent of TRPA1 activity. Indeed, spinal pain pathways have been 
shown to play a critical role in OA and joint pain (Harvey and Dickenson, 2009, Rahman 
et al., 2009, Carr et al., 2014) and systemic administration of a TRPA1 antagonist was 
unable to reverse the heightened activity of spinal cord neurons in the MIA model of OA 
(McGaraughty et al., 2010). Therefore, it seems that TRPA1 only contributes to specific 
components of OA induced mechanical hypersensitivity. Our conclusions in this area 
would be strengthened by looking at the effect of higher doses of MIA in TRPA1 KO 
mice as we may find loss of TRPA1 function with higher MIA doses does not attenuate 
the weight bearing asymmetry, as was reported by Okun et al. (2012). 
Our data suggest that TRPV1 does not have a role in OA induced mechanical 
hypersensitivity as TRPV1 KO mice develop a weight bearing asymmetry and decreased 
paw withdrawal threshold comparable to WT controls (Figure 5.5). TRPV1 is upregulated 
in DRG neurons innervating the knee following administration of MIA (Fernihough et 
al., 2005) as well as in the synovium of the joint following injection of MIA (Kelly et al., 
2015) and has therefore been identified as a potentially interesting analgesic target for the 
treatment of OA pain. However, existing preclinical studies which focus on the use of 
pharmacological antagonists provide conflicting evidence regarding the role of TRPV1 
in mechanical hypersensitivity. Okun et al. (2012) report that TRPV1 blockade can 
attenuate weight bearing asymmetry following administration of 3mg, but not 4.8mg, 
MIA in rats and thus suggest that blocking the function of TRPV1 may only be clinically 
beneficial in mild to moderate OA. Our data does not support a role for TRPV1 in OA 
mechanical hypersensitivity, although it is important to note that the dose we used is not 
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particularly high and therefore is unlikely to model the advanced OA described by Okun 
et al. On the other hand, it has been shown that spinal TRPV1 does not contribute to 
mechanical hypersensitivity in OA (Kelly et al., 2015) and TRPV1 antagonists have 
proved unsuccessful in clinical trials as a result of the hyperthermia they produce through 
binding to centrally expressed TRPV1 (Gavva et al., 2008). As such, it has been suggested 
that a peripherally targeted antagonist may be more successful. Our data does not provide 
evidence to support this, however another group have reported that analgesia through 
blockade of TRPV1 can be more effective when performed in combination with inhibition 
of the endocannabinoid pathway, components of which can lead to TRPV1 sensitisation 
(Malek et al., 2015). It is therefore possible that the reason we do not observe analgesia 
resulting from loss of TRPV1 function is that loss of TRPV1 alone is insufficient to 
produce analgesia as unimpaired nociceptive pathways remain.  
TRPA1 and TRPV1 expression in sensory neurons overlaps in a portion of peptidergic, 
small diameter, unmyelinated fibres. It is well established that there is functional 
interaction between these channels and it has recently been demonstrated that TRPA1 and 
TRPV1 form functional heteromeric complexes (Salas et al., 2009, Staruschenko et al., 
2010, Fischer et al., 2014). As such, we used TRPA1 and TRPV1 double KO mice to 
investigate whether these channels show any combinatorial role in mediating mechanical 
hypersensitivity in OA. DKO mice developed hypersensitivity to the same extent as WT 
mice in both the weight bearing and von Frey tests. This result was somewhat surprising 
as we have shown that loss of TRPA1 prevents the development of a weight bearing 
asymmetry in both single KOs in this experiment and in TRPA1 KO mice. It is not clear 
why TRPA1 and TRPV1 DKO mice showed an asymmetry when TRPA1 KO mice did 
not however we do consistently find that loss of TRPA1 does not alter the hypersensitivity 
shown in the von Frey test. The von Frey test produces a nocifensive, reflex response at 
a site away from the injured joint which is representative of secondary hypersensitivity 
resulting from complex central processing. As such, it seems unlikely that centrally 
expressed TRPA1 contributes to pain in OA though the conflicting results in the weight 
bearing test results remain particularly difficult to interpret. Aforementioned studies 
looking at the effect of TRPA1 and TRPV1 blockade on MIA induced weight bearing 
produce conflicting data (McGaraughty et al., 2010, Okun et al., 2012) which suggests a 
more thorough characterisation of the relationship between MIA dose, behavioural 
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outcome and changes in neuronal activity, in mice is required for us to better understand 
these findings. 
5.4.3 Mechanisms underlying mechanical hyperalgesia in OA 
Altogether, the current data is valuable as it indicates that mechanical hypersensitivity in 
OA is likely to have mechanisms distinct from other pathological pain conditions as loss 
of function of important mechanosensory TRP channels does not alter mechanical 
hypersensitivity in OA. Even in the human condition, the lack of correlation between joint 
destruction and pain illustrates the complex nature of the underlying pain mechanisms. 
Animal models of OA are varied in the histological and pain behaviour phenotypes they 
produce; their use in rats and mice of different backgrounds also contributes to the 
variability in model outcomes as strain-dependent differences can be highly influential 
on development of pain and behavioural outcomes in noxious testing (Mogil, 1999, 
Wilson and Mogil, 2001). Even work performed using the same model in the same 
animals has produced differing reports of cartilage degradation, duration of inflammation 
and pain phenotype. In the case of the MIA model of OA, the influence of the dose used 
to induce OA has a demonstrably influential effect on the success of blocking the function 
of transduction channels which further highlights the complex mechanisms responsible 
for mechanical hypersensitivity in the different stages of OA. As a result, there are clear 
limitations on the use of the data in this study alone and a great deal of work using other 
models of OA and, likely, different doses of MIA will be needed to make more firm 
conclusions from our findings. Nonetheless, these data are unique in the multiple KO 
approach used to characterise the roles of mechanosensory channels in mechanical 
hypersensitivity in OA as many previous studies have focused on the use of 
pharmacological inhibitors which do not take into account the influence of functional 
redundancy and TRP channel subunit interaction.  
In conclusion, we find that TRPA1 plays a selective role in mechanical hypersensitivity 
in OA suggesting that targeting TRPA1 may alleviate pain in some stages of the disease. 
However we do not find evidence to support such a role for TRPV1, TRPC3 or TRPC6. 
Clearly, an all rounded approach is necessary to determining the contribution of putative 
mechanosensors to mechanical hypersensitivity in OA. This includes determining 
whether the dose used causes neuropathy, the time course of inflammation and a better 
characterisation of the changes in neuronal activity which are produced by this dose of 
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MIA. As well as this, more may be gained from examining the roles of these channels in 
other models of OA which mimic different features of the human condition.  
5.4.4 Future work 
To complement the findings in this study, surgical models such as destabilisation of the 
medial meniscus of the knee which causes the joint to become unstable through 
transection of the medial meniscotibial ligament may be useful. In this model, altered 
joint biomechanics lead to progressive degradation of cartilage, thickening of the 
subchondral bone and formation of osteophytes over a longer time course than the MIA 
chemical model (Glasson et al., 2007, Loeser et al., 2013). Used in combination, these 
models encompass pathological changes seen in OA, produce pain behaviour in animals 
and provide a suitable means of testing potential analgesics. It would be interesting to 
corroborate the data produced in TRPA1 KO mice by testing these mice using the DMM 
model. The current approach to determining the role of putative mechanosensory in OA 
induced mechanical hypersensitivity can also be continued through the use of other KO 
mice. 
The varying doses of MIA widely reported in the literature have been shown to produce 
different pathological and behavioural phenotypes. A full characterisation of these doses 
in our transgenic mice would be beneficial as it may allow a better understanding of the 
contribution of, in particular TRPA1, to mechanical hypersensitivity in OA, and therefore 
allow a better dissection of the mechanisms which underlie the different behavioural 
phenotypes observed. It is likely that the doses used in the present study models only mild 
OA. Since some studies have demonstrated a differential role for transduction channels 
in mild and advanced OA, this work would be strengthened by using a higher dose of 
MIA to model a more advanced form of the disease. In addition, such work would likely 
strengthen the clinical relevance of this work as higher doses of MIA reportedly produce 
thermal hyperalgesia (Okun et al., 2012) which is a symptom reported in quantitative 
sensory testing studies on humans with OA (Suokas et al., 2012). 
Finally, many studies in rats have used spinal electrophysiology to characterise the effects 
of pharmacological inhibitors on OA induced pain. Using this approach in our transgenic 
mice may add to the wealth of data available as many of the transduction channels 
expressed peripherally are also expressed in the in the spinal cord, as well as on the central 
terminals of primary afferents.  
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6 Investigating the role of Annexin A6 in mechanosensation 
6.1 Summary 
Mechanically activated currents in sensory neurons can be classified according to their 
adaptation profiles. Rapidly adapting currents are associated with low threshold 
mechanical stimulation while slowly and intermediately adapting currents are produced 
by high threshold mechanical stimuli and are blocked by the conotoxin, NMB-1 (Drew et 
al., 2007). This peptide also attenuates behavioural responses to noxious mechanical 
stimuli in mice. Annexin A6 was identified as a binding partner for NMB-1 thereby 
highlighting it as a candidate transducer of the slowly and intermediately adapting 
mechanically activated current. Our hypothesis that Annexin A6 may be a noxious 
mechanotransducer was strengthened by the fact it is present in the Nav1.8 positive subset 
of sensory neurons (Raouf et al. unpublished data) which are necessary for noxious 
mechanosensation. In the present study we demonstrate that, in fact, Annexin A6 is a 
negative regulator of mechanosensation and is able to attenuate the mechanically 
activated currents of primary mechanotransducer Piezo2. Consistent with this, loss of 
ANXA6 function leads to mechanical hypersensitivity in mice and overexpression of 
ANXA6 is able to partially attenuate mechanical hypersensitivity in Osteoarthritis. 
Together these data demonstrate an exciting and novel mechanism of mechanosensory 
regulation. 
6.2 Introduction 
6.2.1 Annexin A6 binds to NMB-1, a potent blocker of mechanically activated 
currents 
NMB-1 (noxious mechanosensation blocker 1) is a conotoxin peptide which inhibits the 
persistent, non-adapting component of intermediately-adapting (IA) and slowly-adapting 
(SA) mechanically activated currents produced by sensory neurons (Figure 6.1) (Drew et 
al., 2007). In addition to this NMB-1 binds to small diameter, peripherin positive neurons 
(Drew et al., 2007), which is consistent with the neuronal subtypes which express SA and 
IA currents. NMB-1 also inhibits mechanotransduction currents in the cochlea and blocks 
behavioural responses to noxious mechanical stimuli. 
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Figure 6.1 Mechanically activated currents are inhibited by NMB-1 peptide in cultured 
sensory neurons. (Adapted from Drew et al. (2007)). 
 
In order to identify the peptides which NMB-1 binds to, and therefore identify proteins 
which are likely to contribute to mechanotransduction, a co-immunoprecipitation assay 
followed by mass spectrometry analysis was performed and identified ANXA6 as a 
binding partner of NMB-1 (Raouf et. al, unpublished). Strengthening the candidacy of 
ANXA6 as a mechanotransducer is its downregulation in the population of Nav1.8 
expressing neurons (unpublished) which have been shown to be critical for mechanical 
and inflammatory pain (Abrahamsen et al., 2008). In order to investigate the potential 
role of ANXA6 in mechanosensation, we looked at the effects of gene knock out on pain 
behaviour and overexpression on mechanically activated currents in vitro. 
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6.2.2 Annexin A6 knockout mouse 
Anxa6 global knockout mice were kindly provided by Prof. S. Moss. The Anxa6 gene was 
disrupted through insertion of a 1.1kb sequence containing a neomycin cassette into exon 
3 (Figure 6.2); it has been previously reported that these animals are healthy, fertile and 
develop normally (Hawkins et al., 1999). 
 
 
Figure 6.2 Targeting construct for Anxa6 gene knockout. Exon 3 is disrupted by insertion 
of a 1.1kb sequence which renders the gene non-functional. 
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6.2.3 Gene therapy 
Gene therapy is an increasingly popular method of treating monogenic diseases which are 
not successfully targeted by existing pharmacological tools. Administration of vectors 
allows selective gene knockdown through the use of short hairpin RNA sequences and 
delivery of functional genes for overexpression or to confer function when the 
endogenous gene is defective. The success of current analgesics and the development of 
newer therapies is marred by problematic side effects and lack of specific blockers for 
homologous ion channels such as voltage gated sodium channels. Gene therapy offers 
many potential advantages which may tackle these issues and allow a more focused, long 
term means of targeting nociceptive pathways (Glorioso and Fink, 2009).  
Viruses are commonly used as vectors for gene therapy. Herpes simplex virus (HSV) (e.g. 
(Majima et al., 2015)), lentivirus (LV) (e.g. (Meng et al., 2015)) and adeno-associated 
virus (AAV) (e.g. (Samad et al., 2013)) have all been successfully used to transduce gene 
expression in nervous tissue in rodents for the purposes of producing analgesia without 
any reported adverse effects. Adenoassociated virus (AAV) is a small, non-enveloped 
virus with an approximately 4.7kb single stranded DNA genome. There are twelve human 
serotypes of AAV, all of which consist of Rep and Cap genes, necessary for the AAV life 
cycle, transcription regulation and capsid formation, and which are flanked by 145bp 
inverted terminal repeats. Their ability to transduce dividing and non-dividing cells, lack 
of toxicity and persistent expression for long periods of time make them well suited to a 
role in gene therapy (Daya and Berns, 2008, Ojala et al., 2015). AAV1, AAV5 and AAV6 
have been identified as being particularly successful at transducing DRG neurons and 
have distinct cell type transduction specificity; AAV5 preferentially transduces large 
diameter fibres while AAV6 favours small diameter neurons (Mason et al., 2010, Towne 
et al., 2010). Early phase clinical trials also indicate that the use of gene therapy for 
analgesia (Fink et al., 2011) and the use of AAVs in human CNS (Kaplitt et al., 2007, 
Eberling et al., 2008, LeWitt et al., 2011) is safe, despite concerns of a problematic 
immune response. We selected AAV6 and AAVx, a novel vector provided by Prof. M. 
Linden which effectively transduces neurons (AAVx is an arbitrary name as the viral 
serotype is currently under patent processing), to induce sensory neuron overexpression 
of ANXA6 via the clinically relevant (Samad et al., 2013), intrathecal route of 
administration.  
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6.3 Results 
6.3.1 Global deletion of Annexin A6 selectively impairs noxious mechanosensation 
Using von Frey and Randall-Selitto testing, we investigated the role of ANXA6 in 
mechanosensation in vivo. We found that Anxa6 knockout mice had a 50% withdrawal 
threshold of 0.62g±0.10g compared to 0.64g±0.06g in WTs when tested on the paw 
suggesting that impairing the function of ANXA6 does not alter innocuous 
mechanosensation (p=0.84) (a). However, in response to noxious mechanical pressure, 
Anxa6 knockout mice showed a 17.5% decrease in the force required to elicit a response. 
WT mice responded at an average of 188.75g±5.00g compared to 155.83g±7.73g in KO 
(p=0.003) (b). These data suggest that ANXA6 has a negative regulatory role in noxious 
mechanosensation and that its role is modality specific which is consistent with the 
findings of Drew et al. (2007) who found NMB-1 selectively attenuated SA and IA 
currents, which are associated with high threshold mechanical stimuli, and behavioural 
responses to noxious mechanical stimuli.  
 
 
Figure 6.3 Anxa6 KO mice show normal responses to von Frey stimulation (a) but show 
a decrease in the force required to elicit a response in the Randall-Selitto test of noxious 
mechanical sensitivity (b). (WT, n=9; KO, n=8) Data are shown as Mean±SEM with 
Student’s t test. *p<0.05; **p<0.01; ***p<0.001, ****p<0.0001.  
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6.3.2 Electrophysiological properties of Annexin A6 
This work was performed by Dr. Stéphane Lolignier (see Appendix B for methods) 
6.3.2.1 Overexpression of Annexin A6 alters mechanosensitivity of sensory neurons 
Cultured DRG neurons produce RA, IA and SA currents following mechanical 
stimulation of the cell soma. Overexpression of ANXA6 in cultured sensory neurons did 
not alter the proportion of cells expressing each current type (Figure 6.4a), or significantly 
alter the displacement threshold required to produce a 40pA current (Figure 6.4b). 
However it significantly reduced the amplitude of the IA currents produced from 
displacements of 7-9µm (treatment effect, ANOVA p<0.0001; EV v ANXA6 p=0.02 at 
7µm displacement, p=0.0001 at 8µm displacement and p<0.0001 at 9µm displacement) 
(Figure 6.4d). Though there is a substantial reduction in the Imax of IA currents, this 
reduction was not significant (ANOVA p>0.05). At the displacement thresholds shown, 
there was no difference in the amplitude of SA currents produced (Figure 6.4e), however 
the numbers of cells expressing SA currents tested is substantially lower than cells 
expressing RA and IA currents (Figure 6.4 c, d, e, f). Both SA and IA currents are 
associated with high threshold mechanical stimulation so increasing the number of SA 
current recordings is vital to fully characterise the effect of ANXA6 on high threshold 
mechanically activated currents.  
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Figure 6.4 ANXA6 electrophysiology (a) Sensory neurons overexpressing ANXA6 show 
normal proportions of RA, IA and SA currents. (b) Mechanical displacement required to 
elicit a 40pA current. (c-e)  I/displacement kinetics of RA, IA and SA currents in cells 
overexpressing ANXA6 (RA current; EV n=5, ANXA6 n=6; IA current; EV n=10; 
ANXA6 n=9; SA current; EV n=3; ANXA6 n=3). (f) Peak current recorded throughout 
displacement. Data are shown as Mean±SEM. Total n numbers; EV, n=38; ANXA6, 
n=34. *p<0.05; **p<0.01; ***p<0.001, ****p<0.0001. 
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6.3.2.2 Overexpression of Annexin A6 reduces mechanosensitivity of Piezo2 
Piezo2 produces a robust, RA mechanically activated current when expressed 
heterologously. We overexpressed Piezo2 and ANXA6, separately and together in ND-C 
cells, a neuronally derived cell line with a slight, endogenous mechanosensitivity which 
is seen when empty expression vectors were used as controls. Expression of Piezo2 
produces a peak current of 2036.92pA±360.4pA which is reduced to 786.9pA±130.7pA 
when ANXA6 is coexpressed (treatment effect ANOVA, p<0.0001; Piezo2 + EV v. 
Piezo2 + ANXA6 p=0.003) (Figure 6.5a) suggesting ANXA6 is able to negatively 
regulate Piezo2 mechanosensitivity. Similarly, the threshold required to evoke a 40pA 
current response was slightly, but not significantly higher in cells co-expressing ANXA6 
and Piezo2 compared to Piezo2 alone (4.92±0.67µm and 3.31±0.56µm, respectively; 
p>0.05) (Figure 6.5b). Stimulus response curves show that ANXA6 was able to 
significantly reduce the magnitude of Piezo2 current produced by high threshold 
mechanical stimulation (treatment effect ANOVA p=0.006; Piezo2 + EV v. Piezo2 + 
ANXA6 p<0.0003 at displacements greater than 7µm) (Figure 6.5c).  
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Figure 6.5 ANXA6 coexpressed with Piezo2 in ND-C cells. (a) Peak current recorded 
throughout displacement. (b) Mechanical displacement required to elicit a 40pA current. 
(c) Current displacement kinetics of Piezo2 in the presence and absence of ANXA6. Data 
are shown as Mean±SEM. *p<0.05; **p<0.01; ***p<0.001 ****p<0.0001 all groups are 
compared to Piezo2+EV treated cells in (a) and (b); in (c) only Piezo2+EV vs. 
Piezo2+ANXA6 are shown.  
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6.3.3 Virally mediated overexpression of Annexin A6 
6.3.3.1 Viral vector construct design 
The viral vector was provided by Prof. M. Linden and this work was performed by Dr 
Julie Tordo 
As knocking out Anxa6 produced hypersensitivity to noxious mechanical stimuli, we 
hypothesised that overexpression of the protein may produce hypoalgesia and therefore 
be a useful target for gene therapy and used viral vectors to test this hypothesis. 
Human ANXA6 was cloned into the AAV, downstream of an IRES-eGFP construct and 
under the control of a CMV promoter (Figure 6.6). Recombinant virus was produced and 
a viral titer of 5x1012VP/ml was administered by a single intrathecal injection.  
 
Figure 6.6 Construct design for production of virus particles containing AnnexinA6 
transgene. 
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6.3.3.2 Viral overexpression of Annexin A6 leads to reductions in mechanical 
sensitivity 
The Hargreaves test was performed by Sonia Santana-Varela and the weight bearing test 
was performed by Dr. Stéphane Lolignier. 
The human ANXA6 gene was cloned into two viral vectors; AAVx and AAV6. Each 
serotype was administered intrathecally into separate groups of mice with a third group 
treated with an empty AAVx vector (EV-AAVx). Behavioural analysis was used to 
determine whether ANXA6 overexpression in these vectors was able to reduce 
mechanical sensitivity in physiological and pathological conditions (Figure 6.7). 
 
 
 
 
 
 
 
 
 
 
Innocuous and noxious mechanical and noxious thermal sensitivity were monitored 
regularly over a number of weeks. After 20 weeks, 0.5mg MIA was administered into the 
left knee of mice in all groups and behavioural analysis of mechanical sensitivity was 
continued using von Frey and weight bearing asymmetry analysis while Randall-Selitto 
(noxious mechanical) and Hargreaves (noxious thermal) measures were discontinued 
(Figure 6.7). 
 
D0 W4 W8 W12 W16 W20 W21 W23 
Figure 6.7 Time course of AAV study. 20 weeks after viral vector injection, 
Osteoarthritis was induced by a single injection of MIA. Behavioural assessment 
was performed throughout. 
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We observed that overexpression of ANXA6 did not significantly alter sensitivity to 
noxious or innocuous mechanical stimuli in naïve mice at any time point (p>0.05) (Figure 
6.8a,c). However, following a slight, non-significant, increase in noxious mechanical 
threshold, we administered a unilateral injection of MIA in order to see if ANXA6 
expression could instead attenuate mechanical hypersensitivity. A baseline weight 
bearing measurement was taken at week 16 as well as an additional von Frey threshold 
assessment prior to this MIA injection at week 20. 
Thermal sensitivity was not significantly altered from baseline at any time point and was 
not significantly different between treatment groups after AAV administration (Figure 
6.8a). 
One week after injection of MIA, all treatment groups showed a significant decrease in 
50% threshold compared to the threshold recorded at 16 weeks (MIA treatment effect, 
ANOVA p<0.0001; EV-AAVx p=0.02; ANXA6-AAVx p=0.04; ANXA6-AAV6 p<0.001) 
(Figure 6.8c). Three weeks after MIA injection, control (EV-AAVx treated) mice showed 
a further drop in 50% threshold from 0.42g±0.04g (one week post MIA) to 0.28g±0.03g 
(three weeks post MIA) while the 50% threshold of ANXA6-AAVx treated mice dropped 
only slightly from 0.45g±0.04g (one week post MIA) to 0.41g±0.06g (three weeks post 
MIA). Results from ANXA6-AAV6 treated mice are less clear with significant 
hypersensitivity present one week after MIA injection but a less severe hypersensitivity 
three weeks after MIA injection; withdrawal thresholds dropped from 0.57g±0.04g to 
0.30g±0.06g after one week and rose to 0.40g±0.04g after three weeks. A two-way 
ANOVA with Tukey post hoc comparison showed no significant effect between vector-
treatment groups at any time point.  
An attenuation of mechanical hypersensitivity in ANXA6-AAVx treated mice was 
observed in the weight bearing test (Figure 6.8d). While control (EV-AAVx treated) mice 
developed an asymmetry which was significant compared to baseline one week after MIA 
injection (MIA treatment effect, ANOVA p=0.0005), ANXA6-AAVx treated mice did not 
develop a significant weight bearing asymmetry at any time point (MIA treatment effect, 
ANOVA p>0.05). Indeed, in ANXA6-AAVx treated mice weight on the ipsilateral paw at 
baseline was 50.59%±1.77, one week after MIA injection was 49.21%±1.95 and three 
weeks after MIA injection was 51.38%±1.76. Whereas EV-AAVx treated mice showed 
weight on the ipsilateral paw dropped from 50.56%±1.31 to 43.98%±1.58 (p=0.007) one 
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week after MIA and 46.77%±1.48 (p=0.18) three weeks after MIA injection. ANXA6-
AAV6 treated mice showed a significant weight bearing asymmetry following MIA 
injection thus this vector produced no ANXA6 mediated analgesia.  
As in the von Frey test, a two-way ANOVA with Tukey post hoc comparison showed no 
significant effect between treatment groups at any time point in the weight bearing test. 
However, since the EV-AAVx treated mice developed a weight bearing asymmetry which 
was significant compared to baseline and ANXA6-AAVx treated mice did not, it seems 
this treatment produces a partial analgesic effect. Altogether, these data show through 
both von Frey and weight bearing tests that ANXA6 overexpression in the AAVx vector 
is able to partially attenuate MIA induced mechanical hypersensitivity. 
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Figure 6.8 Effects of ANXA6 overexpression on mechanical and thermal sensitivity. ANXA6-AAVx treatment partially attenuates noxious 
mechanosensation (a) but has no effect on thermal sensitivity (b). ANXA6 overexpression has no effect on acute innocuous mechanosensation but 
partially attenuates MIA induced mechanical hypersensitivity (c,d) (n=12 for all groups) Data are shown as Mean±SEM. 
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6.3.3.3 Viral overexpression of Annexin A6 leads to increased protein in DRG and 
spinal cord 
This work was performed by Dr. Stéphane Lolignier and Anna Biller 
Since the most prominent analgesic phenotype was observed after treatment with ANXA6-
AAVx, ANXA6 expression was assessed in tissue taken from these mice to observe. In 
DRG neurons, an anti-GFP antibody shows staining in the cell bodies of sensory neurons 
(Figure 6.9). Co-staining with an anti-Peripherin antibody showed expression of GFP in 
both small and large diameter sensory neurons in both EV and ANXA6-AAVx treated 
neurons. A no-primary-antibody treated sample of ANXA6-AAVx tissue was used as a 
negative control; no peripherin staining is observed as expected however low levels of 
GFP expression are visible, demonstrating effective amplification of the signal with the 
anti-GFP antibody. The percentage numbers of DRG neurons transduced with the 
ANXA6-AAVx vector is shown in Figure 6.9 and is estimated to be 87.98%±3.76%. In 
line with the behavioural results observed, these expression studies strongly suggest that 
the viral vectors had effectively transduced sensory neurons following intrathecal 
administration. In order to better study the expression pattern of GFP it would be valuable 
to perform staining of untreated DRG neurons as both EV-AAVx and ANXA6-AAVx 
treated mice show GFP expression.  
In the spinal cord of untreated mice, IB4 binding is seen in the superficial dorsal horn 
(Figure 6.10) and in mice treated with ANXA6-AAVx, widespread, diffuse GFP staining 
is visible throughout the grey matter. Tissue from the spinal cord of untreated mice 
showed no GFP expression, as expected  
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Figure 6.9 Immunohistochemistry following treatment with 
AAVx shows GFP expression (green; arrows) in DRG in 
ANXA6-AAVx and EV-AAVx treated mice. All sections were 
co-stained with an antibody to Peripherin (red; arrowhead) 
which labelled small fibres in the DRG. A sample of ANXA6-
AAVx treated tissue was tested without primary antibody as a 
negative control. Quantification of  ANXA6-AAVx treated 
cells estimates 87.98%±3.76% neurons are transduced by the 
viral vector (n=4); 61.15%±7.08% neurons are positive for 
peripherin. Double labelled neurons marked with asterisk (*). 
* 
* 
* 
* 
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Figure 6.10 Immunohistochemistry following treatment with AAVx showing GFP expression (green) in the lumbar spinal cord. Panels show GFP 
expression in ANXA6-AAVx treated mice while untreated mice show no GFP expression. Higher magnification of GFP staining is shown in the 
second panel. All sections were co-stained with an antibody to IB4 (red) which labelled inner lamina II of spinal cord sections. No primary antibody 
control images for spinal cord sections were used as a negative control.
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Immunohistochemical analysis demonstrated that sensory neurons were effectively 
transduced by the AAVx viral vector. Next, we used Western blot analysis to determine 
whether ANXA6 protein expression in the DRG of ANXA6-AAVx treated mice had 
successfully increased above endogenous levels. 
Western blots show expression of ANXA6 protein in the DRG of EV-AAVx treated and 
ANXA6-AAVx treated mice. ANXA6 has a molecular weight of 76kDa and β-actin 
42kDa (Figure 6.11a). A β-actin loading control was used to quantify the bands to 
determine whether the levels of ANXA6 protein were increased beyond endogenous 
levels in ANXA6-AAVx treated mice. Though quantification indicates that levels of 
ANXA6 are higher in the DRG of ANXA6-AAVtt treated mice (ratio of ANXA6:β-actin 
2.01±.58) compared to EV-AAVx treated mice (ratio of ANXA6:β-actin 1.67±0.49), this 
increase was not significant (p=0.26) Figure 6.11c). Our behavioural data indicated a 
notable latency from administration of ANXA6 in the viral vector to the development of a 
hyposensitivity to noxious mechanical stimuli. It is possible that the time required for 
translation or trafficking of ANXA6 protein contributed to this delay though the current 
data suggest that by the end of the experiment, ANXA6 protein had successfully been 
overexpressed, in the cell bodies of sensory neurons, following viral administration. 
ANXA6 expression was also observed in the spinal cord, though quantification shows no 
significant difference in ANXA6-AAVx and EV-AAVx treated groups (Figure 6.11c,d). 
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Figure 6.11 Western Blots show expression of ANXA6 protein and βactin in nervous 
tissue in EV-AAVx and ANXA6-AAVx treated mice. Expression levels from 4 mice in 
each treatment group from DRG tissue (a) and spinal cord tissue (b) which were 
quantified using βactin for normalisation in DRG (c) and spinal cord (d).  
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6.4 Discussion 
Mechanical hyperalgesia and allodynia are symptoms frequently presented by patients 
with chronic pain conditions. We identified ANXA6 as a potential contributor to 
mechanotransduction as it binds to NMB-1, a peptide blocker of SA currents. ANXA6 is 
known to bind phospholipid membranes, regulate membrane fluidity and is also involved 
in second messenger pathways; we used Anxa6 KO mice and virus-mediated ANXA6 
overexpression to investigate its role in acute mechanosensation and OA induced 
mechanical hypersensitivity. 
6.4.1 Annexin A6 negatively regulates mechanosensation 
Our data clearly demonstrate that Annexin A6 has a selective role in noxious 
mechanosensation. Anxa6 KO mice showed increased sensitivity to noxious mechanical 
stimuli while leaving responses to innocuous mechanical stimuli unaltered. Mechanical 
stimulation of cultured DRG neurons overexpressing ANXA6 at high stimulus thresholds 
reduced the amplitude of the IA current, which is associated with noxious 
mechanosensation (Drew et al., 2007). Interestingly, overexpressing ANXA6 with Piezo2 
reduced the peak current produced by mechanical stimulation compared to expression of 
Piezo2 alone. Taken together, these data provide strong evidence that ANXA6 negatively 
regulates mechanosensation.  
The current data provides the first evidence of a role for ANXA6 in cutaneous 
mechanosensation. Interestingly, ANXA6 has been linked to roles in mechanosensory 
functions in other physiological systems. For example, in mice overexpressing ANXA6 
in the heart, there is a decrease in the contractility of cardiomyocytes, presumed to be the 
result of reduced free intracellular Ca2+ and reduced Ca2+ release upon depolarisation 
(Gunteski-Hamblin et al., 1996). Similarly, in skeletal muscle, ANXA6 regulates the 
gating properties of the sarcoplasmic reticulum Ca2+ release channel, potentially linking 
it to a role in excitation-contraction coupling responsible for muscle contraction (Diaz-
Munoz et al., 1990). 
Current understanding of the functions of ANXA6 provide insight into the potential 
mechanisms by which it could regulate mechanotransduction. In conditions of low Ca2+ 
annexins are soluble monomeric proteins though when intracellular Ca2+ levels rise, 
annexins can bind to phospholipid membranes (Naciff et al., 1996a). It is proposed that 
to bind the membrane, annexins form trimers and aggregate into a hexagonal array 
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surrounding a target protein (Concha et al., 1993, Voges et al., 1994, Naciff et al., 1996a). 
This is known to affect membrane properties, for example altering Ca2+ mediated 
membrane fluidity (Newman et al., 1989, Junker and Creutz, 1993, Sobota et al., 1993, 
Megli et al., 1998) and potentially interfering with protein-protein or protein-
phospholipid interactions as well as affecting Ca2+ dependent second messenger pathways 
(Kaetzel et al., 1994). If ANXA6 aggregates are able to influence membrane fluidity, 
increasing membrane rigidity in the same way as Annexin A5 for example (Megli et al., 
1998), it is possible that this could increase the force required to elicit a mechanically 
activated response. Alternatively, if ANXA6 aggregates interact with membrane bound 
proteins they may be able to regulate the properties of mechanotransduction channels. 
For example, in sensory and spinal cord neurons, ANXA6 negatively regulates Ca2+ 
channel conductance (Naciff et al., 1996a). If ANXA6functions to bind to and regulate 
Ca2+ permeable ion channels in the cell membrane this may be true for regulation of 
mechanotransduction complexes. We have shown in vitro, that overexpressing ANXA6 
alters the current produced by the primary mechanotransducer, Piezo2 which is a Ca2+ 
permeable channel. As such, it is possible that the effect of ANXA6 on mechanosensation 
is conferred through regulation of conductance of mechanotransduction channels. As well 
as being able to target membrane proteins, it has been shown that annexins, including 
ANXA6, are able to regulate membrane permeability. ANXA6 has been shown to be able 
to have both protective and disruptive effects on the lipid bilayer under stressful 
conditions, including in the presence of arachidonic acid, a key inflammatory mediator 
(Creutz et al., 2012). Other features of ANXA6 include reports of it acting as a Ca2+ 
channel (Pollard et al., 1992), though reconciling this with the reported negative 
regulation of Ca2+ conductance by ANXA6 is somewhat difficult. 
6.4.2 Annexin A6 is a useful gene therapy target for treating pain in OA 
Our data show that ANXA6 negatively regulates mechanosensation; as a result we asked 
whether overexpressing ANXA6 would reduce sensitivity to noxious mechanical stimuli 
in naïve animals and if it would attenuate the mechanical hypersensitivity associated with 
OA. Gene therapy has been shown to be successful in producing analgesia in 
experimental models of pain including cancer induced bone pain (Meng et al., 2015), HIV 
induced pain (Kanao et al., 2015), inflammatory pain (Xu et al., 2003b), surgical models 
of neuropathic pain (Storek et al., 2008, Samad et al., 2013, Fan et al., 2014), diabetic 
neuropathy (Tan et al., 2015) and rheumatoid arthritis (Braz et al., 2001) through 
 173 
 
intraganglionic, intrathecal and cutaneous routes. In these models, the targeting strategies 
have included knockdown of genes encoding ion channels, for example Nav1.3 (Samad 
et al., 2013) and overexpression of proteins such as the mu opioid receptor (Xu et al., 
2003b). We used a novel AAV serotype which has a high tropism for neurons, AAVx, 
and AAV6 to overexpress human ANXA6 in vivo. 
ANXA6 overexpression reduced noxious mechanosensation, though this hyposensitivity 
was only seen 12 weeks after administration of the viral vectors. Throughout this 12 week 
period, innocuous mechanosensation remained unaltered which is consistent with our 
Anxa6 KO data, indicating that ANXA6 does not contribute to light touch sensitivity. We 
also performed a noxious thermal sensitivity test to ensure the hyposensitivity we 
observed was the result of modality specific changes and found no significant effect on 
thermal thresholds compared to baseline or between treatment groups. AAVx appeared 
to be more effective at producing analgesia than AAV6. It has been reported that 
transduction of sensory neurons by AAV6 peaks at a period of 4 weeks and levels of 
AAV6 expression subsequently decline (Mason et al., 2010). It is therefore possible that 
this feature of AAV6 makes it incompatible with our experiment which appears to require 
a substantially longer period to produce sufficient ANXA6 expression to affect pain 
sensitivity. 
After observing the development of analgesia in response to noxious mechanical 
stimulation, we injected MIA into the left knee of virus-injected mice. Mice treated with 
ANXA6 in the AAVx vector did not develop a significant weight bearing asymmetry at 
any time point (whereas control mice did develop a significant asymmetry) and showed 
an attenuation in hypersensitivity of the paw compared to mice treated with the control 
viral vector. The weight bearing measure of mechanical hypersensitivity is considered to 
be a clinically relevant assessment of pain as OA patients report pain on load bearing 
while the von Frey test represents a referred pain to sites distal to the affected joint. 
Existing analgesic therapies for OA are often only partially effective, associated with side 
effects and not appropriate for long term use (see section 5.1). In section 5.3, we also 
demonstrate that the molecular mechanisms underlying mechanical hypersensitivity in 
OA may be distinct from other pathological conditions; similarly, the correlation between 
joint damage and pain is weak which together illustrate the complexities of understanding 
mechanisms responsible for pain in OA and the difficulties in achieving effective 
analgesia. Gene therapy offers a target specific alternative to existing pharmacological 
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interventions and has already been shown to be a viable treatment method for analgesia 
in the clinic (Fink et al., 2011) while in preclinical models, gene therapy for pain relief 
has already been shown to be useful in rheumatoid arthritis (Braz et al., 2001). The current 
data indicate that overexpressing ANXA6 is sufficient to produce partial attenuation of 
the mechanical hypersensitivity induced by OA. However different doses of MIA have 
been shown to produce different pathological and behavioural phenotypes so using a 
higher dose of MIA would allow us to investigate whether this effect is maintained in a 
model of more advanced OA. 
Immunohistochemistry of DRG neurons shows that 23 weeks after injection of viruses, a 
large proportion of neurons were positive for virally expressed GFP, however it would be 
interesting to inject an empty AAVx vector and dissect tissue at different time points 
throughout the 12 week experiment in order to determine at what stage our vectors 
effectively transduce DRG neurons. Validating this data through quantitative PCR would 
provide further information as to the efficiency of virus transduction over the time course 
of the experiment while looking at levels of protein expression throughout would also be 
informative. In the current experiment, after 23 weeks, levels of ANXA6 in DRG appear 
to be higher in ANXA6-AAVx treated mice than the levels of endogenous ANXA6 seen 
in mice treated with empty vector only. Other groups report a maximum of 1.5 fold 
increase in expression of protein levels compared to endogenous protein expression 
which is similar to the increase we observed (1.6 fold increase) however the values were 
highly variable meaning our data is not significant. This conclusion may be strengthened 
by quantifying tissue from a higher number of animals. 
Interestingly, other groups have reported efficient transduction of viruses to DRG within 
a few weeks (Meng et al., 2015, Tan et al., 2015) whereas we only observed a behavioural 
phenotype around 12 weeks after virus injection. It is important to note that many of these 
groups were using short RNA sequences to inhibit transcription of specific genes, 
whereas other groups have reported that – despite efficient transduction of sensory 
neurons by AAV vectors and increased mRNA expression after as little as 1-3 weeks – 
increases in protein levels were much more gradual, including when viral vectors were 
administered directly into DRG (Xu et al., 2003a, Mason et al., 2010, Fan et al., 2014). It 
is also possible that trafficking of the newly translated protein to the peripheral terminals 
of primary sensory neurons increased the latency to an observable phenotype. 
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Another factor which may affect the data we have observed is our initial focus on the non-
diseased state. Many other reports of gene therapy in animal models administer viral 
vectors concurrent to induction of the pain model. Our data taken from after the injection 
of MIA produce exciting results which indicate that overexpressing ANXA6 using the 
AAVx viral vector can reduce mechanical hypersensitivity in OA. This is substantiated 
by our use of two different methods of behavioural assessment, the benefits of each have 
been discussed (see section 5.1). It is possible that if we were to induce OA at an earlier 
time after virus administration we would see similar results to other groups as it may be 
that at the earlier stages of the experiment, any change in acute mechanical threshold is 
subtle and a phenotype is difficult to observe. It is therefore important that the time course 
of the effects of this gene therapy approach is addressed if it is to be a clinically useful 
gene therapy tool.  
6.4.3 Annexin A6 in mechanosensation 
This chapter has demonstrated a novel role for ANXA6 in noxious mechanosensation. 
ANXA6 negatively regulates behavioural responses to noxious mechanical stimuli and 
attenuates IA mechanically activated currents as well as reducing current produced by the 
primary mechanotransducer, Piezo2. When expressed in a viral vector and administered 
intrathecally, ANXA6 is able to attenuate the mechanical hypersensitivity induced by 
OA. Altogether, the current data highlight an exciting potential analgesic therapy for OA 
as well as identifying a novel regulatory mechanism of mechanosensation. We have 
observed that overexpression of ANXA6 is most effective using the AAVx serotype; a 
full characterisation of the time course of this effect is necessary before this can be 
considered as a useful therapy at which point, it may confer analgesia to mechanical 
hyperalgesia and allodynia in other pathological pain conditions. 
6.4.4 Future work 
Our data indicates an exciting novel function for ANXA6 in negative regulation of 
mechanotransduction and cutaneous mechanosensation. In order to completely 
understand the contribution of ANXA6 to mechanosensation and to fully explore its 
potential use in gene therapy a number of additional experiments are required. 
First, as our current data does not elucidate a mechanism for ANXA6 regulation of 
mechanotransduction, it would be interesting to perform further studies to determine the 
mechanism by which ANXA6 has its effects. For example, measuring membrane fluidity 
 176 
 
may indicate whether the effect of ANXA6 on mechanotransduction currents is through 
alteration of membrane properties or if it is more likely through another mechanism such 
as direct regulation of mechanotransducers. The latter could be addressed by performing 
a co-immunoprecipitation with Piezo2 to assess whether ANXA6 directly binds Piezo2 
As previously discussed, looking at the time course of the transduction efficiency of 
ANXA6-AAVx through immunohistochemistry and quantitative PCR may be useful to 
see whether it is possible to produce an earlier onset phenotype in the disease model as 
well as allowing optimising the concentration of virus administered to identify the most 
effective dose. 
Also, despite the many benefits of the MIA model of OA, including rapid onset, minimal 
cost and production of robust pain behaviour, there are some criticisms over the clinical 
relevance of the model. The fact that the model produces arthritis pathology so rapidly is 
not in line with the slow, degenerative progression of human OA. The DMM surgical 
model of OA (see section 5.4.4) produces different features of OA than the MIA model. 
It has been reported that this easy to induce-and-reproduce model produces a pathology 
similar to that seen in spontaneous models of mouse OA (Glasson et al., 2007). The 
altered joint biomechanics produced by severing the medial meniscotibial ligament do 
not produce such an inflammatory response as MIA and onset of symptoms such as 
cartilage damage occur much later after induction than is seen in the MIA model (Glasson 
et al., 2007, Loeser et al., 2013). Moreover, the slowly progressing nature of this model 
makes it more comparable to the human condition so administering our viral vector 
containing ANXA6 to mice with this model of OA may substantiate our claims of the 
clinical usefulness of this therapy. Finally, administering a higher concentration of MIA 
(up to 1mg can be used in mice (Ogbonna et al., 2013)) would strengthen a role for 
ANXA6 in producing OA in analgesia as a result of the dose-dependent effects of MIA 
(Thakur et al., 2012) which have been suggested to model different stages of the human 
condition (Okun et al., 2012). Together, administering ANXA6-AAVx to animals with 
OA induced by DMM surgery and high dose MIA in combination with the current data 
would allow us to further demonstrate the clinical usefulness of our gene therapy 
approach. 
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7 Does ASIC4 have a role in mechanosensation or pain? 
7.1 Summary 
The family of acid sensing ion channels (ASIC) have established roles in sensory 
function, including in pain and mechanosensation. Unlike other subunits of this family 
ASIC4 is poorly characterised and its function in vivo is incompletely understood. Also 
unlike other subunits, ASIC4 is proton insensitive and its expression is limited to specific 
regions of the nervous system and the pituitary gland. In vitro, it has been shown that 
ASIC4 can regulate the expression of other ASIC subunits, namely ASIC1 and ASIC3. 
We considered that if this function was the same in vivo, ASIC4 may indirectly contribute 
to pain and mechanosensory function. In order to investigate whether ASIC4 has any role 
in pain or mechanosensation either directly or indirectly through regulation of expression 
of ASIC1 or ASIC3 we produced and characterised a global ASIC4 KO mouse. We find 
that ASIC4 is expressed in the central nervous system though this does not appear to lead 
to altered ASIC1 protein expression. We also find that loss of ASIC4 function leads to 
altered Formalin induced pain behaviour and decreased sensitivity in a model of visceral 
pain. This is the first report of a role of ASIC4 in these modalities and suggests that 
pursuing an understanding of the role of ASIC4 in vivo will contribute to a better 
understanding of the roles of ASICs in pain and mechanosensation. 
7.2 Introduction 
7.2.1 ASIC4 
Unlike other members of the ASIC family, ASIC4 has remained in relative obscurity. 
Early studies were performed using rat ASIC4 which shares 94% amino acid homology 
with human ASIC4; murine ASIC4 also shares 94% homology to the human orthologue. 
However while it was cloned from rat DRG and brain in 2000, the function of the proton-
insensitive ASIC4 remained unknown until 2008 when it was found to be a regulator of 
the expression of other ASIC proteins (Donier et al., 2008). ASIC4 reduces total protein 
levels of ASIC1a in the cell and reduces the current densities of ASIC1a and ASIC3 when 
the channels are co-expressed. Importantly, the gating properties of these channels are 
not affected by ASIC4.  
Though ASIC4 appears to regulate functional expression of ASIC1a and ASIC3, a yeast-
two hybrid study looking at N-terminal interactions of ASIC subtypes did not identify 
these proteins as binding to ASIC4, suggesting that they may not interact directly (Donier 
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et al., 2008). Through its stretch of amino acids 2-21, ASIC4 is ubiquitinated to a much 
higher level than the other ASIC subtypes (Donier et al., 2008). When this amino acid 
sequence is removed, the ubiquitination levels of ASIC4 drop to a level similar to ASIC1a 
and ASIC3, suggesting this region may be important for regulating ASIC4 function. 
Interestingly however, removal of the 2-21 amino acid region of ASIC4 does not affect 
ASIC4 mediated downregulation of ASIC1a and ASIC3 (Donier et al., 2008). 
The high levels of ASIC4 ubiquitination are interesting. Though ubiquitination of a 
protein is often a signal for its degradation, it can also mediate subcellular location of the 
protein and alter protein interactions (Donier et al., 2008). In the case of ASIC4, deletion 
of the ubiquitin binding region of amino acids 2-21 causes an increase in the total pool of 
ASIC4 and also increases its cell surface expression (Donier et al., 2008). 
During acquisition of data in the present study, Lin et al. (2015a) published 
characterisation of another ASIC4 KO mouse and identified a role for ASIC4 in fear and 
anxiety, but not acute nociception. Importantly, they speculated that ASIC4 is unlikely to 
regulate ASIC3 in vivo because they found no ASIC4 expression in adult mouse DRG, 
where ASIC3 is almost selectively expressed. Indeed, reports of ASIC4 expression vary 
with some studies reporting low levels of expression in DRG (Akopian et al., 2000, 
Usoskin et al., 2015); it is important to clarify this in order to determine the role of ASIC4 
in vivo. 
As ASICs have been implicated in mechanosensation and pain and ASIC4 is a potential 
modulator of other ASICs, we generated a targeting construct to produce a mouse with a 
floxed ASIC4 gene. We crossed this mouse with a Cre recombinase line where Cre is 
ubiquitously expressed from a cytomegalovirus (CMV) promoter, leading to global 
excision of the floxed ASIC4 sequence. In order to determine whether the in vitro findings 
of Donier et al. (2008) translate in vivo, we began by investigating ASIC4 transcript 
expression in different tissues. We also performed behavioural characterisation of these 
global KO animals in order to determine if ASIC4 regulation of other ASICs has any 
influence over their role in pain sensitivity.  
  
 179 
 
7.2.2 ASIC4 targeting construct design 
The ASIC4 targeting construct was created by Dr. Emmanuelle Donier.  
Homologous recombination of the targeting vector into ES cells produced a targeted gene 
with exons 2, 3 and 4 flanked by loxP sites. A neomycin cassette was inserted between 
exons 4 and 5 to confer selectivity and was flanked by FRT sites to allow removal of the 
cassette without affecting the gene of interest. The ASIC4 KO allele retains a single loxP 
site, and does not express exons 2, 3 and 4 which, if translated, is predicted to lead to 
production of a truncated protein similar to that shown in Figure 7.1, producing a protein 
of 218 amino acids compared to the full-length 539 amino acid WT protein. 
 
Figure 7.1 ASIC4 knockout construct design. Exons 2-4 are flanked by loxP sites 
allowing excision by Cre recombinase (Figure by Dr. E Donier).  
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7.3 Results 
7.3.1 Gene knockout and breeding strategy 
The ASIC4 protein is encoded by the Accn4 gene; animals with a heterozygous floxed 
Accn4 gene (ASIC4fl/+) were bred together to produce ASIC4+/+, ASIC4+/fl and ASIC4fl/fl 
pups. Homozygous floxed mice were then crossed with animals expressing a single copy 
of a Cre recombinase under the control of the ubiquitously expressed CMV promoter 
(B6.C-Tg(CMV-cre)1Cgn/J; Jackson Laboratories). Offspring which inherited a single 
floxed allele and Cre recombinase were thus heterozygous knockouts for ASIC4 (ASIC4 
Het; Cre+). These animals were crossed with a mouse ubiquitously expressing Flp 
recombinase, which removed the neomycin cassette present between exons 4 and 5 and 
flanked by FRT sites. Offspring which were ASIC4 Het; Neo- were crossed to produce 
ASIC4 WT, ASIC4 Het and ASIC4 KO (all Neo-). The FLP recombinase was also bred 
out of these mice. 
Genomic DNA, isolated from the ear, was used to confirm that the Accn4 gene was 
flanked by loxP sites (Figure 7.2a) and subsequently that the floxed exons had been 
excised (Figure 7.3a). Primers were targeted to the genomic DNA sequence of the 
targeting construct (Table 7.1; Table 7.2).  
The first set of primers were used to identify WT and floxed animals (Table 7.1); PCR 
products were excised from the gel and the purified DNA was Sanger sequenced. Figure 
7.2b and c show the gDNA sequence obtained from this process confirming the insertion 
of loxP sites into the genomic DNA and the corresponding WT sequence. 
The next set of primers were used to identify WT and KO animals (Table 7.2) and bands 
were also excised and purified for sequencing (Figure 7.3b,c). Sequencing results 
confirmed the deletion of a 1012bp sequence from the WT genome leading to the 
production of a KO gene. 
  
 181 
 
Forward Primer Reverse Primer WT band Fl band 
5’- 
GAGCAGGATTGATAGGATAGC 
5’- 
ATTTGCTACACTGTGTAGCTACAAG 
147bp 292bp 
Table 7.1 Primers to identify floxed and WT ASIC4 gDNA 
 
 
Forward Primer Reverse Primer WT band KO band 
5’- 
GAGCAGGATTGATAGGATAGC 
5’- 
GAACAGTTCTGAGATCTACAGTC 
1430bp 418bp 
Table 7.2 Primers to identify WT and KO ASIC4 gDNA 
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Figure 7.2 Genotyping of WT and floxed ASIC4 mice. (a) WT, heterozygous floxed and 
homozygous floxed bands produced by PCR. Sequence of gDNA extracted from PCR 
bands showing (b) WT and (c) floxed ASIC4 genes. Primer complement sequences are 
in green, loxP sites are in blue and residual plasmid regions in red. Sequence regions 
confirmed by Sanger sequencing are underlined. 
  
(b) 
GAGCAGGATTGATAGGATAGCAAGAGTTCTGAGCCTGGTGTGGTGGTGAATCTCTGTACTCC
CAGCTCTTGGGTGGTTAAAGCAGGAGGATTGGGAATTCAAGGCCGGCTACACAGGGAGTCC
TTGTAGCTACACAGTGTAGCAAAT 
(c) 
GAGCAGGATTGATAGGATAGCAAGAGTTCTGAGCCTGGTGTGGTGGTGAATCTCTGTACTCC
CAGCTCTTGGGTGGTTAAAGCAGGAGGATTGGACTAGTGAATTCCGATCATATTCAATAACC
CTTAATATAACTTCGTATAATGTATGCTATACGAAGTTATTAGGTCTGAAGAGGAGTTTACG
TCCAGCCAAGCTAGCTTGGCTGCAGCAGCTGCATATCGAGAAGCTTCAGTACTGAATTCAAG
GCCGGCTACACAGGGAGTCCTTGTAGCTACACAGTGTAGCAAAT 
   292bp 
   147bp 
    Ladder   Fl  Het Fl  WT 
(a) 
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1430bp 
418bp 
 WT  Het  KO  Ladder 
(b) 
GAGCAGGATTGATAGGATAGCAAGAGTTCTGAGCCTGGTGTGGTGGTGAATCTCTGTACTCC
CANCTCTTGGGTGGTTAAAGCAGGAGGATTGGGAATTCAAGGCCGGCTACACAGGGAGTTCT
TGTAGCTACACAGTGTAGCAAATCTTGGGCAGGGGAATTTCTGGGTTACTGCAAGGCCCTGG
GGAGGAGCAGATCCAATCTCAACTACACAGTAAAAACCTGCCAAAAAAATATTAAGAGTTCT
GTGTCTGCTGTGTTCTTTCTCCCTCCAGGTCTATACTCGCTATGGGAAGTGTTACACCTTTAAT
GCAGATCCTCAGAGTTCACTGCCCAGTAGGGCAGGCGGCATGGGTAGTGGCCTGGAGATCAT
GCTAGACATCCAGCAGGAGGAATACCTACCCTTATGGAGGGAGACAAGTATGCAGGCGGGA
AGGGGATAAGGGCCAGCTCATGGATGGGGCCTGGGCTCGNNTNTACCCCTGAAGGGGGGTN
TGAAGCCTCTCATCTCTGCTGNTCAACGAGACGCCNTTTCNAGGNTCATTCGAGGCAGGGAT
CCGGGTGCAGATCCACAGCCAGGAGGAGCCGCCCTACATCCACCAGCTGGGGTTcGGCGTGT
CCCCAGGCTTCCAGACTTTTGTGTCCTGCCAGGAACAGCGGGTGAGCATCCCCAGCTAGGCC
TAGGCTGGGCACAGGGCAACTCACTGCTTAAAGGGATGCTGGCCACATCTGCCTGGCAGATA
CTCAGTCTGCCAGCCCCATGGCCCTGGCTGGGGCTATTGACACTGGAGGACTGGCCCTGATG
GACACGCTTGGCCTTGACCTTGTCATGCCCCATCTCTGCAGCTAACTTATCTGCCCCAGCCTT
GGGGCAACTGCCGGGCGGAAAGCGAGCTCAGGGAGCCTGAGCTTCAGGGCTACTCAGCCTA
TAGTGTGTCTGCCTGCCGACTGCGCTGTGAGAAGGAGGCCGTGCTTCAGCGCTGCCACTGCC
GGATGGTGCACATGCCAGGTGGGCACCTCCAGCCAGTCTTTGGTGCCACTCTTCTGAGCTCCC
GAACTTCCAGGAGGCAGAGATGCATGCGTACCACATGTACACGCATCTACACGCATGAGCGT
GTGCTCATGTGTATGTCTGGATACTTACACATGGGTTCGTATACTTGGGAGCGCATAGATGTG
CATGCTTGCGTGCATGCTAATATATATTCGTGGGTATGTGTTTTGGGGCTGTGTGCATGACCC
GAAGACTGTAACATGATTGTGTAAGCAAATGTGCAATTACCTGCATATGTGTATGTATGCATT
TTTACTGTTTTTATGCGTGTGTGTGTGTATATACATTGAACTGTTATGCATATGTGTAAACATG
CATACATGTAGATGTCTACACAGGTGTGTGGTGAGGGAGAAGGGAAAGGACTGTAGATCTCA
GAACTGTT 
(c) 
GAGCAGGATTGATAGGATAGCAAGAGTTCTGAGCCTGGTGTGGTGGTGAATCTCTGTACTCC
CAGCTCTTGGGTGGTTAAAGCAGGAGGATTGGACTAGTGAATTCCGATCATATTCAATAACC
CTTAATATAACTTCGTATAATGTATGCTATACGAAGTTATTAGGTCTGAAGAGGAGTTTACGT
CCAGCCAAGCTAGCTTGGCTGCAGGATCCGAGCTCTAGCGAAGTTCCTATTCCGAAGTTCCTA
TTCTCTAGAAAGTATAGGAACTTCGCTAGCGTCGAGGATTGTGTAAGCAAATGTGCAATTACC
TGCATATGTGTATGTATGCATTTTTACTGTTTTTATGCGTGTGTGTGTGTATATACATTGAACT
GTTATGCATATGTGTAAACATGCATACATGTAGATGTCTACACAGGTGTGTGGTGAGGGAGA
AGGGAAAGGACTGTAGATCTCAGAACTGTTC 
(a) 
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Figure 7.3 Genotyping of WT and KO ASIC4 mice. (a) WT, heterozygous and KO bands 
produced by PCR. Sequence of gDNA extracted from PCR bands showing (b) WT and 
(c) KO ASIC4 genes. Primer complement sequences are in green, loxP sites are in blue, 
FRT sites in purple and residual plasmid regions in red. Sequence regions confirmed by 
Sanger sequencing are underlined.   
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7.3.2 ASIC4 is expressed in mouse brain and spinal cord 
In order to determine the expression pattern of ASIC4 in the nervous system, both 
qualitative and quantitative RT-PCR were performed using tissue from adult mice at 8 
weeks of age. 
RT-PCR was performed on cDNA from wild-type mouse tissues using primers specific 
to ASIC4, designed to target exons 2 – 4 and to overlap exon-exon junctions (Table 7.3). 
A band of 147bp was produced (Figure 7.4a) which was consistent with the mRNA 
sequence length produced on NCBI Primer BLAST. Bands were produced in cortex, 
cerebellum and spinal cord while liver was used as a negative tissue control and no band 
was seen in the negative template control or in any tissue taken from the ASIC4 KO. 
Importantly, only a very faint band was seen in WT DRG though this was reproduced 
when repeated. All samples, excluding the no template negative control produced bands 
of 200bp when targeted with primers to GAPDH.  
These data were confirmed using quantitative RT-PCR and results were normalised to 
GAPDH before being displayed as a ratio of ASIC4 expression in the cortex (Figure 
7.4b). The qPCR suggests ASIC4 expression in adult DRG is negligible as levels were 
comparative to the liver negative control tissue. This is in line with findings from other 
groups, who report little or no ASIC4 expression in adult DRG and indicates that overlap 
of ASIC4 and ASIC3 is likely to be minimal and therefore that ASIC4 influence on 
ASIC3 function is unlikely to be of major physiological relevance. It is still possible that, 
as (Lin et al., 2015a) report, that ASIC4 is expressed in DRG early in development. 
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Gene Forward Primer Reverse Primer WT band KO band 
ASIC4 5’- 
GGAGGGAGACAAACGAGACG 
5’- 
AAGTTAGCCGCTGTTCCTGGC 
147bp No band 
GAPDH 5’- 
TGCGACTTCAACAGCAACTC 
5’-CTTGCTCAGTGTCCTTGCTG 200bp 200bp 
Table 7.3 ASIC4 cDNA primers 
 
 
 
 
 
 
 
 
Figure 7.4 ASIC4 transcript expression in cortex, cerebellum, spinal cord, DRG and liver. 
(a) RT-PCR bands show GAPDH expression in all tissue from WT and KO mice; ASIC4 
expression was only observed in cortex, cerebellum and spinal cord of WT mice but not 
in any tissue taken from KO mice. (b) qRT-PCR expression shown relative to GAPDH 
expression using the 2-ΔΔCt method confirms expression of ASIC4 in cortex, cerebellum 
and spinal cord with only negligible expression in DRG and the negative tissue control, 
liver.  
              WT                            KO 
GAPDH 200bp 
ASIC4 147bp 
(a) 
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7.3.3 ASIC protein expression 
This work was performed by Queensta Millet. 
A Western blot was performed to quantify the expression of ASIC1 in the brain, spinal 
cord and DRG of ASIC4 KO mice, compared to WT controls, as well as to investigate 
alteration of ASIC4 protein expression in these tissues. In vitro data suggests that ASIC4 
alters levels of total protein of other ASIC subunits so a Western blot was necessary to 
investigate if these changes occur in vivo following ASIC4 deletion.  
β-actin was used as a loading control for each lane (43kDa) and a peptide control antigen 
was used in each tissue to confirm the specificity of the ASIC band.  
An antibody targeted to ASIC4 (Alomone) showed staining at around 65kDa; the 
estimated mass of the mouse protein on the Uniprot database is 59.22kDa suggesting the 
presence of post-translational modifications which increase the size of the protein (Figure 
7.5a). Due to the fact that the ASIC4 antibody epitope is tagged to the N-terminus and the 
region encoding this was not deleted in the KO, a truncated protein may be produced in 
KO tissue. A peptide mass search estimated the size of the ASIC4 band would be 
24.63kDa in KO tissue, however, as the blot shows, the band in KO tissue was the same 
size as in WT tissue. Moreover, the strong band present in DRG is not in line with the 
results obtained from RT-PCR which suggest that ASIC4 DRG expression is negligible. 
Although the use of a control peptide antigen led to loss of the bands, it is likely that the 
ASIC4 antibody is not specific to this subunit and that the bands are produced through 
non-specific binding to other ASIC subunits as the epitope tag of this antibody is targeted 
to the N terminus which is homologous in many ASIC subunits.  
An anti-ASIC1 antibody which recognises both ASIC1a and ASIC1b splice variants 
produced bands in both ASIC4 WT and ASIC4 KO tissue from DRG, spinal cord and 
brain at 65-70kDa (Figure 7.5b). In the spinal cord and brain a doublet band was produced 
however it is unlikely that this is representative of the two splice variants as ASIC1b 
expression is only reported in the DRG though this could be confirmed through RT-PCR. 
Instead it is possible that one in spinal cord and brain there are some tissue-specific post-
translational modifications to the ASIC1a subunit as this antibody has been shown to be 
specific to ASIC1 (Wemmie et al., 2003). Quantification of band intensity in WT and KO 
tissue relative to β actin controls showed that no significant change in ASIC1 expression 
levels occur following loss of ASIC4 (Figure 7.5c). 
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No ASIC3 antibody was used as the negligible expression of ASIC4 in DRG where 
ASIC3 is almost exclusively expressed renders it unlikely that the two subunits interact 
in-vivo. 
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Figure 7.5 Quantification of ASIC4 protein expression (a) ASIC4 protein is present in 
DRG, spinal cord and brain at 70kDa in WT and KO tissue but is lost in the presence of 
the peptide control. (b) ASIC1 protein expression in ASIC4 WT and ASIC4 KO tissue 
was detected in DRG, spinal cord and brain. A loading control, β actin antibody shows 
expression in all tissues at 43kDa. (c) ASIC1 protein levels relative to βactin in ASIC4 
WT and KO tissue from DRG, spinal cord and brain; ASIC1 expression levels are not 
altered in ASIC4 KO.  
anti-ASIC4 
(a) 
β Actin 
DRG    S.C    Brain  DRG   S.C   Brain DRG  S.C  Brain 
ASIC4 WT tissue    ASIC4 KO tissue     WT tissue+ Peptide 
70kDa 
40kDa 
anti-ASIC1 
(b) 
β Actin 
DRG    S.C     Brain  DRG   S.C     Brain DRG   S.C    Brain 
ASIC4 WT tissue    ASIC4 KO tissue     WT tissue+ Peptide 
70kDa 
40kDa 
(c) 
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7.3.4 Behavioural characterisation of ASIC4 knockout mice 
ASICs have been repeatedly shown to play a role in mechanosensory and nociceptive 
function which has often been demonstrated at the behavioural level (See sections 1.5.3, 
1.5.4). We hypothesised that inhibiting the function of ASIC4 may produce an altered 
pain phenotype as a result of differential expression of other ASIC subunits and used a 
thorough behavioural characterisation to achieve this. 
7.3.4.1 ASIC4 knockout mice develop normally and have normal motor coordination 
ASIC4 heterozygous (Het) mice were produced as described above and bred together to 
produce WT, KO and heterozygous animals. Out of 92 pups born, 28.3% were WT, 
42.3% were Het and 29.3% were KO; close to Mendelian ratios. This normal frequency 
of KO pups suggests loss of ASIC4 function is not developmentally lethal. Litters were 
also of expected sizes and mass of the animals was not different between groups (Figure 
7.6a). 
ASIC4 KO mice show a comparable amount of time to fall from an accelerating rotarod 
(59.79± 8.53s) compared to ASIC4 WT (63.04± 5.39s) and ASIC4 Het (49.17±5.87) 
suggesting that these animals have unimpaired motor coordination (p>0.05) (Figure 
7.6b). As a result, it is reasonable to assume that responses to subsequent sensory tests 
are not altered as a result of motor impairment. 
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Figure 7.6 ASIC4 KO mice show unimpaired motor coordination compared to WT and 
Het controls demonstrated by a comparable latency to fall from an accelerating rotarod. 
(Mass: WT, n=2; Het, n=3; KO, n=3; Rotarod, n=8 per group. Data are shown as 
Mean±SEM with one-way ANOVA with Tukey post-hoc test).  
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7.3.4.2 ASIC4 knockout mice show unimpaired responses to mechanical stimuli 
von Frey fibres were used to test the responses of animals to innocuous mechanical 
stimuli on the glabrous skin of the paw and the hairy skin of the abdomen (as hairy and 
glabrous skin are known to have differential innervation patterns). On the paw, the 50% 
withdrawal threshold for ASIC4 WT was 0.63±0.10g, ASIC4 Het were 0.54±0.07g and 
ASIC4 KO were 0.52±0.06g with no significant differences between groups (p>0.05 
between all groups) (Figure 7.7a).  
The noxious application of a blunt probe to the tail, in the Randall-Selitto test of 
sensitivity to noxious mechanical stimuli, led to similar responses in all groups. ASIC4 
WT, ASIC4 Het and ASIC4 KO, responded at forces 136.3±11.50g, 133.8±8.69g and 
140.4±9.89g, respectively (p>0.05) (Figure 7.7b). When the same probe was applied to 
the hind paw ASIC4 WT, ASIC4 Het and ASIC4 KO responded at forces 63.75±4.02g, 
84.79±6.82g and 72.50±12.28g, respectively but no significance was found in the 
different responses of these groups (p>0.05) (Figure 7.7c).   
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Figure 7.7 Mechanical sensitivity in ASIC4 KO mice is unaltered. (a) responses to von 
Frey hairs on hairy and glabrous skin (b) noxious mechanical sensitivity of the tail and 
(c) noxious mechanical sensitivity on the paw are comparable between all groups. (All 
tests, n=8 per group. Data are shown as Mean±SEM with one-way ANOVA with Tukey 
post-hoc test).  
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7.3.4.3 ASIC4 knockout mice have unimpaired responses to thermal stimuli 
The latency to respond to a thermal stimulus in the Hargreaves test were similar in all 
groups; ASIC4 WT (14.63±1.69s), ASIC4 Het (14.95±2.00s), ASIC4 KO (13.91±2.29s) 
(p>0.05) (Figure 7.8a). In the hot plate test, the latency to respond to temperatures of 50oC 
and 55oC were measured and support results from the Hargreaves test which indicate that 
ASIC4 does not play a role in noxious thermosensation. At 50oC, ASIC4 WT responded 
after 38.71±4.85s, ASIC4 Het after 35.43±3.48s and ASIC4 KO after 33.63±3.24s 
(p>0.05 between all groups). At 55oC ASIC4 WT responded after 15.43±1.81s, ASIC4 
Het after 14.34±0.95s and ASIC4 KO after 16.36±1.22s (p>0.05 between all groups) 
(Figure 7.8b). 
Sensitivity to a noxious cold plate was tested in a place preference set up. ASIC4 WT 
animals spent 8.85±5.93% time on a 4oC test plate in a 2 minute testing period and spent 
the remainder of the time on a baseline temperature plate (Figure 7.8c). ASIC4 Het spent 
8.23±2.56% time and ASIC4 KO spent 17.81±10.2% of the time on the test plate, 
suggesting no difference between ASIC4 WT and ASIC4 Het (p>0.05). 
In the acetone test, ASIC4 KO animals show a slight increase in pain behaviour compared 
to ASIC4 WT and ASIC4 Het groups, though these data are not significant (p>0.05) 
(Figure 7.8d).  
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Figure 7.8 ASIC4 has no role in thermosensation. Responses to (a) latent heat in the 
Hargreaves test, (b) noxious heat in the hot plate test, (c) noxious cold stimuli in the 
thermal place preference test and (d) cooling following Acetone application show that no 
change in thermal sensitivity occurs as a result of loss of ASIC4 function. (All tests, n=8 
per group. Data are shown as Mean±SEM with one-way ANOVA with Tukey post-hoc 
test for (a, d) and two-way ANOVA with Tukey post hoc tests for (b,c)).  
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7.3.4.4 ASIC4 knockout mice show altered responses to certain inflammatory stimuli 
7.3.4.4.1 Formalin Test 
The formalin test has two, well defined phases; the former is an acute phase linked to 
direct activation of nociceptive fibres while the second phase involves a more complex 
inflammatory response. ASIC4 KO mice show comparable pain behaviour to ASIC4 WT 
and ASIC4 WT animals in the first, acute phase. However, the ASIC4 knockouts show a 
significant increase in pain behaviour overall in the second phase of the formalin test. 
This was significant compared to both ASIC4 WT and ASIC4 Het (ANOVA p=0.03; WT 
v KO p=0.047 and Het v KO p=0.004) though not significant at any individual time point 
(Figure 7.9).  
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Figure 7.9 Loss of ASIC4 function has no effect on pain behaviour in phase I of the 
Formalin test though a partial but not significant increase in Phase II pain behaviour is 
observed. (n=6 per group. Data are shown as Mean±SEM with two-way ANOVA with 
Bonferroni post-hoc test *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001).   
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7.3.4.4.2 Complete Freund’s Adjuvant 
As ASIC4 KO mice show increases sensitivity in the inflammatory phase of the Formalin 
test, we tested sensitivity to another inflammatory agent, CFA. Following CFA injection, 
WT and Heterozygous mice developed both thermal and mechanical hypersensitivity. 
The 50% withdrawal threshold dropped from 0.47±0.06g to 0.21±0.17g by 24 hours while 
the response latency to the thermal stimulus dropped from 12.79±1.25s to 4.20±0.55s. At 
all time points tested following CFA injection, KO mice show comparable mechanical 
and thermal hypersensitivity to WT and Het groups (p>0.05 between all groups at all time 
points) (Figure 7.10).  
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Figure 7.10 Mechanical (a) and thermal (b) hypersensitivity induced by administration of 
CFA was present in ASIC4 KO mice and not significantly different from any other group 
at any time point. (n=6 per group. Data are shown as Mean±SEM with two-way ANOVA 
with Tukey post-hoc test). 
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7.3.4.5 ASIC4 knockout mice develop acute hypersensitivity in a model of acid 
induced muscle pain 
ASIC subunits have been implicated in a role in mediating deep tissue pain including 
musculoskeletal pain. If ASIC4 regulates the expression of these channels, it is possible 
that loss of function of ASIC4 will affect the normal development of mechanical 
hypersensitivity in a model of muscle pain. We used the established approach of 
administration of acidic saline into the gastrocnemius muscle and assessed mechanical 
hypersensitivity using von Frey testing and a weight bearing asymmetry measure. 
Control animals develop ipsilateral mechanical hypersensitivity by 4 hours after the first 
injection of acidic saline into the gastrocnemius muscle, which was still present at 24 
hours but by 3 days was beginning to resolve. KO animals developed hypersensitivity to 
the same extent and for the same duration as WT controls (Figure 7.11a). Although a 
slight decrease in withdrawal threshold developed by day 1 on the contralateral paw, this 
was not significant compared to baseline or between groups.  
The mechanical hypersensitivity shown by the change in 50% withdrawal threshold was 
not reflected by any change in weight bearing on the ipsilateral paw, which was not 
significantly different from baseline at any time point in control or KO groups (p>0.05 
between all groups at all time points) (Figure 7.11b). 
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Figure 7.11 ASIC4 does not contribute to mechanical hypersensitivity in a model of 
muscle pain. (a) ASIC4 KO mice developed hypersensitivity to the same extent as 
controls which was restricted to the ipsilateral side. (b) No significant weight bearing 
asymmetry was seen in either groups at any time point. (n=6 per group. Data are shown 
as Mean±SEM with two-way ANOVA with Tukey post-hoc test).  
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7.3.4.6 ASIC4 knockout mice show reduced hypersensitivity in a model of visceral 
pain 
ASIC subunits, ASIC1 and ASIC3, have been shown to have a role in pain and 
mechanosensation in the viscera; we used an established visceral pain model to determine 
whether ASIC4 has any role, direct or indirect in these functions. 
In the 20 minutes immediately following colonic administration of capsaicin visceral 
hypersensitivity was monitored through observing behaviours indicating pain. These 
include writhing, licking the abdomen and pressing the abdomen to the floor. WT mice 
showed an average of 38±5.81 pain behaviours compared to only 24.8±1.28 shown by 
KO mice (Figure 7.12a). This decrease was significant (p=0.04) demonstrating increased 
visceral nociception in ASIC4 KO mice.  
A 12.5% decrease was observed in the number of responses to 10 stimulations of the 
abdomen with a 0.16g von Frey filament in KO compared to WT mice, though this was 
not significant (p>0.05) (Figure 7.12b).  
 
Figure 7.12 Loss of ASIC4 function reduces pain behaviours following colonic 
administration of capsaicin (a) though no significant change in visceral mechanical 
hypersensitivity is observed (b). (n=5 per group. Data are shown as Mean±SEM with 
Student’s unpaired t test (a) and Mann-Whitney test (b) *p<0.05; **p<0.01; ***p<0.001; 
****p<0.0001).  
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7.4 Discussion 
ASICs have been widely studied for many years and have been shown to have roles in 
sensory functions including mechanosensation and pain. ASIC4, by comparison, is less 
well understood. The work of Donier et al. (2008) highlighted a potential modulatory role 
for this protein in vitro; the creation of an ASIC4 knockout mouse has allowed us to 
investigate whether this role is reflected in vivo and to better understand the contribution 
of this protein to sensory function.  
7.4.1 ASIC4 is expressed in the central nervous system 
In Chinese hamster ovary (CHO) cells, ASIC4 down regulates current density and total 
protein levels of ASIC1a and ASIC3 however its role in vivo has not been fully explored. 
If such a role is reflected in the nervous system, the loss of ASIC4 function may lead to 
increased levels of ASIC1 and ASIC3 in the cell which may, in turn, have pro-nociceptive 
effects. We began this study by confirming that a global knockout mouse had been 
successfully been produced through sequencing of genomic DNA products. We found 
expression of ASIC4 transcript in adult wild-type mouse cortex, cerebellum and spinal 
cord though we saw negligible expression in DRG. Other studies have produced 
conflicting results regarding ASIC4 expression in DRG. The first reports of ASIC4 by 
Akopian et al. (2000) found low levels of protein and Grunder et al. (2000) found no 
ASIC4 transcript in DRG; where both studies were performed in rat. Alvarez de la Rosa 
et al. (2002) reported ASIC4 protein expression in adult rat DRG, whereas an RT-PCR 
performed by Du et al. (2014) showed no expression in mouse DRG. A database produced 
by single cell RNA sequencing identified low levels of ASIC4 transcript in mouse DRG 
(Usoskin et al., 2015) and though Lin et al. (2015a) report expression in DRG during 
development, they did not observe it in adult tissue. It is possible that if ASIC4 is only 
expressed at low levels in DRG, as reported by Akopian et al. (2000) using in situ 
hybridisation, other techniques are not sensitive enough to identify its expression. For 
example, Lin et al. used a tdTomato reporter protein with an inducible Cre under the 
control of the ASIC4 promoter however a number of studies have demonstrated that the 
efficiency of this system can be dose and tissue dependent, including in peripheral 
neurons and DRG  (Hayashi and McMahon, 2002, Leone et al., 2003, Zhao et al., 2006).If 
the induction of Cre activity was not fully penetrant in the case of the ASIC4 CreERT2, 
it is possible that in the small number of cells expressing ASIC4 in DRG there was no 
recombinase activity or it was insufficient to produce visible expression of tdTomato. 
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Similarly, it is possible that the RT PCR used in the present study was not sensitive 
enough to detect low levels of ASIC4 in the DRG which were able to be detected through 
the single cell RNA sequencing performed by Usoskin et al. (2015). Alternatively, it is 
possible that there is a different expression pattern of ASIC4 in rat and mouse nervous 
tissue. This is the case with ASIC3 in rodents and humans for example, where rodent 
expression is predominantly seen in DRG and human expression is higher in the brain 
and spinal cord (Delaunay et al., 2012). Determining the expression pattern of ASIC4 is 
important because if it is not coexpressed with ASIC1 and ASIC3 then it is unlikely to be 
modulating their function; as ASIC3 is almost exclusively expressed in the periphery, 
findings in this chapter suggest that it is unlikely to be modulated by ASIC4 in vivo due 
to the likely negligible expression of ASIC4 in DRG. 
We performed a Western blot to determine whether loss of ASIC4 function alters levels 
of total ASIC1 protein. No significant difference was observed between levels of ASIC1 
protein expression in ASIC4 WT and ASIC4 KO tissue, which suggests that the in vitro 
role of ASIC4 is not reflected in vivo. However, it may be the case that the total ASIC1 
protein level is not altered in the cell; rather, there may only be a change in the levels of 
ASIC1 expression at the membrane if its ubiquitination state is altered as this could 
regulate the normal functional activity and trafficking of the protein. Performing the same 
Western blot using a membrane preparation could confirm this, but overall the current 
data do not allow an accurate conclusion to be drawn as to whether ASIC4 alters ASIC1 
protein expression in vivo. Importantly, Donier et al. (2008) reported the function of 
ASIC4 based on its expression in CHO cells. Though this is a mammalian cell line it is 
not neuronal; it is possible that the function of ASIC4 is context dependent and that this 
was not represented in this exogenous expression study. As such, it is likely that further 
features of ASIC4 function will be elucidated by in vivo studies. 
7.4.2 ASIC4 knockout mice show altered responses to inflammatory stimuli 
The major aim of this study was to determine the role of ASIC4 in sensory function in 
vivo with a particular focus on mechanosensation and nociception, both of which involve 
the function of other ASIC subunits. For example, ASIC1 and ASIC3 have roles in 
cutaneous inflammatory pain, visceral pain and mechanosensation as well as chronic 
muscle pain. If ASIC4 does contribute to these processes it could do so through 
modulation of other ASIC subunits as happens in vitro, or as a direct result of ASIC4 
activity.  
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ASIC4 global knockout mice were viable, developmentally normal and showed unaltered 
motor coordination in the rotarod test despite expression of ASIC4 in the cerebellum (Lin 
et al., 2015a). Although ASICs have been implicated in mechanosensation, our 
mechanical sensitivity tests did not identify any acute changes in mechanosensitivity in 
ASIC4 KO animals. Similarly, thermal sensitivity was unimpaired in KO mice. In a 
model of cutaneous inflammatory pain, produced by administration of CFA, mechanical 
and thermal hypersensitivity developed to the same extent and for the same duration as 
in WT mice. Staniland and McMahon (2009) found no role for ASIC1 in thermal or 
mechanical inflammatory hyperalgesia which was substantiated by the ineffectiveness of 
ASIC1 block with PcTx1, even though it has been shown that CFA induced thermal 
hyperalgesia can be prevented by administration of APETx2, an ASIC3 blocker (Deval 
et al., 2008). Our findings here indicate that both thermal and mechanical inflammatory 
hyperalgesia develop independently of functional ASIC4.  
ASIC4 KO mice showed a slight increase in the duration of pain behaviours in the second 
phase of the formalin test (Figure 7.9). While the first phase of the test is associated with 
direct activation of afferent neurons, the second phase is believed to represent an 
inflammatory response and increased activity in neurons in the dorsal horn of the spinal 
cord (Abram and Yaksh, 1994, Ji et al., 1999). If indeed peripheral expression of ASIC1 
and/or ASIC3 is altered by loss of ASIC4 function, the partially augmented pain 
behaviour we observed in the second phase of the formalin test may be due to this 
negative regulation of ASIC expression by ASIC4 and consequent heightened sensitivity 
of peripheral neuron to inflammatory mediators. Moreover, at the spinal cord level, 
upregulation of ASIC1a could also account for the hypersensitivity observed in the 
second phase of the formalin test. Duan et al. (2007) and Baron et al. (2008) showed that 
ASIC1a is a major contributor to ASIC currents in the dorsal horn and levels of ASIC1a 
transcript are increased in spinal cord following inflammation (Wu et al., 2004). ASIC1a 
antagonists such as PcTx1 have been shown to reduce inflammatory hyperalgesia (Dube 
et al., 2005, Duan et al., 2007) and Mazzuca et al. (2007) showed that intrathecal block 
of ASIC1a produces analgesia through activation of endogenous enkephalin pathways. 
These data indicate ASIC1 has a pro-nociceptive role in inflammatory pain, which 
supports the possibility that ASIC4 KO mice have an upregulation of ASIC1 that 
underlies the increased pain behaviour we observed. In contrast to this, Staniland and 
McMahon (2009) report that ASIC1a KO mice show increased pain behaviour in the 
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formalin test, as do mice where all ASIC currents are abolished (Mogil et al., 2005) which 
would suggest that the phenotype observed in the ASIC4 KO is not dependent on changes 
which occur in ASIC1 expression.  
A model of visceral inflammation involving colonic administration of capsaicin produces 
spontaneous pain behaviours and hypersensitivity to von Frey hairs applied to the 
abdomen. Previously, it has been shown that ASIC1 KO mice show increased activity in 
visceral mechanoreceptors (Page et al., 2004). The current data shows ASIC4 KO leads 
to reduction in both pain behaviours and mechanical hypersensitivity. This is consistent 
with a role for ASIC4 in upregulation of ASIC1 protein levels as the opposite phenotype 
was observed to data published using ASIC1 KO mice.  
The increased sensitivity of ASIC4 knockout mice in the formalin test along with the 
decreased sensitivity in the model of visceral inflammation and the normal phenotype in 
the CFA model of cutaneous inflammation are difficult to reconcile given that all are 
based on types of inflammatory pain. In the formalin test ASIC4 KO mice show an 
increase in pain behaviour whereas following administration of CFA no hypersensitivity 
was observed. It is possible that no hypersensitivity was observed in the latter test as a 
result of limitations of the behavioural assessment approaches used or a ceiling effect of 
the dose of CFA; using a milder inflammatory stimulus may produce a similar outcome 
of increased hypersensitivity in the formalin test. Alternatively, it is also possible that 
these inflammatory models are regulated by different mechanisms which do not both 
involve ASICs, as other groups have observed similar discrepancies in ASIC contribution 
in different models of inflammatory pain (Mogil et al., 2005, Staniland and McMahon, 
2009). It is important to mention that structures such as the viscera and skeletal muscles 
are differentially innervated than cutaneous structures and it has been shown that the 
relative contribution of ASICs  to nociceptive signalling depends on the neurons they are 
expressed in (e.g. (Page et al., 2004)). This highlights the importance of investigating the 
effect of ASIC4 KO in multiple models of pain. Nonetheless, it is a recurring issue in 
studies using transgenic approaches to determine ASIC function that ASICs have been 
shown to be both pro- and anti-nociceptive, thus complicating conclusive findings on 
ASIC function in normal and pathophysiological pain. 
Intramuscular injection of acidic saline is a widely used model of muscle pain, where 
repeated injections of saline produce chronic hypersensitivity (Sluka et al., 2001). ASICs 
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are expressed in afferents innervating skeletal muscle, in particular ASIC3, and have been 
shown to play a role in mediating the development of hypersensitivity and, critical to this 
study, the development of spinal sensitisation following acid injection which induces a 
localised increase in protons. We used a single injection of acidic saline to model acute 
muscle pain which produced significant mechanical hyperalgesia on the ipsilateral paw 
of WT mice. Unlike some reports from Sluka and colleagues (Sluka et al., 2001), the 
current data show that no contralateral hypersensitivity developed in WT mice. Similarly, 
ASIC4 KO mice developed ipsilateral but not contralateral hypersensitivity to the same 
extent as WT controls and neither group showed a significant weight bearing asymmetry 
suggesting ASIC4 has no direct role in development or maintenance of secondary muscle 
hyperalgesia. Sluka et al. (2003) observed that although ASIC3 was necessary for 
mechanical hypersensitivity, ASIC1a was not. Mogil et al. (2005) reported that inhibiting 
ASIC currents led to hypersensitivity to intramuscular acidic saline which contradicts the 
findings of Sluka et al, though this was attributed to a strain difference in the mice. Sluka 
et al. used mice with a C57BL/6 background which is consistent with our ASIC4 KO 
mice. As such, though the current data rule out a direct role for ASIC4 in acid-evoked 
muscle pain, it is still possible that ASIC4 regulates ASIC1, and since ASIC1 is not 
involved in muscle pain no phenotype was observed in this model. 
While these data are insufficient to conclude whether ASIC4 regulates other ASICs in 
vivo, they suggest that such a function is possible with regard to ASIC1 and unlikely for 
ASIC3 due to the negligible DRG expression of ASIC4. This is consistent with the 
findings of Lin et al. (2015a) who performed assessment of their own, different ASIC4 
KO mouse. Moreover, they highlight that ASIC4 function influences hypersensitivity in 
some cutaneous and visceral inflammatory pain conditions. 
7.4.3 Understanding the function of ASIC4 
A distinctive feature of ASIC4 is its insensitivity to protons. ASIC2b is also insensitive 
to protons. However, by heteromerising with other, pH sensitive channels ASIC2b is able 
to modulate their gating properties, thereby having an indirect effect on proton sensitivity 
(Lingueglia et al., 1997). However, if ASIC4 is mutated in ways which cause constitutive 
activation of ASIC2b it remains insensitive to protons (Grunder et al., 2000). Also, 
ASIC2b is able to contribute to proton sensitive heteromeric complexes though it is 
unlikely that ASIC4 does the same as a pull-down assay did not identify other ASIC 
subunits as binding partners for ASIC4 (Donier et al., 2008). It has been suggested that 
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the proton sensitivity of ASICs may not determine their primary function as the rapidity 
and degree of pH drop required to activate them is rarely seen in physiological conditions. 
Examples of non-proton ligands have been described for a number of ASIC subunits (see 
section 1.5.4) which alter their proton sensitivity and can cause direct activation of ASICs. 
Specific residues in ASIC3 have been shown to be the site of a ligand binding domain 
which is distinct from the proton binding site (Yu et al., 2010). Understanding the 
contribution of other ligands to ASIC function is crucial for both understanding the 
contribution of their proton sensitivity in physiological conditions and potentially 
elucidating other functions such as in mechanosensation where lipid activators may be 
influential. It is possible that ASIC4 is also bound by non-proton ligands; it is particularly 
highly expressed in the pituitary gland where many peptides are secreted. A snail ENaC 
orthologue of ASICs is only activated by a neuropeptide and when first cloning ASIC4 
and discovering it was proton insensitive, Grunder et al. (2000) suggested this may be 
true for ASIC4. The presence of a large extracellular domain in all ASIC subunits has 
also fostered the idea of ligands other than protons as it seems unlikely such a structure 
exists merely to sense protons (Wemmie et al., 2006). It is possible that through its 
extracellular domain, ASIC4 binds other non-proton ligands or that it interacts with 
extracellular matrix, as is the case with ASIC orthologues in C.Elegans (Gu et al., 1996), 
in a way which influences its function. 
ASIC4 was determined as a member of the acid sensing ion channel family because of its 
amino acid sequence, however it bears some crucial differences to other ASICs in its 
structure. This includes more N-linked glycosylation sites in the large extracellular 
domain of the protein. N-linked glycosylation of ASIC1a has been shown to regulate 
efficiency of trafficking to the cell membrane which in turn affects current density (Jing 
et al., 2011) while mutating these residues in ASIC2a reduces proton affinity and current 
amplitude, demonstrating the influence of N-linked glycosylation on channel function 
(Saugstad et al., 2004). Two N-glycans present in ASIC1b but not ASIC1a are necessary 
for its expression and function; ASIC4 is the only other ASIC subunit to contain these 
two N-linked glycosylation sites (Delaunay et al., 2012). It has been proposed that these 
may contribute to protein folding and stabilisation and this same group also report that all 
eight glycosylation sites in ASIC4 are likely to bind glycans suggesting a drastically 
different extracellular domain is present in ASIC4 compared to other ASIC subunits. In 
addition to this, a pull down assay used to identify proteins which interact with ASIC4 
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found that the protein interacted with substantially fewer proteins than other ASIC 
subunits (Donier et al., 2008). Its N-terminus has five lysine residues which have the 
potential for ubiquitination and this has already been shown to alter its expression and 
function in vitro as well as providing a possible mechanism by which presence of ASIC4 
reduces expression of other ASIC subunits. As such, pursuing a better understanding of 
the structurally unique features of ASIC4 are likely to provide critical insight into its 
function. 
The current data suggest that ASIC4 is unlikely to have a major role in acute nociception 
though it appears to be important in inflammatory pain. Thus far, it does not provide us 
with a mechanism by which inhibiting ASIC4 function alters noxious sensation. 
Speculating that its functions in vitro translate to ASIC4 function in vivo, it is reasonable 
to assume that modulating the functional expression of other ASICs is one way in which 
these changes could be occurring. However, it remains possible that ASIC4 itself is 
directly activated by non-proton ligands which have shown to be able to activate other 
ASICs. As a result of its expression in the pituitary gland, Lin et al. investigated the effect 
of loss of ASIC4 function on body weight and composition and activity in the cage but 
found no changes in KO mice (Lin et al., 2015a). However, peptide release from the 
hypothalamic-pituitary axis has been linked to pain sensation. For example, 
corticotrophin-releasing factor (CRF) attenuates bone cancer induced mechanical 
allodynia (Fan et al., 2015). If ASIC4 is sensitive to neuropeptides produced by the 
pituitary gland it is possible that its function in the spinal cord is also mediated by their 
presence. Obtaining a complete understanding of ASIC4 function in pain will require 
investigations into its role in areas where it most highly expressed, including the pituitary 
gland and in specific cell subtypes in the cortex, subcortical structures and cerebellum 
and importantly these supraspinal structures that are involved in central nociceptive 
processing and top-down modulation of spinal cord excitability. 
7.4.4 Future work 
The work produced in this study has begun to demonstrate roles for ASIC4 function in 
the nervous system. Corroborated by the findings of Lin et al. (2015a), it suggests that 
ASIC4 function is not involved in acute nociception though it influences cutaneous and 
visceral inflammatory pain. At the behavioural level, it appears that ASIC4 contributes to 
spinally mediated hypersensitivity in the inflammatory phase of the formalin model. In 
order to determine the mechanism underlying this phenotype, it would be interesting to 
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perform spinal cord recordings to see if there is hyperactivity of spinal neurons after 
inflammatory insults. 
In order to determine if there is a role for ASIC4 in mediating ASIC1a expression in the 
cell membrane, more work needs to be done. Performing a Western blot focussing on 
protein expression in the cell membrane may provide more insight than the whole cell 
protein lysate study performed so far.  
It may also be interesting to determine whether impairing the function of ASIC4 alters 
expression of other genes in areas where it is highly expressed through use of a microarray 
or RNA sequencing. If the primary function of ASIC4 is modulatory of other ASICs, 
expression arrays would be useful; however, as its modulation of ASIC1 in vitro was 
post-translational it may be more helpful to investigate further the functional links to its 
protein binding partners identified by (Donier et al. (2008)). 
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8 Summary 
The work in this thesis used transgenic techniques to explore the mechanisms responsible 
for pain and mechanosensation in physiological and pathological conditions which 
remain incompletely understood. 
Characteristic features of TRP channels include their high structural homology and their 
propensity to form heteromeric complexes which suggests potential functional 
redundancy. Using a novel, multiple knockout approach we examined both touch and 
hearing in behavioural and electrophysiological assays, and provide evidence that 
TRPC1, TRPC3, TRPC5 and TRPC6 multiple knockout mice have deficits in innocuous 
mechanosensation as well as in hearing and vestibular function. In some cases, these 
deficits were larger than the deficits found in double KO mice which have previously 
been shown to be critical for normal touch sensation, suggesting a combinatorial role for 
these channels in light touch and hearing. Importantly, mechano-electrical transducer 
currents of cochlear outer hair cells were normal. This suggests that TRPC1, TRPC3, 
TRPC5 and TRPC6 channels contribute to cutaneous and auditory mechanosensation in 
a combinatorial manner, but have no direct role in cochlear mechanotransduction.  
Pain in Osteoarthritis represents a huge, unmet clinical need as existing analgesics are 
often ineffective or produce undesirable side effects with chronic use. For reasons stated 
above, we used multiple knockout approaches to examine the combined roles of putative 
mechanosensory TRP channels in mechanical hypersensitivity in OA. Using the MIA 
model of OA we, surprisingly, found no role for TRPC3, TRPC6 or TRPV1 in mechanical 
hypersensitivity. However our data suggest that TRPA1 is necessary for the complete 
manifestation of mechanical hypersensitivity in OA. Until now, the MIA model has been 
widely used in rats where pharmacological compounds have been tested for their 
analgesic efficacy. This multiple knockout approach therefore provides a novel insight 
into the role of key pain mediators in OA as well as taking into account the potential 
influence of heteromerisation or functional redundancy which other monogenic studies 
may have been unable to do. 
We have firmly established a role for Annexin A6 in negative regulation of 
mechanosensation. This was demonstrated using knockout animals which show increased 
behavioural responses to noxious mechanical stimuli. Annexin A6 reduces IA current 
responses in sensory neurons and attenuates the current produced by the primary 
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mechanotransducer, Piezo2 in heterologous expression systems. Critically, we 
demonstrate that virally mediated overexpression of Annexin A6 is a viable gene therapy 
approach for reducing mechanical hypersensitivity in OA. These findings demonstrate a 
previously unidentified regulatory mechanism of cutaneous mechanosensation and 
provide an exciting insight into a potential, clinically relevant approach to treating pain 
in OA. 
Finally, we identified a role for ASIC4 in formalin induced pain and potentially in visceral 
pain and mechanical hypersensitivity. This is the first report of such a role for this poorly 
understood protein and suggests that further investigation may elucidate more about the 
contribution of acid sensing ion channels to nociceptive function. 
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